Last updated: June 14, 2026
Back to directoryCompare products by workflow fit, risk tier, review boundary, and the first source-backed claims to verify before a pilot.
These clusters connect product profiles with adjacent workflow pages and alternatives where the site already has relevant search footholds.
Current search demand around VisualDx overlaps with visual diagnosis, clinical decision support software, picture diagnosis, dermatology AI, and pricing or login checks. Compare the workflow before treating VisualDx as the right product.
Related searches: visual dx · visual diagnosis · clinical decision support software · picture diagnosis · visualdx login
| Product | Why compare | Workflow guide |
|---|---|---|
| VisualDx | Clinicians and educators who need image-rich differential diagnosis support, skin-of-color representation, patient education visuals, and supervised dermatology decision support. | clinical decision support AI · ai for medical diagnosis · dermatology AI tools · best ai for medical questions |
| Isabel DDx Companion | Compare when the main need is differential diagnosis generation from clinical features rather than image-rich dermatology reference. | Clinical evidence and questions |
| Glass Health | Compare when clinicians want AI-assisted differentials and plan drafting with a broader clinical reasoning workflow. | Clinical evidence and questions |
| UpToDate Expert AI | Compare when the buying criterion is evidence-backed answer retrieval from a widely used clinical reference base. | Clinical evidence and questions |
| DermaSensor | Compare only for clinician-used skin lesion assessment where regulated device status and lesion workflow matter more than reference content. | Medical imaging and radiology |
Current search demand around Caris Life Sciences overlaps with Caris testing, precision oncology companies, precision medicine companies, life sciences labs, and portal or access checks. Compare Caris in the context of oncology data, molecular profiling, and tumor board workflow.
Related searches: caris · caris life sciences · caris testing · precision oncology companies · precision medicine companies
| Product | Why compare | Workflow guide |
|---|---|---|
| Caris Life Sciences | Oncology teams evaluating molecular profiling and AI-assisted insight workflows for cancer care and research. | oncology AI tools · laboratory AI tools · ai for clinical trial matching · best ai model for medical data analysis 2025 · ai for medical affairs |
| Tempus | Compare when the evaluation spans molecular testing, multimodal oncology data, imaging insights, and trial matching. | Precision medicine and data |
| SOPHiA GENETICS | Compare when genomic, radiomic, and multimodal analytics workflows are the main selection criteria. | Precision medicine and data |
| Guardant InfinityAI | Compare when precision oncology data, liquid biopsy context, and real-world evidence workflows are central. | Precision medicine and data |
| Flatiron Assist | Compare when point-of-care oncology pathway support and EHR-embedded treatment guidance matter more than molecular profiling. | Precision medicine and data |
| Product | Regulatory / FDA | Privacy | Evidence | Workflow |
|---|---|---|---|---|
| OpenEvidence | Treat as clinician-facing medical information and clinical reference support unless a deployment uses it for patient-specific clinical decision support that changes regulatory obligations. | Check user eligibility, PHI-entry policy, HIPAA-aligned processing claims, retention, sponsorship or network-profile terms, and whether organization-level agreements are available. | Verify every answer against the displayed citations and confirm which licensed journals, guidelines, or source partnerships are available for the clinical question. | Best governed as fast evidence lookup for verified clinicians, with local rules for patient-specific prompts, citation review, and documentation of decisions made outside the tool. |
| ClinicalKey AI | Treat as clinician-facing clinical reference and decision-support software; verify whether local use remains non-device CDS or creates regulated obligations because patient context and clinical recommendations may be involved. | Review HIPAA-compliant claims, encryption, query history, pseudonymized support access, institutional license terms, and whether prompts or patient details are shared with model or cloud partners. | Confirm the answer cites current licensed content that actually supports the claim, and sample high-risk specialty questions before trusting it in point-of-care workflows. | Best governed as a clinician-reviewed evidence lookup layer with local rules for patient-specific prompts, citation checking, flagged answers, and documentation outside the product. |
| UpToDate Expert AI | Treat as high-risk clinician-facing clinical decision support; confirm whether the exact use remains reference support or becomes regulated patient-specific CDS in the deployment setting. | Review UpToDate terms before entering patient context, because public terms restrict personal data and PHI for Expert AI; enterprise agreements may differ and should be checked directly. | Validate that each answer links to current UpToDate topics that support the recommendation, and sample complex specialty cases for assumptions, omissions, and hallucination handling. | Best governed as a clinician-reviewed UpToDate search layer with local rules for PHI, source checking, documentation, escalation, and when to consult primary guidelines or specialists. |
| Dyna AI | Treat as high-risk clinical decision-support retrieval rather than autonomous care; review whether local use remains clinician reference support and how DynaMed Decisions or shared-decision tools are separated. | Check institutional contract terms, because public AI terms prohibit HIPAA-protected or similar medical data input into AI tools and place responsibility for output review on the user. | Verify answers against DynaMed, DynaMedex, or Dynamic Health source links, update timestamps, and specialty coverage before using output in point-of-care decisions. | Best governed as a switchable AI/search mode inside existing EBSCO clinical content workflows, with clinician review, source checking, query reruns, and documentation outside the tool. |
| Glass Health | Treat differential diagnosis, treatment planning, triage, ambient insights, and encounter-specific recommendations as high-risk CDS; map every deployed function against FDA non-device CDS criteria, intended use, explainability, clinician independence, and any local medical-device obligations. | Review individual versus clinic or enterprise terms, BAA availability, prompts and outputs, audio and transcripts, EHR context, API payloads, payment data, support access, retention, de-identified or aggregated data, and whether service-improvement or model-training rights fit the deployment. | Require citation review, guideline currency checks, local chart audits, ambient transcript accuracy testing, drug-information verification, subgroup review, and clinician override tracking before using Glass outputs in patient-specific decisions. | Best governed as clinician-reviewed reasoning and documentation support with clear rules for when outputs may enter notes, orders, referrals, discharge instructions, patient handouts, or software workflows. |
| Consensus | Treat as research and education support, not clinical decision support or a diagnostic system. | Avoid entering patient-identifiable information unless contract and privacy terms explicitly support the use case. | Verify database coverage, study filters, Consensus Meter interpretation, and whether each cited paper supports the generated answer. | Best for literature discovery, study triage, and student or writer workflows where users manually review the underlying papers. |
| Elicit | Treat as literature-review and evidence-synthesis workflow software rather than patient-care decision support. | Use de-identified literature and project materials unless enterprise terms explicitly cover confidential or patient-related documents. | Validate search recall, screening decisions, extraction fields, source quotes, and PRISMA-style audit trail on the review topic before relying on outputs. | Best for systematic-review teams that keep human reviewer reconciliation, protocol documentation, and final appraisal outside the automation. |
| Scite | Treat as research support and citation-context analysis, not clinical decision support. | Avoid uploading PHI or confidential manuscripts unless the subscription and privacy terms cover that workflow. | Check coverage for the specialty, how citation statements are classified, and whether assistant summaries match the cited source context. | Best for claim checking, literature mapping, and manuscript review where humans still appraise study quality and clinical relevance. |
| Atropos Health | Treat as high-governance evidence generation and clinical-reference support; verify whether local use affects care decisions enough to trigger CDS, IRB, data-use, or policy review. | Confirm whether questions use local EHR data, federated network data, or de-identified inputs, then review data-use agreements, PHI handling, and Microsoft or EHR integration terms. | Require methods transparency for each real-world evidence report, including cohort definition, source network, statistical approach, uncertainty, and literature support. | Best for health systems and life-sciences teams that can route outputs through clinician, methods, data-governance, or medical-affairs review before action. |
| Doximity Ask | Treat as clinician workflow support unless a local deployment uses it for regulated clinical decision support; verify intended-use claims before point-of-care reliance. | Doximity states HIPAA-compliant protocols, PHI support, and encryption in transit and at rest; confirm contract, retention, audit, and enterprise controls for organization use. | Support materials say responses can use referenced evidence and preferred journals; clinicians still need to check sources and hallucination warnings. | Best evaluated as a clinician-authenticated assistant for first drafts, education, translation, document review, and clinical reference inside Doximity. |
| Medwise AI | Treat as clinical information and research support rather than a regulated medical device based on the public terms, but review any local deployment that uses patient context, uploaded files, or care-pathway decisions. | Review the terms and privacy notice before entering patient context because public terms restrict personal, confidential, privileged, proprietary, or sensitive uploads and the app separately warns against identifiable medical-image and PII uploads. | Require clinicians to open and verify the displayed source passages, UK SPCs, local guidance, literature, and no-answer behavior before relying on a generated summary. | Best governed as a clinician-reviewed lookup layer for UK practice, with local rules for prompt content, uploaded files, recordings, source checking, and documentation outside the tool. |
| AvoMD | Treat as clinical decision support whose risk depends on the pathway, calculator, automation, and intended use; verify whether any local workflow needs FDA, SaMD, or institutional CDS review. | Review PHI flow through EHR integration, prompts, analytics, user access, retention, vendor subprocessors, BAA terms, and security documentation before enabling patient-context workflows. | Require current guideline sources, local approver records, logic transparency, test cases, and monitoring for outdated or unsafe pathway behavior. | Best deployed through a clinical governance process with named pathway owners, version control, clinician override paths, and staged rollout monitoring. |
| VisualDx | Treat as clinician-reviewed clinical decision support and dermatology image-analysis support; confirm whether the selected function is non-device CDS, educational reference, or a regulated workflow in the deployment jurisdiction. | Review institutional privacy and security terms before uploading patient photos or using mobile image analysis, including consent, retention, account access, API use, and whether an enterprise agreement or BAA is required. | Validate performance and usability with local clinicians across skin tones, ages, body locations, common mimics, rare diagnoses, and referral thresholds rather than relying on image-search convenience alone. | Best governed as supervised differential support with clinician confirmation, source review, documentation outside the tool, escalation rules for dangerous rashes, and clear patient-education boundaries. |
| Isabel DDx Companion | Treat as high-risk clinician-facing diagnostic decision support; verify local SaMD, CDS, EHR integration, and institutional review requirements before relying on patient-specific outputs. | Review PHI entry, EMR extraction, API data flow, hosted service terms, access controls, audit logs, BAA or DPA coverage, and retention before using real patient records. | Validate top-differential behavior, red-flag coverage, rare-disease handling, evidence links, drug-related symptom suggestions, and false reassurance risk against local cases and clinician review. | Best governed as a differential broadening and teaching aid with accountable clinician review, documentation outside the tool, escalation rules, and monitoring for missed or over-weighted diagnoses. |
| Causaly | Treat as biomedical research and R&D decision-support infrastructure unless a deployment supports regulated submissions or care decisions; then require study-specific validation, audit, and compliance review. | Review enterprise terms for internal documents, private data, third-party data, AI-agent access, retention, customer IP, and any patient-derived or confidential dataset before deployment. | Validate factual grounding, source traceability, graph provenance, no-answer behavior, and expert-review requirements for each target assessment, indication search, or regulatory-evidence workflow. | Best governed as a repeatable scientific research workspace with named reviewers, versioned evidence packages, documented assumptions, and escalation for uncertain or unsupported conclusions. |
| AMBOSS AI Mode | Treat as clinical reference, medical education, and evidence-navigation support unless a local deployment uses patient-specific context in a way that triggers clinical decision-support or medical-device governance. | Review AMBOSS privacy, institutional-license terms, prompt policies, upload handling, account data, retention, processor roles, and whether PHI or identifiable patient context is permitted before clinical use. | Require users to open the linked AMBOSS articles, guidelines, drug references, and selected external sources because AI Mode is still an evidence-navigation layer that needs human verification. | Best governed as a source-backed lookup and learning assistant with explicit rules for clinical use, student assignments, patient-specific prompts, source checking, and documentation outside the tool. |
| Abridge | Position it as clinician documentation support unless a local workflow extends it into coding, prior authorization, or other regulated decision support that needs separate review. | Review the contract path for BAA terms, recording consent, retention, training-data use, and security documentation from the trust center before piloting with PHI. | Pilot with specialty-specific encounters and measure missing facts, hallucinated text, source-to-note provenance, and clinician edit burden. | Best evaluated where note provenance, clinician review, and direct EHR insertion are required inside enterprise documentation workflows. |
| Ambience Healthcare | Treat it primarily as documentation and revenue-support workflow software unless local use expands into clinical guidance or order support that changes the review burden. | Confirm how PHI is processed under customer agreements, whether a BAA applies, and how recordings, transcripts, and downstream chart data are retained and secured. | Validate specialty-specific documentation, coding, and CDI performance on real encounters before expanding beyond a controlled pilot. | Most relevant for organizations that want one vendor spanning chart prep, ambient capture, note generation, and post-visit documentation tasks inside supported EHR workflows. |
| Nuance DAX Copilot | Treat it as documentation support rather than autonomous clinical decision support unless a connected workflow adds higher-risk reasoning or coding automation. | Review Azure-hosting, recording, retention, HITRUST/security documentation, and the exact Microsoft or Nuance contract path for PHI handling and business-associate terms. | Measure documentation quality, specialty fit, review burden, and any vendor-published productivity claims against your own clinician pilot. | Best suited to organizations already aligned with Dragon, Microsoft Cloud for Healthcare, and supported EHR insertion workflows. |
| Microsoft Dragon Copilot | Treat documentation as lower-to-medium risk, but review radiology reporting, coding suggestions, order capture, and decision-support features separately because each can change regulatory and clinical accountability. | Review Microsoft healthcare contract terms, Azure/security documentation, role-based access, audit controls, recording and transcript retention, EHR integration permissions, third-party reference content, and business-associate coverage before PHI use. | Validate Dragon Copilot's output against real specialty encounters, radiology reports, nurse flowsheet workflows, cited medical references, and Microsoft transparency limits instead of relying on broad productivity claims. | Best governed as a role-specific clinical workspace with deployment checklists, user acceptance testing, local configuration, clinician review, EHR insertion checks, and separate approval for automation beyond note drafting. |
| Oracle Health Clinical AI Agent | Treat chart review and care-related summaries as higher-risk clinical decision support because outputs use patient-specific EHR data; planned administrative or patient-facing features need separate intended-use review. | Review Oracle Health security materials, EHR access permissions, audit logging, incident reporting, data residency, and contract terms before enabling patient-specific workflows. | Validate source links, summary completeness, missed data, hallucinated facts, and workflow-specific recommendations against representative charts before clinicians rely on outputs. | Best governed as an embedded EHR agent with role-based permissions, source review, clinician judgment, exception escalation, and clear separation between live and planned functionality. |
| AWS HealthScribe | Treat it as documentation infrastructure for draft notes; review the finished application, specialty scope, EHR insertion, and any clinical-decision or coding extensions separately. | Design PHI controls across the full AWS workflow, including BAA eligibility, S3 storage, customer-managed keys, IAM, retention, logging, application databases, and downstream EHR integrations. | Use transcript evidence mapping during pilots and measure factual completeness, factual correctness, speaker attribution, omitted observations, hallucinated text, and performance under noisy or complex encounters. | Best governed as a builder platform with explicit clinician review, correction capture, exception handling for unsupported visits, and monitoring for audio-quality and specialty-specific failure modes. |
| DeepScribe | Treat core scribing as clinician-reviewed documentation support, but evaluate diagnosis-intelligence, pre-chart synthesis, E/M, ICD-10, HCC, and revenue-integrity features separately because they may affect clinical or billing decisions. | Review BAA terms, recording consent, audio and transcript retention, de-identification, EHR permissions, mobile or desktop capture, SSO/MFA setup, support access, security documentation, and whether customer data is used for model improvement. | Validate note completeness, hallucinated or omitted details, source-chart summary accuracy, coding-support rationale, specialty terminology, language support, and clinician edit burden against representative encounters before expansion. | Best governed as an ambient documentation workflow with explicit patient notice, clinician review and signoff, EHR insertion checks, exception handling for unsupported visits, and separate oversight for coding or diagnosis-surfacing outputs. |
| Suki | Treat it as clinician workflow support unless a local deployment leans on reasoning or coding features as unsupervised clinical decision support. | Review HIPAA, security, BAA, recording-consent, and webhook or integration controls for the exact deployment model you plan to use. | Pilot documentation quality, coding assistance, and any Q&A features separately because each workflow carries a different verification burden. | Most useful where voice-enabled documentation, edits, and EHR-connected assistant actions need to fit into clinician-controlled workflows. |
| Nabla | Use it as clinician documentation support unless your deployment expands into higher-risk clinical reasoning or patient-specific decision support. | Verify no-audio-storage defaults, feedback-data handling, chosen hosting region, BAA or regional privacy terms, and the exact scope of security certifications. | Pilot on specialty language, multiple speakers, accents, and complex visits instead of assuming general scribe performance transfers to your setting. | Best for teams comparing lighter-weight scribe adoption against enterprise governance requirements and supported EHR integrations. |
| Epic Art for Clinicians | Separate documentation drafting, chart summarization, order queuing, prior-authorization support, and level-of-service suggestions because each may carry different clinical, billing, and medical-device oversight needs. | Review Epic customer configuration, user access, audit logs, model pipeline, audio and transcript handling, chart-context scope, patient consent, external-data use, and organization-specific privacy terms before enabling PHI-bearing workflows. | Validate outputs in local Epic workflows with specialty-specific cases, comparing draft notes, summaries, queued orders, and billing suggestions against clinician-reviewed source charts and final signed records. | Best governed as EHR-native assistant functionality with explicit clinician review, edit tracking, order and note signoff, exception reporting, and separate approval for billing-sensitive or patient-facing uses. |
| Freed | Treat it as draft documentation support, not autonomous clinical documentation or coding submission. | Confirm HIPAA or BAA terms, audio-retention settings, account controls, and whether the planned workflow fits local privacy policy before entering PHI. | Use a small pilot to measure note completeness, specialty fit, and clinician correction burden instead of assuming consumer-like ease means clinical readiness. | Best for individual clinicians or smaller practices that need a simpler scribe workflow before evaluating heavier enterprise integrations. |
| Heidi Health | Separate documentation, evidence, and communications workflows because risk changes if users move from scribing into clinical-reference or patient-facing tasks. | Review regional privacy terms, retention, consent, and any de-identified data-improvement rights before using the broader platform with PHI. | Test the exact Heidi product in scope and measure note quality, evidence reliability, or communications safety separately rather than treating the suite as one workflow. | Best for teams that want configurable clinician tooling but can govern product-by-product rollout across scribe, evidence, and communication features. |
| ModMed Scribe | Treat it as specialty documentation and coding-support software unless downstream automation crosses into unsupervised clinical or billing action. | Review how native EHR integration changes PHI scope, recording-consent workflow, retention, and access controls for your specialty deployment. | Validate specialty note quality and coding suggestions in the real EMA workflow before trusting downstream automation or specialty-specific claims. | Best for specialty groups where built-in EMA integration matters more than a standalone ambient scribe with broader EHR reach. |
| Augmedix | Treat Augmedix as documentation workflow support unless a local implementation adds coding, ordering, or clinical decision functionality that changes intended use. | Hybrid human-assisted models require extra review of workforce access, offshore or subcontractor handling, recording consent, retention, and BAA terms beyond generic AI-scribe checks. | Pilot each mode separately because AI-only and human-assisted documentation can differ in turnaround time, note quality, clinician edits, and operational cost. | Best evaluated where teams need a governed documentation operating model rather than only a self-serve scribe app. |
| Commure Ambient AI | Treat documentation as lower-to-medium risk, but separately review AI Assistant, CareCues, autonomous coding, and revenue-cycle features because each can change clinical, coding, or compliance accountability. | Confirm BAA path, HIPAA scope, audio and transcript retention, training-data use, clinician preference learning, EHR access, audit logs, and subcontractor controls before using PHI. | Validate note quality, specialty fit, coding cue accuracy, prior-history summarization, and generated care-plan content against real encounters before expanding. | Best governed as EHR-connected clinician support with explicit consent, clinician editing, final signoff, exception queues, and separate approval for coding or billing automation. |
| Tali AI | Treat Tali as draft documentation and dictation support unless a deployment adds clinical advice, coding automation, or patient-facing use that changes review obligations. | Review the exact regional product terms for audio deletion, transcript retention, data residency, BAA or data-processing agreement coverage, subprocessors, and model-training restrictions. | Validate note accuracy, specialty terminology, hallucinated facts, missing negatives, and template fit on local encounters before using generated notes at scale. | Best governed as a clinician-controlled scribe with recording consent, draft status, final signoff, EHR insertion checks, and documented correction tracking. |
| Twofold Health | Treat as clinician-reviewed note drafting, not autonomous diagnosis, therapy assessment, coding, or treatment planning without a professional review boundary. | Behavioral health and therapy use needs extra review of consent language, psychotherapy-note segregation, minimum necessary access, BAA terms, retention, and deletion workflow. | Test session-note quality across visit lengths, modalities, speakers, and required formats, with specific review for invented findings or inappropriate therapy-plan language. | Best governed as a draft-note assistant where the clinician controls recording, edits every note, manages EHR transfer, and documents patient consent. |
| Nabla Copilot | Treat as clinician-reviewed documentation and workflow support unless coding, patient-instruction, or real-time intelligence features are configured in ways that affect clinical or billing decisions. | Review BAA terms, audio capture, transcript and note retention, optional feedback audio, de-identification, EHR context, API logs, subprocessors, model-training restrictions, and organization-specific retention controls. | Validate note accuracy, specialty language, coding-support precision, patient-instruction safety, edit burden, and clinician satisfaction against local encounters before broad rollout. | Best governed with consent scripts, draft-note labeling, clinician signoff, EHR insertion review, template ownership, exception reporting, and separate approval for coding or patient-facing outputs. |
| Eleos Health | Treat as behavioral health documentation, compliance, and care operations support; confirm whether any workflow-agent or predictive decision-support capability creates additional health IT or state-law obligations. | Review client consent, psychotherapy-note boundaries, audio and transcript deletion, AI suggestions retained for model refinement, EHR embedding, geographic data residency, access controls, BAA terms, and minimum-necessary staff access. | Validate note quality, compliance flags, word-error performance, provider workload, Medicaid audit defensibility, and equity across programs, accents, languages, and visit types. | Best deployed with clinical documentation integrity ownership, compliance-review queues, provider training, client notice language, EHR transfer rules, and routine audit of AI-suggested content. |
| TORTUS | Treat TORTUS as documentation support under UK clinical-safety and information-governance review; verify current DTAC, DCB0129/DCB0160, procurement, and local approval status before rollout. | Review UK GDPR lawful basis, processor/controller roles, retention, deletion, subprocessor, security, browser capture, cloud processing, and patient notice requirements. | Validate note and code output against local NHS documentation standards, specialty workflows, clinician edits, safety incidents, and patient opt-out handling. | Best governed as a clinician-reviewed NHS scribe workflow with local DPIA, patient notice, opt-out path, final signoff, and post-deployment safety monitoring. |
| NextGen Clinical AI | Treat as clinician-reviewed documentation and EHR workflow support; verify whether any coding, medication, lab, imaging, or order suggestion is governed locally as clinical decision support or revenue-cycle support. | Review recording notice and consent, transcript retention, audio deletion, mobile capture, EHR insertion, BAA terms, access logs, hosted-data controls, ISO scope, and whether generated content can be used for product improvement. | Validate specialty note quality, clinician edits, hallucinated or omitted details, coding suggestion accuracy, patient-summary usefulness, and workflow impact against representative encounters before broad rollout. | Best governed as a NextGen-native ambient documentation workflow with explicit provider review, patient notice, mobile-device policy, EHR signoff, and monitoring of note defects and suggestion overrides. |
| Aidoc | Verify the exact Aidoc algorithm, version, modality, anatomy, intended use, quality-system documentation, and FDA or local authorization before clinical deployment. | Review DICOM routing, AWS or Azure processing, metadata handling, retention, access controls, trust-center evidence, and security documentation for the selected PACS/RIS workflow. | Evaluate performance by finding and site, including false positives, false negatives, alert fatigue, turnaround-time impact, and downstream care-team response. | Best governed as radiology triage and care-coordination support, with radiologist review, escalation rules, and post-deployment monitoring for every enabled module. |
| AIRS Medical SwiftMR | Treat SwiftMR as regulated MRI image-processing software and verify the specific 510(k) scope, product version, anatomy, sequence, region, scanner, and any OEM deep-learning reconstruction pairing before clinical protocol changes. | Map DICOM image and metadata flow through the SwiftMR gateway, PACS, cloud or local storage, logs, support access, retention, deletion, subprocessors, BAA, and customer contract terms before processing clinical images. | Validate image quality and scan-time claims locally by scanner model, field strength, body region, sequence, coil, acceleration factor, patient population, artifacts, radiologist acceptance, and physicist review. | Best governed by radiology, MRI technologists, medical physics, PACS administration, privacy/security, and operations teams with protocol approval, failure handling, monitoring, and manual fallback. |
| Viz.ai | Do not treat a platform-level FDA-cleared-algorithm count as clearance for every pathway; verify the specific disease module, indication, and geography. | Check imaging, mobile, messaging, and EHR data flows, including notification content, user access, trust-center controls, retention, and business-associate terms. | Review pathway-specific evidence for time-to-notification, treatment activation, false alerts, missed cases, and outcome measures in comparable hospitals. | Use when the care pathway has named responders, escalation windows, and specialist confirmation rather than as standalone diagnostic interpretation. |
| Ferrum Health | Treat Ferrum as governance and deployment infrastructure; regulatory review still needs model-by-model intended-use, clearance, local-validation, and change-management checks. | Review whether deployment is on-premises, private cloud, or vendor-connected, then verify PHI routing, de-identification, retention, deletion, encryption, access control, BAA, and subprocessor terms. | Require local validation and ongoing monitoring for every model in the catalog, including scanner mix, patient population, drift, false positives, false negatives, and downstream action rates. | Best used when a health system has a clinical AI governance committee, named model owners, incident review, and post-deployment monitoring rather than isolated AI pilots. |
| Blackford Platform | Treat Blackford as deployment infrastructure plus a marketplace; verify regulatory status, intended use, and local authorization for each algorithm routed through it. | Review the on-prem connector, cloud application paths, DICOM metadata, PACS/RIS/EMR links, retention, HITRUST documentation, subprocessors, and customer contract terms. | Evaluate algorithm-level evidence and platform operational metrics separately, including routing accuracy, uptime, failure handling, monitoring, and radiologist interaction. | Best governed as enterprise imaging AI infrastructure with radiology, IT, security, clinical engineering, and governance review before adding each algorithm. |
| CARPL.ai | Treat CARPL as a cleared imaging platform plus marketplace; verify K232891 scope, software version, intended users, modalities, geography, and the separate regulatory status of every connected AI algorithm before clinical use. | Map DICOM image flow, metadata, account data, viewer access, cloud or local deployment, retention, support access, storage regions, subprocessors, research or analytics rights, and BAA or data-processing terms. | Evaluate platform reliability, routing, viewer behavior, validation tooling, monitoring coverage, and each algorithm's local performance separately across scanner mix, patient population, prevalence, and radiologist interaction. | Best governed as enterprise radiology AI infrastructure with radiology, IT, security, legal, procurement, and clinical AI governance approval before enabling each marketplace application. |
| deepcOS | Treat deepcOS as an AI deployment platform plus marketplace; verify regional clearance, intended use, version, and clinical responsibility for every algorithm or reporting module enabled through it. | Review cloud or on-premise deployment, DICOM data flows, metadata, role access, encryption, pseudonymization, retention, data-processing terms, subprocessors, and security attestations before sending imaging studies. | Evaluate algorithm-level evidence separately from platform evidence, then test routing accuracy, monitoring coverage, local-data evaluation, alert handling, and radiologist interaction in a pilot. | Best governed as enterprise radiology AI infrastructure owned jointly by radiology, imaging IT, security, procurement, clinical engineering, and AI governance before adding each marketplace application. |
| Enlitic Curie / ENDEX | Treat Curie, ENDEX, and ENCOG primarily as imaging data-management and de-identification infrastructure, then review any connected workflow that affects clinical interpretation, routing priority, billing, research release, or downstream AI-model deployment. | Map DICOM metadata, pixel data, burned-in PHI, private tags, identifiers, re-identification keys, audit logs, archive exports, customer portal access, subprocessors, retention, and cloud-region terms before using it for migration, analytics, or research workflows. | Validate normalization accuracy, PHI removal, retained clinical relevance, audit completeness, routing impact, and staff time savings against representative local studies, scanners, modalities, historical descriptions, and edge cases. | Best governed as radiology data-quality infrastructure owned jointly by imaging IT, PACS administration, radiologists, privacy/compliance, and data-governance teams before enabling archive release, routing changes, or AI-readiness workflows. |
| Brainomix 360 Stroke | Review each Brainomix module separately because e-ASPECTS, e-CTA, Triage Stroke, core-volume, e-MRI, mobile alerts, and regional releases can carry different indications and clearance status. | Map DICOM transfer, on-premises or cloud processing, pseudonymized mobile notifications, user access, retention period, secure deletion, and customer contract terms before production routing. | Evaluate acute-stroke evidence against the local pathway, including scanner mix, ASPECTS agreement, LVO detection, core-volume estimation, false-positive burden, thrombectomy activation, and transfer outcomes. | Best governed as specialist-reviewed stroke decision support with named responders, escalation windows, downtime handling, audit trails, and post-deployment monitoring for alert quality and treatment delays. |
| Avicenna.AI CINA-ASPECTS | Match CINA-ASPECTS to FDA 510(k) K233342, local CE or other market status, exact intended use, software version, age range, scanner manufacturer, and acute-stroke context before using outputs in care decisions. | Review DICOM routing, identifiers, cloud or on-premise processing, user access, audit logs, retention, support access, incident response, and customer data-processing terms; the public privacy policy mainly covers website interactions and points buyers to compliance documents. | Evaluate performance on local non-contrast head CT studies against neuroradiologist or stroke-team ASPECTS assessment, including artifacts, scanner mix, early ischemic changes, excluded pathologies, and treatment-decision impact. | Best governed as clinician-reviewed ASPECTS decision support inside an acute stroke protocol, with explicit ownership for reviewing heat maps, resolving AI-clinician disagreement, documenting decisions, and monitoring drift. |
| Qure.ai | Separate each Qure.ai product and regional deployment because chest X-ray, CT, TB, lung-nodule, and stroke workflows may have different authorization status. | Review image routing, cloud or local deployment, de-identification before cloud processing, retention, public-health data sharing, DICOM metadata handling, and cross-border processing terms. | Validate performance for the target population, prevalence, scanner mix, and clinical pathway, especially when moving from public-health screening into hospital care. | Best evaluated with radiologist or clinician review, escalation rules, and equity monitoring for false positives and false negatives across deployment sites. |
| Qure.ai qXR | Treat qXR as a family of chest X-ray AI functions rather than one universal clearance; match qXR-LN, qXR-BT, qXR-PTX-PE, qXR-CTR, or any newer module to the exact indication, version, anatomy, geography, and user workflow. | Review whether images are de-identified before cloud processing, whether deployment is cloud or on-premise, how DICOM metadata, overlays, reports, audit logs, retention, and cross-border transfers are handled, and whether contract terms cover PHI. | Require local validation by finding and workflow, including scanner types, adult population, prevalence, reporting queue effects, false-positive burden, missed critical findings, and equity across deployment sites. | Best governed as radiologist-reviewed chest X-ray assistance with documented worklist rules, report-review boundaries, escalation paths, downtime procedures, and post-deployment monitoring. |
| Oxipit ChestLink | Treat ChestLink as a high-risk autonomous radiology workflow and verify the exact CE Class IIb certificate, intended use, country availability, version, and absence or presence of FDA authorization before any clinical deployment. | Review DICOM image routing, patient identifiers, RIS/PACS integration, analytics dashboards, support access, retention, security controls, and the customer data-processing agreement rather than relying on the public website privacy notice. | Require local retrospective validation and supervised operation data before autonomous release, with special attention to false negatives, abnormality prevalence, scanner mix, excluded cases, and monitoring sensitivity. | Best governed as a staged autonomous-normal-CXR program with explicit release thresholds, radiologist oversight for all uncertain or abnormal cases, audit review, downtime fallback, and safety-event escalation. |
| Rad AI | Treat reporting assistance separately from image-interpretation software; verify whether guideline insertion, discrepancy detection, or local configuration changes clinical decision-support or quality-system obligations. | Review how dictated findings, generated reports, account and professional information, identifiers, templates, worklists, EHR/RIS data, audit logs, de-identification, retention, support access, and model-improvement terms are handled under the current customer agreement. | Pilot against local report templates, modalities, and subspecialties, tracking clinically significant omissions, incorrect impressions, turnaround time, edit burden, discrepancy catches, and radiologist satisfaction. | Best used as radiologist-controlled report drafting where the interpreting physician remains responsible for final report content, consensus-guideline wording, discrepancy resolution, and QA. |
| Rad AI Continuity | Treat as radiology workflow and patient-safety infrastructure; reassess risk if the system changes recommended follow-up timing, patient instructions, escalation criteria, or care-team prioritization beyond the radiologist's report. | Review report ingestion, patient identifiers, messaging channels, EHR/RIS links, provider fax or EHR messages, direct mail, audit logs, retention, access controls, and BAA or security documentation. | Validate against local reports and follow-up programs by measuring extraction accuracy, missed recommendations, inappropriate outreach, completion rates, navigator workload, subgroup performance, and downstream outcomes. | Best governed as a closed-loop radiology follow-up program with radiology, ordering-provider, navigator, compliance, and patient-communication ownership explicitly assigned. |
| Sirona RadOS | Treat RadOS as enterprise radiology infrastructure with module-specific obligations; verify viewer, reporting, PACS, AI automation, and any prospective pixel-to-report claims against local device and health-IT requirements. | Review image archive, DICOM metadata, report text, speech, EHR context, user audit trails, cloud regions, local point-of-presence caching, support access, BAA terms, retention, and incident response. | Pilot against real modality, subspecialty, template, prior-comparison, speech, and worklist scenarios while measuring reporting accuracy, omitted findings, turnaround time, downtime behavior, and radiologist edit burden. | Best governed as a radiologist-controlled platform migration with staged rollout, site-by-site integration testing, downtime fallback, QA review, and explicit controls for AI-assisted report content. |
| Bayer Calantic Digital Solutions | Treat Calantic as a platform plus selected application stack; verify each deployed app's device status, intended use, indication, version, jurisdiction, and responsibility split between Bayer and the app vendor. | Review image routing, DICOM metadata, cloud hosting, viewer access, app-vendor data flows, support access, retention, security controls, BAA or DPA terms, and whether PHI crosses vendors or regions. | Validate each selected app locally by service line, scanner mix, prevalence, patient population, false-positive and false-negative profile, alert behavior, radiologist acceptance, and operational impact. | Best governed as radiology AI infrastructure with an application intake board, per-app validation checklist, PACS/RIS integration testing, monitoring plan, and retirement process for underperforming algorithms. |
| Cleerly | Confirm product-specific clearance, Rx-only status, trained-user requirements, indication, eligible CCTA acquisition protocol, and geography before using plaque analysis in a clinical pathway. | Review coronary CTA upload, cloud processing, image retention, report distribution, authorized users, application access, and data-use terms for cardiology workflows. | Evaluate evidence for the intended patient population, scanner protocols, plaque metrics, downstream testing, preventive treatment decisions, and follow-up outcomes. | Best governed as cardiologist-reviewed CCTA analysis feeding structured prevention or treatment-planning workflows, not as autonomous cardiovascular diagnosis. |
| Elucid PlaqueIQ | Match the PlaqueIQ version, 510(k) record, indication, CCTA acquisition requirements, geography, and reimbursement use before adding it to a clinical pathway. | Review coronary CTA upload, remote access to PHI, encrypted transfer, retention, support access, subcontractors, customer-controller obligations, and DPF or local transfer terms. | Assess validation for the target CCTA population, scanner/protocol mix, plaque-composition metrics, lesion-level outputs, reader agreement, and downstream treatment or testing decisions. | Best governed as physician-reviewed coronary CTA plaque analysis feeding structured cardiology risk assessment, prevention, referral, and follow-up workflows. |
| LumineticsCore | Because this is positioned as autonomous diagnostic AI, match use exactly to the FDA-cleared indications, contraindications, trained operators, Topcon camera requirement, and required workflow. | Review retinal-image capture, device connectivity, diagnostic-result hosting, storage, access controls, report delivery, referral communication, and patient-consent documentation. | Monitor unreadable-image rates, false positives, false negatives, referral completion, and local prevalence instead of relying only on clearance status. | Best suited to protocolized diabetic-eye-exam workflows with defined eligibility screening, patient instructions, referral routing, billing, and quality oversight. |
| Eyenuk EyeArt | Match deployment to the current FDA-cleared EyeArt version, indication, supported cameras, trained-user requirements, adult diabetes population, geography, and referral workflow. | Review retinal-image upload, cloud processing, API integrations, EHR/PACS connectivity, encryption, retention, support access, audit logging, BAA terms, and privacy/security contacts before sending PHI. | Validate performance locally across camera model, operator skill, image quality, disease prevalence, patient demographics, false-positive burden, missed-referral risk, and follow-up completion. | Best governed as an autonomous screening workflow with eligibility checks, trained image capture, report review, referral routing, documentation, billing, and post-deployment quality monitoring. |
| AEYE-DS | Match deployment to the current AEYE-DS 510(k), camera, indication, contraindications, trained-user workflow, eligible adult diabetes population, and local diagnostic-screening rules. | Review retinal-image capture, identifiers, EHR ordering and result return, de-identified model-improvement use, U.S. hosting, retention by provider agreement, access controls, and BAA or data-processing terms. | Validate local performance against the clinic's camera, operator skill, image-quality rate, patient demographics, disease prevalence, follow-up capacity, and expectations for non-diabetic eye disease. | Best governed as a protocolized care-gap closure workflow with eligibility checks, trained capture, report review, referral routing, billing review, and quality monitoring. |
| RETINA-AI Galaxy | Use only within the current FDA-cleared indication, camera list, adult diabetes population, contraindications, warnings, and physician-review workflow. | Request current HIPAA audit evidence, BAA terms, image and report retention, support access controls, EHR export details, and any secondary-use or model-improvement terms. | Review pivotal-study results and run local monitoring by camera, operator, image quality, dilation rate, disease prevalence, false-negative risk, and referral follow-through. | Best governed as autonomous screening that still requires physician review of results, patient instructions, retest or referral rules, and follow-up tracking. |
| RetInSight Fluid Monitor | Verify current MDR/CE status, local availability, intended nAMD use, OCT compatibility, and whether any U.S. use is investigational, research-only, or otherwise restricted. | Review OCT upload, cloud or local processing, patient identifiers in reports, retention, user access, export controls, support access, and clinic data-processing terms. | Validate segmentation and volumetric trends against specialist review for local OCT devices, scan quality, disease severity, treatment intervals, and fluid types. | Best governed as retina-specialist-reviewed OCT quantification and monitoring support, with documented override rules and treatment decisions made outside the algorithm. |
| RetinAI Discovery | Confirm device status by region and module, because the Discovery platform, CE-marked AI modules, FDA-cleared platform claims, and U.S. RUO AI-module limits may differ. | Review DICOM/proprietary image storage, data-sharing permissions, real-world evidence reuse, role access, cloud hosting, GDPR/HIPAA/PIPEDA posture, DPA terms, and study contracts. | Assess validation for the exact retinal disease, OCT/device source, AI module, endpoint, and clinic or research workflow before relying on extracted measurements. | Best governed as a secure retinal imaging data and AI-enrichment layer with ophthalmologist, reader, or study-team review before clinical or trial decisions. |
| Cercare Medical Neurosuite | Treat CMN as regulated image-processing decision support and verify each module separately because MRI, CT, Virtual Expert, and CBCT Perfusion clearances have different indications and workflow assumptions. | Review DICOM metadata handling, PACS/RIS routing, remote desktop or virtual platform access, retention, support uploads, audit logs, cybersecurity documentation, and any cloud or distributor data-processing terms. | Check FDA summaries, validation testing, local scanner protocols, perfusion-map comparability, reader agreement, and stroke-team outcomes before using outputs to change triage or treatment pathways. | Best governed as a neuroradiologist- and stroke-team-reviewed perfusion layer, with explicit escalation, downtime, quality-control, and post-thrombectomy review procedures. |
| RapidAI | Validate the selected RapidAI module against its own clearance, modality, anatomy, and intended use rather than applying platform claims across all workflows. | Review edge, hybrid, on-prem, and cloud deployment choices; PACS/RIS/EHR integration; image routing; mobile notifications; DPF/privacy terms; data retention; uptime; audit logs; and cybersecurity requirements for acute-care use. | Measure pathway-specific impact on notification timing, transfer decisions, false alerts, missed findings, and downstream outcomes during a controlled rollout. | Best deployed where stroke, vascular, hemorrhage, or aortic teams have clear alert ownership, escalation rules, downtime procedures, and monitoring dashboards. |
| Heartflow | Separate FFRCT, plaque, roadmap, and other Heartflow modules because each may have different clearance, indication, contraindication, and reimbursement requirements. | Review CCTA image submission, cloud analysis, report delivery, retention, access controls, and cardiology-record integration before production use. | Assess clinical utility for the target coronary-artery-disease population, scanner protocols, image quality thresholds, downstream testing, and treatment changes. | Best governed as cardiology-reviewed coronary CTA analysis feeding shared decision-making, referral, preventive-care, or cath-lab planning workflows. |
| Caristo CaRi-Plaque and CaRi-Heart | Separate CaRi-Plaque from CaRi-Heart and match every deployment to the exact module, software version, country, FDA 510(k) K242240 or other local authorization, trained-user requirement, and intended-use statement. | Review CCTA de-identification, cloud SaaS transfer, DICOM metadata, regional processing, report delivery, retention, support access, audit logs, customer-controller obligations, BAA or DPA terms, and patient notice language. | Evaluate ORFAN and other Caristo evidence against the local CCTA population, scanner protocols, age range, plaque burden, inflammatory-risk distribution, cardiologist review, prevention decisions, and downstream testing impact. | Best governed as cardiologist-reviewed CCTA analysis with explicit rules for report interpretation, discordant findings, prevention escalation, reimbursement documentation, and post-deployment monitoring. |
| Ultromics EchoGo | Match the EchoGo Heart Failure version, 510(k) record, indication, product code, geography, and reimbursement workflow before using output in a heart-failure pathway. | Review echocardiography upload flow, cloud or integration partner processing, customer-controller obligations, retention, deletion, access controls, DPO contact path, and support-data handling. | Evaluate HFpEF detection evidence, eligible echo views, image-quality failures, false-positive and false-negative burden, patient population fit, and downstream testing or referral impact. | Best governed as cardiologist-reviewed echo decision support that feeds HFpEF diagnostic workups, structured reporting, and follow-up planning rather than autonomous diagnosis. |
| Us2.ai | Match the exact Us2.ai version, intended use, automated parameter set, disease-detection output, geography, and market authorization before using results in clinical echo reporting. | Review DICOM routing, cloud versus on-premises deployment, regional data residency, PACS/CVIS/report delivery, subprocessors, BAA or data-processing terms, access controls, and support-data handling. | Validate automated measurements and disease-detection outputs against local echo-lab readers, scanner mix, patient population, image quality, false-alert burden, and downstream clinical decisions. | Best governed as cardiologist-reviewed echo automation that feeds structured reporting and quality-control workflows, with explicit rules for failed studies, overrides, and post-deployment monitoring. |
| Gleamer BoneView | Verify BoneView US K222176 and any local CE, Health Canada, or other authorization for the exact module, anatomy, patient age, and clinical site. | Review imaging-data flow, DICOM metadata, pseudonymized patient data, processor/controller roles, subcontractors, security controls, and retention in the deployment contract. | Validate performance on local trauma X-rays, pediatric and adult case mix, fracture type, body region, scanner workflow, false positives, false negatives, and report turnaround. | Best used as a second-reader and prioritization aid inside existing radiology or emergency workflows, with explicit responsibility for accepting, rejecting, and documenting AI marks. |
| iCAD ProFound AI | Verify the exact ProFound module and version because FDA-cleared detection, density, and risk-related features do not share one blanket authorization. | Review mammography image routing, DICOM metadata handling, PACS/viewer integration, cloud or local deployment, retention, access controls, and security documentation. | Check reader-study evidence, breast-density subgroup performance, recall impact, cancer subtype detection, specificity, and whether priors are used in the selected version. | Map where marks, case scores, density output, risk signals, and worklist prioritization appear in the radiologist workflow before clinical use. |
| GI Genius | Verify the exact GI Genius module, labeling, De Novo record, software version, intended use, prescription restriction, and country-specific status before using it in screening or surveillance workflows. | Map whether the deployment processes, stores, transmits, or logs endoscopy video, patient identifiers, room metadata, support diagnostics, and service records under the provider's privacy and security agreements. | Review clinical evidence for the target screening population, adenoma detection rate, missed lesions, false-positive markers, operator reliance, withdrawal time, and impact on pathology-confirmed outcomes. | Best governed as real-time endoscopist decision support with explicit rules for training, visual-marker response, biopsy decisions, downtime, documentation, and periodic performance review. |
| SKOUT | Confirm the SKOUT 510(k), software version, labeling, intended adult population, white-light limitation, component compatibility, and any region-specific availability before clinical use. | Review endoscopy-video flow, identifiers, support logs, retained quality metrics, processor roles, access controls, deletion, audit logging, and business-associate terms before room integration. | Evaluate evidence for adenoma and polyp detection, sessile lesions, procedure time, false markers, missed lesions, resection mix, and whether results generalize to local endoscopists and case mix. | Best governed as an assistive detection overlay with training, over-reliance safeguards, documentation expectations, downtime plans, and ongoing monitoring of colonoscopy quality metrics. |
| Fujifilm CAD EYE | Match CAD EYE, EW10-EC02, SCALE EYE, and any characterization feature to the exact FDA record, indication, hardware configuration, and market availability because they should not be treated as one blanket authorization. | Review whether endoscopy images, video, metadata, support diagnostics, service access, and software-update logs stay on local equipment or move through vendor-managed systems. | Validate clinical evidence for the local colonoscopy population, endoscope hardware, lesion size and morphology, false markers, missed lesions, and effect on procedure quality metrics. | Best governed as physician-reviewed detection support inside a compatible Fujifilm room, with explicit training, equipment checks, documentation rules, and post-live quality monitoring. |
| Olympus CADDIE | Match the deployed CADDIE version to the exact FDA 510(k), intended use, white-light limitation, hardware dependencies, and U.S. detection-only scope rather than assuming all OLYSENSE features share one authorization. | Because the workflow is cloud-connected, map endoscopy video, metadata, network transport, hub logs, support access, retention, security controls, and business-associate terms before installation. | Review the EAGLE trial, FDA summary data, and local validation for adenoma detection, high-risk lesions, false positives, latency, procedure time, and performance across endoscopists and patient mix. | Best governed as physician-reviewed real-time detection support with room-readiness checks, connectivity downtime rules, training, documentation expectations, and ongoing quality metric review. |
| MammoScreen | Match each MammoScreen module and version to its specific FDA, CE, or local authorization because detection, breast density, and workflow assistance should not be treated as one blanket clearance. | Review mammography image routing, DICOM metadata, SaaS processing, retention, access controls, audit logs, subprocessor terms, and business-associate or data-processing agreements. | Validate reader-study evidence and local performance for the target modality, density mix, scanner fleet, cancer prevalence, recall patterns, and radiologist interaction model. | Best governed as radiologist-reviewed breast-screening support with explicit rules for how scores, priors, density output, and draft-report signals influence final interpretation. |
| Kheiron Mia | Review each module separately because Mia Triage, Mia Reader, Mia IQ, and RSViP may have different intended uses and country-specific authorization paths. | Assess mammography image flow, patient identifiers, PACS/RIS integration, cloud or distributor processing, retention, access controls, audit logs, and data-processing terms. | Require local screening-program evidence for detection, recall, workload, image quality, population fit, scanner mix, and post-market monitoring rather than relying only on headline performance claims. | Best governed as pathway support for radiologist-reviewed screening, with explicit rules for triage thresholds, quality-audit actions, second-reader escalation, and patient-safety review. |
| ScreenPoint Transpara | Verify the exact Transpara module, version, country, modality, and 510(k) or CE status because detection, density, and comparison features should not be treated as one blanket authorization. | Review mammography image routing, DICOM metadata handling, cloud or on-prem deployment, retention, access controls, subprocessors, and business-associate or data-processing terms. | Check evidence for the target screening population, dense-breast subgroup, 2D versus DBT workflow, cancer subtype, recall impact, and radiologist interaction model. | Best governed as radiologist-reviewed mammography support with local rules for when AI marks or scores change read order, second-read strategy, recall decisions, and documentation. |
| Koios DS Breast | Match K212616 or the relevant current clearance to the exact breast ultrasound workflow, patient group, lesion type, and trained interpreting-physician use. | Review ultrasound image transfer, DICOM metadata handling, cloud or local processing, retention, user access, audit logs, and security documentation before sending clinical studies. | Validate CADx performance on local ultrasound equipment, operator mix, lesion prevalence, benign/malignant balance, subgroup representation, and downstream biopsy decisions. | Best used as adjunctive physician-reviewed ultrasound decision support, with explicit documentation of ROI selection, AI output review, BI-RADS reconciliation, and final clinician accountability. |
| Subtle Medical | Treat each Subtle product as a separate imaging device workflow; match clearance, sequence, modality, and intended-use language before changing clinical protocols. | Verify image transfer, cloud or on-prem processing, retention, DICOM metadata handling, business associate terms, access controls, and vendor security materials. | Validate image quality, artifact risk, scan-time or dose claims, and radiologist acceptance on local scanner models, protocols, body regions, and patient populations. | Coordinate radiology, technologist, physicist, PACS, modality, and protocol governance because image-enhancement tools can affect acquisition and interpretation steps. |
| Lunit | Verify the exact Lunit product, version, modality, anatomy, and intended use against FDA, CE/MDR, and local product-registration materials before clinical deployment. | Review image routing, cloud or partner integrations, retention, access controls, DICOM metadata handling, security documentation, and any research or training-data terms. | Require module-level validation for the local population and scanner workflow rather than relying on platform-level publication or site-count claims. | Map radiologist, breast-imaging, pathology, oncology, PACS/RIS, and escalation workflows separately because Lunit's product family spans multiple clinical pathways. |
| annalise.ai | Separate U.S. triage-cleared findings from broader regional Enterprise feature sets; not all findings, reporting features, or regions have the same status. | Review DICOM flow, viewer access, cloud or local deployment, audit logs, retention, and customer security documentation before routing imaging studies. | Evaluate performance by finding, modality, geography, patient population, radiologist workflow, and reporting-time objective instead of treating 100-plus finding coverage as uniform evidence. | Define whether AI output changes reporting order, draft reports, critical-findings escalation, or second-reader behavior, then monitor alert fatigue and missed findings. |
| CureMetrix | Verify cmTriage's FDA-cleared notification-only intended use and do not generalize it to diagnosis, DBT, cmAssist, or any region-specific product without separate clearance review. | Review DICOM routing, cloud processing, hospital-network integration, metadata handling, retention, access controls, and contract terms before routing mammography studies. | Evaluate local breast-density mix, scanner workflow, suspicious-case prioritization, recall impact, and radiologist performance rather than relying only on vendor benchmark claims. | Best treated as breast-imaging worklist prioritization that supports standard radiologist interpretation, with monitoring for alert fatigue and missed suspicious cases. |
| Hologic Genius AI Detection | Match the installed version to the correct FDA 510(k), product code, compatible Hologic systems, and intended use before applying case scores or markers clinically. | Review whether images, case scores, logs, support data, or remote-service access leave the facility, and confirm retention, access-control, audit, and contract terms. | Evaluate reader-study evidence and local monitoring for cancer detection, recall, breast-density mix, false markers, missed cancers, and effects on radiologist workload. | Best governed as radiologist-reviewed breast-screening CAD support where AI marks and case scores inform but do not replace final interpretation. |
| GE HealthCare Caption AI | Separate scan-guidance features, automated measurement software, and the ultrasound hardware because each can have different cleared indications, compatible systems, and trained-user expectations. | Review device connectivity, image and measurement storage, PACS/EHR export, user access, service telemetry, cloud features, retention, and customer security documentation for ultrasound deployments. | Pilot with the target clinician group and patient mix, measuring diagnostic-quality view acquisition, unusable scans, measurement disagreement, credentialing outcomes, and downstream echo utilization. | Best governed as assisted image acquisition and measurement support with explicit credentialing, QA review, escalation for inadequate studies, and qualified clinician interpretation. |
| UltraSight Guidance | Match the deployed UltraSight Guidance version to the exact FDA 510(k), compatible ultrasound equipment, adult 2D-TTE indication, intended users, and supported views before clinical use. | Review whether ultrasound video, still images, quality metrics, device telemetry, user identifiers, and support logs are processed locally or in cloud services, and confirm retention, access, audit, and contract terms. | Validate acquisition quality and failure modes with the local operator mix, care setting, ultrasound devices, patient population, and quality-review process instead of treating clearance as site-specific performance proof. | Best governed as acquisition assistance for focused cardiac ultrasound with trained operators, cardiology or qualified physician oversight, QA sampling, escalation for inadequate images, and separate interpretation accountability. |
| Butterfly iQ3 | Separate the iQ3 ultrasound system, education tools, workflow software, and gestational-age AI because hardware clearance and AI-tool clearance do not authorize every clinical use. | Review cloud exam storage, device-user identity, mobile-device controls, sharing links, retention, support access, EHR/PACS export, and enterprise data-processing terms. | Validate image quality, measurement reliability, user training outcomes, gestational-age workflow performance, and follow-up completion for the intended care setting. | Best deployed with POCUS governance: operator credentialing, QA overreads, exam protocols, escalation rules, connectivity fallback, and documentation ownership. |
| Sonio Detect | Match the deployed Sonio Detect version to the exact FDA 510(k), intended use, compatible ultrasound systems, supported gestational ages, and local regulatory clearance before clinical use. | Review cloud upload, DICOM and clip handling, HL7/EHR integration, user identity, support access, retention, subprocessors, and BAA or regional data-processing terms. | Pilot against local prenatal ultrasound protocols and track view acquisition, quality-check agreement, false confidence, repeat scans, referral patterns, and subgroup performance. | Best governed as acquisition and quality-control support for trained ultrasound users, with specialist interpretation, documentation, escalation, and patient communication remaining outside the AI. |
| DeepHealth Breast Suite | Separate each Breast Suite component before deployment because FDA clearance for Saige-Dx does not automatically cover risk assessment, breast ultrasound, BAC, viewer, or future suite modules. | Review mammography image routing, cloud processing, PACS or worklist integration, user roles, support access, retention, audit logging, BAA terms, and regional data-processing commitments. | Pilot against local mammography baselines for cancer detection, recall, reading time, density distribution, subgroup performance, scanner mix, and radiologist disagreement rather than relying on broad suite claims. | Best governed as radiologist-reviewed breast imaging decision support with module-specific protocols, quality monitoring, override capture, escalation rules, and clear patient communication boundaries. |
| Pearl Second Opinion | Match the exact Pearl module, 2D or 3D modality, patient age, anatomy, and intended use to FDA and local clearance before using findings in diagnosis or treatment planning. | Review Pearl's data-protection, privacy, BAA, image-retention, support-access, and cross-border processing terms before routing identifiable dental images. | Validate local performance on bitewing, periapical, panoramic, and CBCT workflows separately, including false positives, missed findings, dentist overrides, and patient-education effects. | Best governed as a dentist-reviewed second-reader and patient-communication layer, with clear rules for editing findings and documenting final clinical judgment. |
| Overjet | Review each FDA clearance separately because caries detection, bone-level measurement, pediatric claims, image enhancement, CBCT, payer review, and voice workflows have different intended uses. | Confirm BAA terms, HIPAA policy, encryption, image and PMS-data retention, patient scheduling data handling, vendor access, and payer-provider data boundaries. | Pilot against local dental images and charting standards, tracking missed lesions, extra findings, periodontal measurements, image-enhancement artifacts, and dentist overrides. | Best deployed with dentist review, patient-communication scripts, PMS/imaging integration testing, payer-use separation, and monitoring for over-treatment or inconsistent documentation. |
| VideaAI | Separate FDA-cleared Clinical Assist detections from patient education, voice, claims, dashboard, and operational analytics features that may not share the same intended use. | Review customer agreements, privacy terms, data retention, image/PMS integration, user access, support access, and analytics use before deploying across practices. | Validate per finding and age group on local dental radiographs, including pediatric cases, calculus, PARL, caries, bone level, false positives, and dentist overrides. | Best governed as clinician-reviewed radiograph support with explicit patient-education boundaries, rollout training, and monitoring for treatment-plan and documentation effects. |
| Denti.AI | Separate Detect, Auto-Chart, Voice Perio, Scribe, receptionist, and voice-assistant features because imaging-device clearance does not automatically cover every documentation or communications workflow. | Review image, voice, PMS, SMS, analytics, retention, transfer, support-access, BAA, and customer-contract terms before routing identifiable dental data through connected services. | Pilot on local radiographs and charting workflows, tracking per-finding sensitivity, false positives, missed findings, perio-chart corrections, note defects, and dentist overrides. | Best governed as dentist-reviewed imaging and documentation support, with explicit patient-consent language for voice features, PMS write-back controls, and quality sampling before scaling. |
| Diagnocat | Use the FDA-cleared CBCT indication narrowly: second-read support for periapical radiolucency in permanent teeth for trained dental professionals, not a replacement for complete clinical judgment. | Review DICOM routing, cloud storage, desktop or web viewer access, report sharing, support access, HIPAA materials, SOC 2 evidence, retention, and business-associate terms. | Validate against local CBCT cases, scanner protocols, oral-radiologist review, periapical-radiolucency prevalence, segmentation accuracy, and how often clinicians dismiss AI findings. | Best deployed after CBCT necessity is independently determined, with clinician review of heat maps, report edits, patient-communication boundaries, and documented final interpretation. |
| DentalMonitoring | Match use to DEN230035 and local MDR/CE scope, including patient age, permanent teeth, cleared indications, orthodontist oversight, and country-specific product availability. | Review patient app data, photos, scan metadata, messaging, clinician accounts, cloud processing, retention, transfers, consent, support access, and data-processing terms. | Assess local scan quality, false alerts, missed treatment-tracking issues, visit reduction claims, patient adherence, subgroup performance, and clinician response times. | Best governed as clinician-supervised remote orthodontic monitoring, with protocols for no-go alerts, patient messages, scan failures, in-office escalation, and record documentation. |
| DermaSensor | Treat as regulated prescription medical-device software and hardware; match use to DEN230008, age limits, lesion exclusions, trained users, adjunctive role, and post-market performance expectations. | Review device connectivity, cloud synchronization, software updates, remote monitoring, identifiers, access controls, BAA terms, retention, and support workflows before clinical rollout. | Assess FDA summary evidence and local pilot data for sensitivity, specificity, false reassurance, false referral, skin type, lesion location, and prevalence differences. | Best governed as a suspicious-lesion referral aid where clinicians first identify eligible lesions, interpret the AI output with clinical findings, document decisions, and track biopsy or dermatology follow-up. |
| Skin Analytics DERM | Verify the exact jurisdiction and pathway because CE-marked UK deployment, MHRA oversight, NHS use, and U.S. investigational status create different obligations. | Review dermatology-image capture, teledermatology routing, identifiers, data protection, ISO 27001, GDPR, NHS DSP Toolkit, DTAC, retention, support access, and patient notice. | Use post-market surveillance and independent evaluations as starting evidence, then validate local imaging quality, lesion mix, melanoma prevalence, equity, and escalation outcomes. | Best governed as a pathway-level triage system with explicit image acquisition standards, dermatologist review rules, safety-netting, audit, incident review, and patient communication. |
| FotoFinder Moleanalyzer pro | Confirm device/software version, country, intended use, compatible FotoFinder hardware, and labeling before using AI score or heatmap outputs in clinical care. | Review FotoFinder Hub account use, anonymized image transfer for online AI scoring, local offline options, ports, server access, image storage, consent, and data-protection terms. | Validate on local dermoscopy images with supported magnification, artifacts, calibration quality, lesion types, biopsy outcomes, and clinician disagreement review. | Best governed as dermatologist-supervised dermoscopy support with manual assessment, longitudinal comparison, second opinion when needed, and final diagnosis outside the AI score. |
| DermEngine | Separate image management, teledermatology workflow, analytics, mole matching, and any diagnostic support claim because each can carry different local obligations. | Review cloud storage, mobile apps, MoleScope images, patient portal, consent forms, referral networks, retention, encryption, access controls, and enterprise privacy terms. | Validate matching, tracking, search, and workflow outputs against local image quality, lesion history, skin tone, and specialist review rather than treating platform analytics as diagnosis. | Best governed as dermatology image infrastructure with explicit rules for who reviews images, how changes are escalated, and how outputs enter the clinical record. |
| Model Dermatol | Treat as medical information retrieval unless local deployment changes the intended use; verify CE MDR Class I marking, FDA non-approval, diagnostic disclaimers, app-store labeling, and country-specific medical-device rules before clinical use. | Review image upload, metadata fields, symptoms, language and country processing, device information, transfer for analysis, no-storage claims, consent, and whether organizational use needs a separate agreement. | Use published algorithm and research materials as background only, then test local cases for image quality, skin tone, condition mix, false reassurance, and whether reference links support safe next steps. | Best governed as an educational or clinician-reviewed visual search aid with explicit escalation to dermatology or urgent care for concerning lesions, changing symptoms, or uncertain outputs. |
| SkinVision | Confirm country availability, EU MDR certification, medical-device status, patient-facing claims, and whether local deployment creates additional clinical or payer obligations. | Review photo upload, encryption, deletion, dermatologist review, account data, insurer or partner data sharing, consent, retention, and cross-border processing before recommending use. | Review published validation and monitor false reassurance, missed malignancy, skin-tone performance, image quality, user adherence, and escalation completion. | Best governed as access and awareness support with clear safety-net language, clinician referral paths, no diagnostic substitution, and review of high-risk or uncertain results. |
| Paige | Verify the exact Paige product, scanner, tissue type, and intended use, especially for prostate workflows that have FDA-authorized claims. | Review whole-slide image storage, cloud processing, LIS links, access controls, retention, and any secondary-use terms before diagnostic deployment. | Validate performance in the local lab across scanner, stain, tissue preparation, case mix, pathologist workflow, and cancer-prevalence differences. | Best used as pathologist-supervised digital pathology support where suspicious regions, exceptions, and final diagnostic responsibility remain reviewable. |
| PathAI | Separate AISight Dx image-management clearance from AISight research workflows, third-party algorithms, PathAI AI Product Solutions, ArtifactDetect, TumorDetect, and biopharma tools before allowing diagnostic use. | Review cloud slide storage, LIS integration through AISight Link, PHI and metadata flow, user roles, audit logs, retention, support access, vulnerability process, BAA or DPA terms, and customer data-use limits. | Validate primary-diagnosis viewing performance, scanner compatibility, image quality, lab population fit, algorithm-result review, pathologist workload, and any AI claims in the exact deployment setting. | Best governed as a pathologist-reviewed digital pathology IMS with explicit lab validation, signout responsibility, scanner and LIS controls, downtime procedures, and separation of diagnostic versus RUO algorithm outputs. |
| Hologic Genius Digital Diagnostics | Confirm the exact cleared system components, ThinPrep cervical cytology intended use, region, and current recall or correction status before clinical use. | Review image-management storage, remote review, access controls, audit logging, support access, retention, and cytology LIS integration under customer contract terms. | Validate sensitivity, specificity, abnormal-cell gallery behavior, cytotechnologist workload, pathologist escalation, and quality-control effects in the local screening population. | Best evaluated as a full cytology workflow change where AI prioritization, review-station ergonomics, QA, and final signout are governed together. |
| Ibex Medical Analytics | Verify the specific Galen module, tissue type, geography, scanner, and intended use; do not generalize Ibex's U.S. 510(k), CE-IVD, IVDR, or other regional claims across all cancer workflows. | Use the customer agreement, BAA or regional data-processing terms, DICOM/WSI transfer path, retention, DPF/GDPR controls, access logs, and deployment model rather than the public website privacy policy alone. | Review validation by organ system, stain, scanner, case mix, false-negative risk, biomarker endpoint, and structured-reporting workflow before routine clinical use. | Best governed as pathologist-supervised cancer-diagnostics support with explicit signout responsibility, exception review, LIS/reporting integration, and post-deployment QA. |
| Deep Bio DeepDx Prostate | Confirm the exact DeepDx Prostate module, specimen type, region, CE or MFDS status, and U.S. RUO limitation; do not treat CE or Korea MFDS approval as FDA clearance. | Review cloud or on-premise architecture, WSI and metadata handling, LIS/viewer integration, access controls, support access, retention, regional hosting, and customer data-processing terms. | Evaluate validation evidence and local performance for prostate biopsy slides, scanner/stain variability, Gleason-pattern accuracy, false-negative risk, edit burden, and final-report impact. | Best governed as pathologist-supervised diagnostic support with mandatory overlay review, editable annotations, exception tracking, second-read escalation, and manual signout fallback. |
| Proscia | Separate Concentriq AP-Dx primary-diagnosis clearance from Concentriq AP, Concentriq LS, third-party AI applications, and research workflows; scanner and specimen limitations matter. | Confirm hosting, storage, scanner ingestion, LIS integration, user roles, collaboration access, retention, audit logs, and contract terms for diagnostic and life-sciences deployments. | Review the multi-site primary-diagnosis study and any AI-application evidence against the lab's scanner, tissue, specimen, pathologist, and workload context. | Best evaluated as a digital-pathology operating layer where primary diagnosis, AI launch, collaboration, and data-science workflows each need separate governance. |
| Aiforia | Match every Aiforia model to its CE-IVD, RUO, PSO, FDA, or local status; EU/EEA diagnostic claims for selected models should not be applied to all suites or markets. | Verify cloud processing, hosting region, slide upload, scanner integration, retention, customer data-processing terms, access controls, audit logs, and whether public website privacy terms are separate from clinical deployment terms. | Assess model-level performance by cancer type, tissue, stain, scanner, biomarker threshold, grade group, case prevalence, and pathologist review burden. | Best used as pathologist-controlled whole-slide image support where overlays, quantitative scores, triage, case review, and final report responsibility remain explicit. |
| Mindpeak | Verify the exact module, intended use, CE-IVD or local status, ISO 13485 scope, and whether the planned workflow is diagnostic, research, pharma, or deployment-specific. | Do not infer PHI terms from the public website privacy policy alone; require customer-contract, hosting, retention, access-control, scanner/LIS integration, and data-use terms. | Review product-specific validation and publications for the tissue, stain, biomarker, scanner, patient population, and scoring threshold used in the lab. | Map how AI hotspots, biomarker scores, tumor regions, and exceptions appear in the pathologist viewer and report before diagnostic use. |
| Aignostics | Treat Atlas H&E-TME as research-use pathology AI unless Aignostics provides product-specific diagnostic authorization for the intended workflow. | Verify customer-contract data handling, GDPR scope, ISO 27001 controls, processing location, retention, deletion, and slide-identification handling before upload. | Review the validation benchmark for each cancer type, tissue segment, cell class, scanner/stain context, and quantitative endpoint used in the research protocol. | Keep outputs in translational research, biomarker discovery, or study-analysis workflows with scientific review rather than clinical reporting. |
| Lumea | Separate Viewer+ primary-diagnosis claims from BxLink, AI marketplace tools, molecular-ordering workflows, and tissue-handling products; each module and partner algorithm needs its own intended-use review. | Review HIPAA/HITECH documentation, endpoint controls for remote pathologists, encryption, authentication, image storage, AI partner integrations, LIS data flow, retention, and customer-contract terms. | Check viewer validation, scanner compatibility, specialty workflow claims, AI partner evidence, molecular-ordering performance, and local turnaround-time or diagnostic-quality metrics. | Best evaluated as a full pathology operating workflow where specimen handling, slide viewing, AI review, molecular ordering, and final signout are mapped together. |
| Visiopharm | Treat each APP independently because diagnostic, IVDR-certified, CE-IVD, RUO, EU/UK, U.S., and partner-integration status can differ by use case. | Verify data-processing agreements, customer-data roles, image storage, cloud or local deployment, research-data sharing, access controls, retention, and partner-platform data paths. | Review APP-level validation for tissue, stain, biomarker threshold, scanner, laboratory population, performance evaluation, and post-market follow-up before clinical use. | Best used where AI outputs remain reviewable inside existing pathology platforms and where lab teams can govern APP selection, batch processing, QA, and signout. |
| Tribun Health | Match CaloPix, TeleSlide, AI Apps, and partner modules to regional FDA, CE, Health Canada, RUO, EULA, and AI Module Terms before diagnostic deployment. | Review hosting, Azure or local storage, remote access, scanner ingestion, LIS/PACS/EHR integration, customer data-processing terms, role access, audit logs, retention, and AI module data flow. | Assess validation and operational evidence for viewer performance, scanner compatibility, AI module accuracy, archive retrieval, second-opinion workflows, and user adoption in comparable labs. | Best evaluated as an image-management and AI-integration platform where pathologist review, second-opinion routing, telepathology, and final signout remain explicit. |
| Roche navify Digital Pathology | Match Roche Digital Pathology Dx, navify Digital Pathology, scanner/display configuration, specimen type, geography, and each AI algorithm to country-specific labeling, FDA 510(k), RUO, or local diagnostic-use status. | Review Roche digital trust materials, cloud hosting, Amazon S3 storage, encryption, authentication, audit logs, user roles, LIS/PACS data exchange, support access, BAA or DPA terms, and third-party algorithm data paths. | Validate scanner compatibility, viewer performance, image quality, algorithm accuracy, pathologist workload, LIS/PACS integration, downtime handling, and local specimen variability before clinical use. | Best governed as an enterprise digital-pathology operating layer where viewing, case collaboration, AI analysis, analytics, and final pathologist signout each have explicit boundaries. |
| PathPresenter | Separate the FDA-cleared Clinical Viewer configuration from ConsultConnect, education, biorepository, third-party AI models, other scanners/displays, non-U.S. regions, and research-use workflows. | Verify contractual HIPAA/BAA or DPA terms, cloud versus hybrid storage, de-identification requirements, user roles, remote consult sharing, audit logs, retention, and AI model data pathways before uploading patient slides. | Review FDA 510(k) materials, local scanner/display validation, pathologist viewer performance, consult turnaround, AI model validation, and any institution-specific V&V results before clinical signout use. | Best evaluated as a digital-pathology operating layer where image management, primary viewing, remote consults, education, research, and AI model testing each have explicit governance boundaries. |
| DoMore Diagnostics Histotype Px Colorectal | Confirm CE-IVD or other local status for the exact version, market, stage II/III colorectal indication, and whether the deployment is diagnostic, research, or platform-enabled. | Review slide upload, hosting, customer-contract data roles, platform-partner processing, retention, access controls, audit trails, and whether oncology data leaves the lab or hospital environment. | Check validation studies, endpoint definitions, patient population, scanner/site diversity, calibration, and whether evidence supports the actual treatment decision under consideration. | Best used as a tumor-board or oncology decision-support input where pathologists and oncologists review the biomarker beside conventional pathology, ctDNA, and guideline-based factors. |
| Regard | Treat as documentation, chart-review, and clinical-insight support; review any suspected-diagnosis or quality-capture workflow that affects diagnosis documentation, coding, or care decisions. | Verify EHR data access, mobile recording, transcript retention, BAA terms, role-based access, audit logs, and whether scribe-app privacy terms differ from the contracted enterprise deployment. | Require patient-record evidence for each recommended diagnosis, medication, history element, or documentation suggestion and monitor clinician acceptance alongside error and query rates. | Best governed as physician-reviewed proactive documentation with explicit override, correction, coding, CDI, and quality-reporting handoffs. |
| Bayesian Health | Treat the sepsis flagging workflow as high-risk medical-device software and match use to FDA 510(k) K250680; verify intended use, local policy, CDS review, and regulatory posture for any other Bayesian module. | Do not rely on marketing-site privacy alone; require customer security documentation, BAA terms, EHR integration details, PHI retention, audit logs, access controls, and analytics-data boundaries. | Review the FDA summary, peer-reviewed evidence, local validation, calibration, alert precision, sensitivity, adoption, equity monitoring, and whether outcome claims reproduce in comparable units. | Best deployed with pathway owners, clinician education, response protocols, alert escalation rules, override tracking, and ongoing governance review. |
| CLEW ICU | Treat as high-risk medical-device software and match deployment to the FDA-cleared indication, adult critical-care setting, prediction outputs, labeling, and change-control boundaries for K233216. | Review EHR, bedside-device, tele-ICU, and cloud data flows; BAA terms; PHI retention; access controls; audit logs; security posture; support access; and whether privacy materials are website-only or customer-contract specific. | Do not rely on clearance alone; validate local performance, alert thresholds, sensitivity, PPV, low-risk labeling, false negatives, false positives, workflow response, and subgroup performance. | Best governed by ICU, tele-ICU, rapid-response, biomedical, informatics, and patient-safety owners with defined escalation rules, override review, downtime plans, and post-deployment monitoring. |
| Mednition KATE | Treat as high-risk emergency-department clinical decision support; verify current FDA status for each KATE module because Breakthrough Device Designation can expedite review but does not by itself authorize marketing. | Review customer-data privacy terms, BAA, EHR data feeds, free-text processing, PHI retention, audit logs, support access, analytics exports, and whether retrospective cohort searches create separate governance obligations. | Validate published and vendor-stated triage and sepsis performance against local ED acuity mix, documentation quality, sepsis prevalence, nurse workflow, false alerts, missed alerts, and subgroup performance. | Best governed as nurse-reviewed triage and sepsis-risk support with explicit escalation rules, alert documentation, override capture, quality review, downtime plans, and post-deployment monitoring. |
| Fathom | Usually revenue-cycle automation rather than clinical decision support, but audit any workflow that directly assigns codes, affects claim submission, or changes coder accountability. | Review BAA, HITRUST scope, EHR and billing-system integrations, data retention, access controls, audit logs, and whether customer data is used to tune automation. | Validate automation rate, accuracy, denial impact, specialty coverage, low-confidence routing, and payer-rule behavior on local claims before reducing coder review. | Best deployed with coder QA, exception queues, denial monitoring, and compliance review rather than blanket touchless submission. |
| CodaMetrix | Primarily coding and revenue-cycle automation, but review service-line scope, coder accountability, payer compliance, and any autonomous coding claims before production use. | Verify health-system data ingestion, Epic or EHR connection path, BAA terms, retention, audit trails, access controls, and whether longitudinal clinical context is reused for model improvement. | Require service-line evidence for coding accuracy, denial reduction, turnaround time, ROI, payer-rule updates, and exception routing on local data. | Best for enterprise coding teams that can stage automation by specialty, keep human review for exceptions, and monitor denials, audits, and coder workload. |
| Apicare AuthAdvisor | Treat as high-risk payer utilization-management decision support because it can affect access to care; verify current CMS, state, accreditation, medical-policy, appeal, and adverse-determination requirements before automating any decision path. | Review BAA terms, Datavant/Apixio contracting entity, PHI and administrative-data feeds, historical decision-data use, model-training boundaries, role-based access, audit logs, retention, and subcontractors. | Require local validation for auto-approval precision, reviewer workload, overturned decisions, appeal rates, service-line performance, subgroup impact, and whether thresholds drift after policy or network changes. | Best governed as payer prior authorization routing and approval support with configurable thresholds, clinical reviewer oversight, policy-change controls, denial safeguards, appeal monitoring, and provider/member communication checks. |
| Nym | Treat Nym as revenue-cycle automation rather than clinical diagnosis support, while still reviewing coder accountability, payer compliance, claim submission controls, and any autonomous-release workflow that changes billing governance. | Verify enterprise BAA terms, chart-data flows, EHR or Epic connectivity, SOC 2/HITRUST scope, HIPAA assessment details, retention, support access, audit logs, and model-improvement data use. | Require service-line-specific validation on local encounters and track accuracy, denial rates, clean claims, audit trail completeness, exception rates, and the workload shift for coding staff. | Best staged by specialty or facility, with confidence thresholds, exception queues, compliance sampling, denial monitoring, and rollback criteria before reducing human coding review. |
| SmarterDx | Treat it as revenue integrity and documentation-support software; review any diagnosis, charge, or appeal recommendation that could affect coding, billing, quality reporting, or clinical documentation obligations. | Do not rely on the public website privacy policy for PHI terms; verify the customer agreement, BAA, retention, access controls, audit logs, and any Smarter Technologies data-sharing path. | Require chart-level evidence for every suggested diagnosis, charge, or appeal argument and monitor revenue lift alongside denial, audit, and compliance outcomes. | Map how findings move from AI review into CDI, coding, physician query, denials, and claim workflows before expanding beyond a controlled pilot. |
| Waystar AltitudeAI | Usually revenue cycle and administrative workflow software, but module-level review matters when outputs influence documentation specificity, coding, patient financial communication, or payer appeals. | Verify BAA, platform security, patient communication consent, EHR and payer connectivity, role-based access, audit logs, and any data-network or AI-training terms for the chosen modules. | Do not generalize platform-level claims; measure each module against local denial rates, reimbursement accuracy, patient AR, query response, coding accuracy, and compliance review outcomes. | Start with a named revenue cycle workflow and define human approval, exception handling, writeback, payer communication, and reporting ownership before automating. |
| Cedar Intelligence | Usually patient financial engagement and revenue cycle software, but review outreach, payment-plan, discount, financial-assistance, and support recommendations for consumer protection, consent, nondiscrimination, and payer/provider policy obligations. | Verify PHI, payment, voice, SMS, portal, PCI, HIPAA, BAA, HITRUST, subcontractor, retention, audit-log, and model-improvement terms before enabling personalized billing journeys. | Treat vendor lift and call-reduction metrics as directional; pilot against local patient AR, payment completion, complaint rates, assistance routing, call handle time, and resolution quality. | Best governed with revenue cycle, compliance, patient experience, and call center ownership over approved messages, escalation paths, financial-assistance routing, and exception monitoring. |
| Carta Healthcare Voyager | Primarily clinical data management and quality registry workflow software, but treat registry submission, quality reporting, research cohorting, and patient-care analytics as high-accountability outputs requiring local governance. | Confirm dedicated deployment, FHIR scope, AWS Bedrock and model-vendor terms, BAA coverage, SOC 2 scope, encryption, retention, access controls, audit logs, and whether any data is reused for product improvement. | Require field-level source evidence and compare AI-assisted abstraction against local abstractors for accuracy, IRR, missed data, hallucinated facts, and registry-specific edge cases. | Best deployed as hybrid intelligence with named abstractor review, submission controls, exception queues, registry change management, and audit sampling before scaling. |
| Layer Health | Treat as high-accountability chart-review and quality workflow support. Registry submission, clinical pathway, quality reporting, and research uses need workflow-specific governance and human validation. | Do not rely on the website privacy policy for PHI handling; verify the customer agreement, BAA, source-system access, retention, model-provider terms, audit logs, and whether customer data trains or tunes models. | Require field-level source evidence and compare outputs with local abstractors or clinical reviewers for accuracy, uncertainty handling, false inferences, and registry-specific definitions. | Best deployed with named review owners, source-link review, exception queues, registry change management, quality-program signoff, and post-launch sampling before scaling to new use cases. |
| Wellsheet Care Team Copilot | Treat as high-accountability EHR workflow, documentation, and clinical decision-support-adjacent software; review whether AI Pathways, calculators, discharge planning, or documentation outputs create regulated CDS or hospital policy obligations. | Verify customer-specific BAA, API/FHIR access, EHR marketplace terms, PHI retention, support access, audit logs, role controls, and whether customer data can be used for model or product improvement. | Require patient-chart source links for summaries, pathway suggestions, handoff content, discharge barriers, and documentation drafts, then compare outputs against local clinician review and quality measures. | Best piloted in one inpatient workflow with named clinician owners, source-evidence review, exception queues, documentation signoff, pathway override capture, and post-launch monitoring. |
| Tennr | Usually administrative patient-flow software, but review any workflow that influences patient prioritization, coverage criteria, authorization, or clinical documentation before automation. | Verify the customer agreement, BAA, retention, de-identified data use, access controls, audit logs, and payer/provider communication channels before sending PHI. | Require field-level evidence for extracted referral/order facts, missing-document decisions, payer criteria, and automated actions, then monitor denial and delay outcomes. | Start with one referral or order workflow and define staff approval, exception handling, payer contact, patient contact, writeback, and escalation ownership. |
| AKASA | Treat as revenue-cycle and documentation-integrity support; review any coding, CDI, quality, or authorization recommendation that can affect claims, payer communication, or clinical documentation. | Confirm customer-specific model training, clinical and financial data access, EHR/API/EDI integrations, BAA, SOC 2/NIST/CIS scope, retention, audit logs, and reporting visibility. | Validate evidence-backed recommendations, human expert review, local model tuning, prebill results, denial impact, and quality-reporting effects before scaling. | Best deployed one workflow at a time with explicit review queues for coding, CDI, auth status, claim status, and revenue-cycle research outputs. |
| Forus | Treat as medication-access and administrative automation; review payer-policy logic, appeal drafting, patient messaging, and any medication-specific recommendation boundary with compliance and prescribing leadership. | Verify BAA coverage, SOC 2 documentation, EHR integration, patient communication consent, PHI retention, pharmacy or affordability-program sharing, audit logs, and subcontractor terms. | Require traceable links between the prescription, chart evidence, payer criteria, generated forms, appeal content, and staff actions, then monitor approvals, delays, denials, renewals, and abandonment. | Best piloted in one specialty medication workflow with staff approval for submissions, denials, appeals, patient updates, and pharmacy routing exceptions. |
| Case Health AI | High-impact payer workflow software because outputs can influence medical necessity, approvals, denials, outreach, appeals, and CMS-0057-F implementation; require legal, clinical, compliance, and health-equity review. | Confirm BAA/MSA scope, PHI fields, model-training permissions, audit logs, role access, encryption, retention, subprocessors, patient-rights handling, and whether plan data stays in the United States. | Validate criteria matching, abstraction accuracy, denial rationales, incomplete-case routing, appeal outcomes, subgroup performance, and reviewer override data against real plan cases before production. | Map each case path from intake through AI extraction, policy comparison, clinician review, automatic approval, denial routing, outreach, member/provider notice, and appeal evidence. |
| Notable | Usually administrative automation, but review patient-access, quality, risk, prior-authorization, care-gap, and patient-message workflows for clinical, payer, and consent implications. | Verify customer agreement and BAA terms rather than relying on website privacy language; check patient messaging consent, EHR access, automation logs, retention, and vendor subprocessors. | Measure containment, booking accuracy, care-gap closure, authorization outcomes, no-show reduction, and exception quality against local baselines and patient-complaint data. | Best governed through workflow-specific guardrails that route urgent needs, failed automations, billing disputes, and clinical questions back to staff. |
| Qventus | Primarily operations automation, but review any workflow that changes patient prioritization, discharge timing, contact, or care coordination for clinical governance impact. | The platform depends on EHR and operational data; verify BAA, security documentation, user permissions, patient-contact consent, and audit logging. | Require local baselines and pilot metrics for capacity, throughput, cancellation reduction, follow-up completion, productivity, and exception handling. | Map the exact action loop from prediction to staff task, patient contact, schedule change, EHR update, or escalation before automating. |
| Caremaze | Treat as operational care-coordination support with patient-safety implications because discharge timing, placement, and outreach can affect care access and outcomes. | Map EMR feeds, notes, patient identifiers, voice recordings or call transcripts, task logs, U.S. hosting, BAA terms, access controls, retention, and subprocessors before launch. | Require local validation against discharge delay categories, disposition types, social-risk patterns, failed outreach, readmissions, and unintended access or equity effects. | Best deployed with staff approval gates, clear task ownership, escalation paths, audit logs, discharge-policy review, and monitoring for automation failure or over-reliance. |
| Laudio | Primarily operational workforce and patient-experience software, but review patient rounding, audit, compliance, staffing, and leader recommendations for employment, privacy, and care-quality governance impact. | Verify workforce, patient-rounding, EHR, HRIS, timekeeping, communication, and analytics data flows plus access controls, retention, audit logs, security reports, and customer contract terms. | Ask for comparable health-system evidence and monitor retention, engagement, manager capacity, patient-experience measures, staff burden, subgroup effects, and recommendation override behavior. | Best governed as leader decision support with manager accountability, explicit escalation paths, workforce-policy review, and periodic checks that AI recommendations are useful and fair. |
| LeanTaaS iQueue | Treat as operational capacity and scheduling decision support; review any configuration that affects patient prioritization, staffing, discharge timing, or access to care with clinical and operational governance. | Verify customer agreement terms for EHR, scheduling, staffing, bed, infusion, and user data; public privacy language separates website data from customer-directed service data. | Ask for workflow-specific evidence in comparable OR, infusion, or inpatient-flow settings and measure local utilization, access, delay, cancellation, overtime, and safety metrics before scaling. | Map who sees each recommendation, who can override it, what can change automatically, and how exceptions are escalated during day-of operations. |
| Iodine AwareCDI | Treat as CDI, coding, and revenue-cycle decision support; review any diagnosis, quality, or reimbursement recommendation that could affect claims, documentation, or payer communication. | Confirm BAA terms, PHI access, aggregation or de-identification rights, EHR data flows, support access, audit logs, retention, and customer-specific service agreements. | Require chart-level evidence for every suggested condition or query and monitor false positives, missed opportunities, denial outcomes, and physician response burden. | Best deployed with CDI and coding review queues, clear query policies, appeal handoffs, and compliance auditing rather than automatic documentation changes. |
| Cohere Health | Treat as payer operations and clinical-policy workflow software; review medical necessity, denial, appeal, CMS-0057 API, delegated review, and payment integrity obligations before production use. | Verify customer BAA terms, PHI upload paths, access controls, encryption, retention, subcontractors, provider portal controls, and whether public website privacy terms differ from contracted platform terms. | Ask for workflow-specific evidence on authorization accuracy, auto-approval quality, reviewer productivity, clinical guideline alignment, appeal outcomes, and provider/member impact in comparable specialties. | Map the full loop from provider request to AI evidence extraction, policy comparison, clinician review, determination, provider communication, appeal, and downstream payment integrity monitoring. |
| Rhyme | Treat as prior-authorization and utilization-management infrastructure with compliance impact; review CMS interoperability and prior authorization rules, state UM requirements, payer medical-policy governance, appeal rights, and who remains accountable for determinations. | Review contracted BAA and platform terms rather than relying only on website privacy because the public policy says platform data is governed by customer agreements; verify PHI minimization, AWS controls, access logs, retention, support access, and subprocessors. | Use vendor scale claims and partner materials as diligence inputs, then validate local touchless processing, approval accuracy, unnecessary request reduction, denial and appeal outcomes, patient delay, and payer/provider satisfaction by service line. | Best governed as staff-supervised authorization automation with clear payer-policy ownership, auto-approval boundaries, exception queues, real-time status reconciliation, audit sampling, appeal handoffs, and monitoring for delays or inappropriate automation. |
| Xsolis Dragonfly | Treat as high-impact operations and clinical-policy workflow software because recommendations can affect medical necessity, admission status, concurrent authorization, denials, appeals, and care coordination. | Verify PHI flows from EMR and financial systems, payer-provider data sharing, access controls, retention, audit logging, support access, customer BAA terms, and privacy-policy limitations. | Require evidence for the exact utilization-management workflow and compare local outcomes for accuracy, denials, appeals, LOS, reviewer productivity, and unintended access or equity effects. | Define which recommendations are advisory, which trigger reviewer queues, who signs off, how disagreements are handled, and how payer-provider collaboration is documented. |
| Navina | Treat as clinical and revenue-adjacent decision support because outputs can influence chart review, diagnosis documentation, care gap closure, risk adjustment, quality reporting, and reimbursement. | Verify the customer contract and BAA, EHR/HIE/claims data flows, scanned document handling, access logs, retention, support access, audit reports, and any model-improvement rights before using PHI. | Require patient-level source links for every surfaced condition, care gap, HCC, summary, or documentation suggestion and validate performance on local primary-care and value-based populations. | Best used with named clinician, coder, quality, and compliance review loops so AI-surfaced insights become auditable recommendations rather than automatic documentation changes. |
| Artisight | Treat smart-room and ambient-monitoring use as high-accountability clinical operations infrastructure; review monitoring, documentation, alerting, device, and patient-safety obligations module by module. | Map cameras, microphones, sensors, EHR links, room context, command-center views, recordings, retention, access controls, BAA terms, support access, and patient-notice obligations before go-live. | Validate each workflow locally, especially fall prevention, virtual sitting, virtual nursing, OR throughput, voice documentation, alarm fatigue, response times, and safety-event review. | Best deployed with named nursing, virtual care, IT, privacy, security, quality, and biomedical owners for room activation, escalation, downtime, review, and post-deployment monitoring. |
| care.ai | Treat ambient monitoring and smart-room workflows as high-accountability clinical operations infrastructure; review device, video monitoring, alerting, patient-safety, and local regulatory obligations by workflow. | Map camera, audio, sensor, room, EHR, command-center, and virtual-care data flows, then verify consent, patient notice, retention, access controls, support access, cybersecurity, BAA terms, and recording restrictions. | Validate workflow-specific performance locally rather than relying on platform claims, especially for fall risk, patient deterioration, protocol adherence, alarm fatigue, staff response, and safety-event reduction. | Best deployed with named nursing, virtual care, IT, privacy, security, biomedical, and quality owners for alert routing, escalation, downtime, review, and post-deployment monitoring. |
| AvaSure Intelligent Virtual Care | Treat as high-accountability inpatient operations and patient-safety infrastructure; review each workflow separately because virtual nursing, observation, fall or elopement alerts, environmental sensing, and AI assistant functions can carry different device, clinical, labor, and patient-notice obligations. | Map video, audio, room sensors, patient identifiers, EHR links, device feeds, command-center views, recordings, analytics, support access, hosting model, retention, access controls, privacy mode, BAA terms, and patient-notice requirements before activation. | Validate AI-enabled observation and virtual nursing locally, measuring false alerts, missed events, observer ratio, response time, nursing burden, patient experience, incident reduction, subgroup effects, and whether analytics match the deployed workflow. | Best governed with named nursing, virtual care, patient safety, IT, security, privacy, biomedical, and quality owners for room activation, escalation, handoff, downtime, audit review, and post-deployment monitoring. |
| Caregility Connected Care | Treat as high-accountability inpatient operations and patient-safety infrastructure; review each module separately because telehealth, observation, contactless vitals, voice workflows, and AI alerts can carry different clinical, device, labor, and patient-notice obligations. | Map video, audio, radar, vitals, patient identifiers, room context, telehealth sessions, EHR links, recordings, analytics, support access, retention, access controls, BAA terms, and patient-notice requirements before activation. | Validate each deployed workflow locally rather than relying on platform claims, especially virtual nursing, sitter ratios, fall or elopement detection, vitals trends, response times, missed events, false alerts, and staff burden. | Best governed with named nursing, virtual care, patient safety, IT, security, privacy, biomedical, and quality owners for room activation, escalation, handoff, downtime, audit review, and post-deployment monitoring. |
| Oxehealth Oxevision | Separate Sleep, Vital Signs, Activity Tracker, Seclusion, and local observation workflows because FDA, UK/EU device status, CDSS status, version, and intended use can differ by module. | Map camera/infrared data, live-view windows, clear-video requests, room context, reports, retention, access controls, patient notices, consent, ward policy, and support access before go-live. | Validate the product in the target ward type and patient population, measuring false alerts, missed events, observation burden, nighttime disturbance, patient dignity, and incident-review quality. | Best governed as supervised nursing and safety support, with trained users, explicit escalation rules, downtime plans, patient communication, and governance review of each ward deployment. |
| Cadence Clinical Intelligence | Treat as high-impact remote care delivery and clinical operations support; review physician control, medication titration, remote monitoring, care-management, billing, and state-practice obligations before launch. | Review Cadence privacy materials, provider Notices of Privacy Practices, device and EHR integrations, patient consent, access controls, retention, support access, and customer or partner agreements for PHI handling. | Use Cadence's public outcome and publication claims as a starting point, then validate alert performance, medication workflow, utilization impact, rural or underserved reach, and adverse-event review locally. | Best governed as clinician-led remote care infrastructure with explicit protocols for AI-agent suggestions, nurse or clinician escalation, medication changes, device failures, and patient nonresponse. |
| Biofourmis Biovitals | Verify the exact Biovitals product, version, device configuration, intended use, country, and FDA or local authorization before treating analytics as clinical monitoring support. | Review Biofourmis privacy materials and customer agreements for PHI, cloud storage, cross-border transfer, device data, retention, audit logging, support access, and whether HIPAA notices govern patient data. | Validate personalized baseline and deviation logic on the local care pathway, sensor mix, acuity level, adherence pattern, and escalation capacity rather than relying only on platform claims. | Best governed with explicit clinical review, alert triage, device troubleshooting, patient outreach, escalation ownership, downtime plans, and post-deployment safety monitoring. |
| Current Health | Treat as remote monitoring and care-at-home infrastructure; verify whether any module changes clinical triage, patient prioritization, alarm routing, reimbursement, or device-regulated responsibilities. | Review Current Health patient privacy terms, customer agreements, healthcare-organization notices, device data, questionnaire data, cloud analytics, retention, support access, and EHR integration controls. | Measure local reliability, adherence, alarm quality, response time, readmission or utilization impact, patient experience, and staff burden before scaling monitoring pathways. | Best governed through care-at-home playbooks that define device onboarding, alarm triage, nurse review, escalation, tech support, downtime, and discharge from monitoring. |
| Huma Cloud Platform | Classify each Huma-built application separately because platform, RPM, triage, clinical dashboard, research, and SaMD workflows can carry different intended-use and jurisdiction requirements. | Review Huma documentation and contract terms for patient data settings, consent, access controls, integrations, device data, retention, export, subprocessors, and regional hosting before deployment. | Require pathway-specific validation for triage, RPM, screening, clinical dashboard, or research workflows; platform scale does not prove local clinical safety or performance. | Best governed as configurable infrastructure with named product, clinical, privacy, security, and safety owners for every app built, changed, monitored, and retired. |
| John Snow Labs Healthcare NLP | Treat as clinical data infrastructure and workflow support unless a configured pipeline directly informs care, diagnosis, or regulated medical-device use; classify each deployment by intended use and jurisdiction. | Review license terms, BAA, hosting model, de-identification workflow, PHI categories, prompt and output handling, support access, audit logs, retention, and whether sample/demo data are used to improve models. | Validate extraction, assertion, terminology mapping, summarization, OCR, and de-identification performance on local notes, scanned documents, specialty language, rare entities, and downstream registry or analytics definitions. | Best governed as a reviewed data-curation layer with quality sampling, exception queues, privacy approval, reviewer signoff, and change control before scaling to new document types or downstream analytics. |
| Hippocratic AI | Start by confirming whether the planned agent is access, follow-up, RPM adherence, inpatient nurse support, life-sciences, or clinical conversation support; reclassify if local configuration influences diagnosis, prescribing, triage, medication decisions, or care escalation. | Do not infer deployment PHI terms from public website privacy language alone; verify the customer contract, BAA, call recording and transcript handling, de-identification, retention, model-improvement rights, support access, and subcontractors for the exact workflow. | Treat vendor safety counts, benchmark claims, and de-identified call examples as directional; require local scripts, adversarial cases, escalation audits, patient-experience metrics, nurse-review results, equity checks, and post-launch incident review. | Constrain each agent to named intents, approved scripts, handoff rules, emergency escalation, exclusions, monitoring dashboards, and accountable owners before exposing it to patients or inpatient teams. |
| Tucuvi | Treat as high-accountability patient-facing clinical workflow software; verify the CE-marked SaMD scope, intended use, jurisdiction, clinical protocol, and whether each deployment is monitoring, scheduling, documentation, or triage-like support. | Review consent capture, call recording, transcripts, health data, PHI, HIPAA/GDPR terms, regional data location, subprocessors, access controls, retention, deletion, and controller/processor roles before activating patient calls. | Use vendor case studies as directional only; require local testing of alert accuracy, missed deterioration, false escalation, call completion, language performance, patient comprehension, and nurse-review burden. | Deploy with named clinical, nursing, patient-access, privacy, security, and integration owners for protocol design, anomaly review, urgent escalation, downtime handling, and post-deployment monitoring. |
| Infermedica | Separate the hosted product from the Engine API: Infermedica says the Engine API itself is not intended for direct clinical use and that final device classification depends on the customer-built application and jurisdiction. | The docs say Engine API processes de-identified symptom sets while Platform API can store personal data; verify which mode you are buying, whether anonymous mode is enabled, and how retention and access are handled contractually. | Do not rely on global accuracy or validation claims alone; test triage disposition, language performance, symptom coverage, and false reassurance risk in your local population and care-routing setup. | Decide whether the product is being used for intake, symptom checking, triage, or nurse-support, then define emergency scripts, escalation paths, and who owns the final recommendation. |
| Ubie | Treat as high-risk patient-facing symptom assessment; confirm jurisdiction, intended use, labeling, and whether the deployment changes care-routing or regulated-device obligations. | Review Ubie's collection of health inputs, medication and appointment information, account data, analytics, transfers, retention, and any enterprise agreement before directing patients to it. | Validate triage, possible-cause, and red-flag behavior against local protocols and population needs rather than relying only on global accuracy or publication-count claims. | Use only with clear warnings, emergency instructions, escalation paths, and a plan for how patients move from self-check output to appropriate care. |
| Hyro | Treat Hyro as patient-access infrastructure unless the configured agent starts handling symptoms, medication questions, or clinical guidance that could change the regulatory and clinical accountability profile. | Verify the actual healthcare deployment terms for PHI, patient record access, recordings, SMS or chat retention, Epic or CRM integrations, and any BAA or customer-specific privacy obligations. | Vendor accuracy and ROI claims should be treated as case-study signals only; measure automation, abandonment, handoff quality, incorrect routing, and unsafe-answer rates on your own intents before scaling. | Define exactly which requests are auto-resolved, which are routed, and which require staff takeover so the agent stays within approved access and support boundaries. |
| Infinitus | Treat as healthcare communications and access workflow automation; reassess risk when agents collect symptoms, side effects, adverse events, financial eligibility, or payer denial details that require regulated or staffed follow-up. | Review consent, call recording, transcripts, PHI, identity verification, retention, subprocessors, customer contracts, and BAA coverage before deploying agents into patient, payor, or provider calls. | Validate call-completion, data accuracy, protocol compliance, adverse-event detection, handoff quality, and patient experience on your own call types instead of relying on aggregate platform claims. | Define each call script, forbidden statements, escalation trigger, staff queue, retry behavior, documentation destination, and monitoring owner before scaling agentic calls. |
| Artera Harmony | Treat as patient access and communications infrastructure unless a configured workflow collects symptoms, provides triage-like guidance, or changes clinical escalation. | Review PHI handling, secure versus unsecure channels, consent, retention, EHR/vendor integrations, message content, role access, and provider-specific privacy responsibilities. | Measure no-show, scheduling, intake, billing, response, and staff-time outcomes separately, and test edge cases before adding autonomous voice or text agents. | Map every message source, cadence, channel, escalation path, and staff queue so AI automation does not create duplicate, conflicting, or unsafe patient communications. |
| Fabric | Separate administrative access workflows from symptom gathering, triage, and virtual care, because physician-built clinical logic and routing can carry a different clinical-governance and device-review burden than scheduling alone. | Fabric publishes HIPAA and SOC 2 Type 2 positioning, but you still need the customer contract, access-control design, retention terms, integration boundaries, and patient-consent model for the exact deployment. | Use case studies as a starting point only; validate routing accuracy, symptom-intake safety, scheduling completion, handoff quality, and downstream clinical or access outcomes in your own setting. | Map where symptom collection ends, where routing or virtual care begins, and when a human clinician or access team member must review or take over. |
| Corti | Risk depends on the configured Corti workflow, so separate documentation, coding, prior authorization, and patient-facing agent use before deciding what clinical-governance or regulatory review is required. | Verify regional hosting, PHI retention, voice and transcript controls, subcontractors, customer logging boundaries, and BAA or DPA terms for the specific deployment rather than relying on generic platform claims. | Treat benchmark and launch claims as a starting point only; run workflow-specific tests for escalation, hallucinations, multilingual quality, coding accuracy, and human override burden before production use. | Constrain each agent, model, and tool path to a named job with auditability, handoff rules, and rollback paths so governed deployment remains practical. |
| C the Signs | Treat as high-risk clinical decision support and cancer-pathway software; verify UKCA Class I, MHRA-regulated status, NHS clinical-risk files, intended users, patient self-assessment boundaries, and any non-UK regulatory pathway before deployment. | Review controller/processor roles, GP or provider data agreements, NHS number use, EHR record access, coded writeback, UK hosting, self-assessment flows, retention, subprocessors, cross-border transfers, and patient-facing consent. | Use the official research trail as a starting point, then validate sensitivity, tumour-origin prediction, referral burden, stage shift, equity effects, and missed-cancer review against local cancer pathways and population mix. | Define when the platform runs during consultation, self-assessment, or population scanning; who reviews outputs; how referrals are made; how false positives or missed cases are audited; and how pathway updates are governed. |
| Sully.ai | Risk varies sharply by agent role; separate administrative reception, documentation support, coding extraction, triage intake, nurse-agent behavior, interpreter workflows, and any clinical-advice or CDS behavior before deployment. | Verify HIPAA/BAA terms, PHI/PII data maps, audio and transcript retention, bidirectional EHR flow, webhook security, API logging, cookies, support access, subcontractors, deletion rights, and whether marketing-site privacy terms differ from signed clinical agreements. | Do not rely on broad agent or time-saved claims alone; run role-specific safety tests for note accuracy, coding precision, escalation sensitivity, multilingual communication, EHR writeback errors, and staff override behavior. | Constrain each Sully agent to a named job with allowed actions, forbidden actions, handoff rules, clinician or staff review, rollback paths, audit trails, downtime procedures, and monitoring before broad rollout. |
| Memora Health | Separate care management, education, symptom collection, remote monitoring, and escalation workflows because patient-facing risk changes by program and message content. | Review SMS consent, PHI in text channels, account and profile retention, subcontractors, customer-contract terms, BAA coverage, opt-out controls, and how any Commure transition affects data governance. | Validate engagement, adherence, symptom escalation, patient satisfaction, and safety outcomes in the specific care program rather than relying on cross-program performance claims. | Best governed as care-team extension software with defined message libraries, escalation paths, queue ownership, after-hours behavior, and clinical review for program updates. |
| Ada Health | Confirm which Ada product and geography are in scope, because Ada positions some enterprise flows as regulated symptom-assessment technology and says jurisdiction-specific limits still need to be verified. | Ada publishes privacy and compliance claims, but the deployment review still needs to cover consent, partner data sharing, retention, automated-decision boundaries, and any HIPAA or regional health-data obligations. | Use published studies and enterprise claims as supporting context only; validate routing accuracy, false reassurance risk, escalation quality, and handover usefulness in your own population and service map. | Define how symptom assessment, care navigation, and clinician or access-team handover connect so users are not left with ambiguous next steps or delayed escalation. |
| Mediktor | Separate symptom assessment, routing, telemedicine support, and LLM-enhanced agent behavior because each deployment can change clinical, regional, and regulated-device obligations. | Review privacy, security, consent, retention, subprocessor, integration, and customer-contract terms before using Mediktor with PHI or patient-identifiable symptom data. | Ask for clinical-validation materials that match the target language, patient population, care setting, acuity distribution, and routing protocol. | Configure it as a bounded digital-front-door workflow with clear service routing, emergency escalation, human handoff, and post-launch safety review. |
| Luma Health Navigator | Treat as patient access and operational automation unless a configured workflow starts making clinical recommendations, handling urgent symptoms, or changing medication/refill decisions. | Review Luma's policy documents, AI data handling claims, voice/SMS data flows, EHR integrations, subprocessors, retention, access controls, and BAA terms for the exact Navigator workflow. | Use public customer outcomes as directional only; validate call automation, patient verification, cancellation accuracy, refill routing, escalation quality, language performance, and safety edge cases locally. | Define each self-service task, fallback path, staff queue, channel switch, patient-identity check, and monitoring owner before letting Navigator resolve patient requests autonomously. |
| Clearstep Smart Care Routing | Treat as high-risk patient-facing triage and routing; verify intended use, jurisdiction, protocol ownership, clinical-review process, and whether the deployment creates regulated medical-device obligations. | Review BAA coverage, transcript and symptom-data retention, AWS hosting, encryption, identity handling, email limitations, EHR/CRM integrations, and customer-controller responsibilities before launch. | Validate triage dispositions, emergency handling, endpoint fit, false reassurance, over-triage, and patient completion in the local service map and acuity mix. | Deploy with explicit care endpoints, emergency scripts, staff escalation queues, scheduling rules, marketing boundaries, and post-launch review of unexpected triage patterns. |
| Fabric Health | Treat as patient-facing triage, navigation, and clinical workflow support; verify intended use, jurisdiction, clinical protocol ownership, physician-built logic, escalation language, and whether any configured workflow creates regulated clinical decision-support obligations. | Review customer-specific BAA, PHI handling, patient-facing notices, EMR integration permissions, chat and symptom-data retention, support access, access controls, deletion, subprocessors, and how website versus patient-solution privacy terms differ. | Use official case studies and vendor performance claims only as diligence inputs; run local validation for triage dispositions, urgent escalation, routing completeness, patient completion, call-center deflection, and subgroup performance. | Best governed as a digital front door with explicit endpoint maps, emergency scripts, live escalation, care-team queue ownership, clinical-quality review, analytics monitoring, and periodic audit of unexpected routing patterns. |
| Canary Speech | Treat as high-impact screening and clinical decision-support software. Confirm the intended-use boundary for each vocal biomarker, whether local deployment triggers medical-device, CDS, behavioral-health, employment, or trial-endpoint obligations, and who owns final clinical interpretation. | Review consent, audio recording, survey data, identifiers, device metadata, de-identification, model-improvement rights, service providers, international transfers, retention, access controls, audit logs, BAA terms, and whether public privacy language matches the customer agreement. | Require condition-specific validation for the exact population, language, device, setting, and workflow; review sensitivity, specificity, calibration, subgroup performance, background-noise robustness, and evidence behind any outcome or early-detection claims. | Best governed as a supervised screening signal that routes uncertain or high-risk results to qualified staff, documents limits, avoids standalone diagnosis, and monitors false positives, missed cases, escalation quality, and patient experience after launch. |
| Ellipsis Health | Treat as high-risk behavioral-health screening and clinical decision-support software unless a deployment is explicitly limited to non-clinical wellness or research. Verify intended use, jurisdiction, claims, and whether medical-device obligations apply. | Review audio capture, voiceprint sensitivity, transcripts, derived features, consent, deletion rights, BAA/DPA coverage, retention, model-training boundaries, subcontractors, and telehealth or call-center data flows. | Require condition-specific validation for the deployment population, language, phone or microphone channel, care setting, and workflow; inspect calibration, bias, sensitivity, specificity, and clinical follow-up results. | Best governed as clinician- or care-manager-reviewed screening support with documented escalation, crisis routing, score interpretation guidance, and post-launch safety monitoring. |
| Syllable Healthcare Agents | Treat as access and workflow automation unless an agent is configured for symptoms, clinical guidance, or autonomous EHR actions that require clinical-governance and regulatory review. | Verify BAA terms, Epic authorization scope, transcript retention, third-party model routing, speech vendor routing, logs, role access, and audit evidence for the exact channels and agents. | Run scripted and live-shadow tests for scheduling accuracy, patient verification, handoff quality, latency, tool failures, speech recognition, and unsafe or out-of-scope responses. | Limit each agent to named intents, approved tools, identity checks, escalation rules, and monitoring dashboards before expanding to additional access-center workflows. |
| Assort Health | Treat as patient access and operational automation unless a configured workflow handles symptoms, care routing, refills, or clinical questions that need clinical governance and escalation review. | Verify BAA terms, patient privacy policy scope, call recording and transcript retention, SMS/email consent, EHR/PMS permissions, deidentified-data use, and subcontractor/model terms. | Validate booking accuracy, escalation quality, specialty-protocol adherence, abandonment reduction, patient satisfaction, care-gap completion, and payment workflows against local call recordings and staff audits. | Start with named intents and approved scripts, then define identity checks, forbidden advice, staff handoff, EHR writeback, QA sampling, and stop rules before expanding to more complex calls. |
| Anima Health | Treat as high-accountability patient-access and primary-care workflow software. Verify exact module scope, MHRA Class I status where applicable, NHS clinical-safety documentation, local DCB0160 deployment duties, and whether configured workflows cross into clinical triage or decision support. | Review DPA, DPIA templates, UK GDPR controller/processor roles, patient identifiers, message and document content, video-call metadata, SMS suppliers, UK hosting, staff access, retention, EHR integration permissions, and whether any AI or ambient-scribe processing changes the data-flow map. | Use vendor claims and practice testimonials as directional only; measure local demand management, response time, routing accuracy, document-processing errors, code-suggestion quality, unsafe request handling, accessibility, complaints, and clinician workload. | Deploy with named GP, nursing, admin, clinical-safety, IG, and integration owners; define approved request categories, red-flag escalation, inbox ownership, EHR writeback review, scribe signoff, downtime plans, and post-launch audit cadence. |
| Limbic Access | Treat as high-risk patient-facing mental health intake and clinical decision-support software; verify UKCA status, IFU, NICE evidence-generation conditions, local DTAC or equivalent approvals, age limits, and whether diagnosis-predictor functions are in scope. | Review consent, mental health data handling, dashboard access, EHR integration, privacy-policy region, retention, safety notices, support access, subcontractors, and service-provider information-governance controls before launch. | Use NICE's evidence-generation requirements as a minimum: track information quality, clinical-assessment impact, administrative burden, time saved, patient feedback, costs, equality, and local safety events. | Best governed as a digital front door that prepares clinician-led mental health assessments, with clear emergency routing, excluded-use rules, human review of reports, and post-launch monitoring. |
| Wysa | Treat as high-risk behavioral-health software. Verify the exact product, intended use, population, geography, clinical-program status, and whether any FDA Breakthrough designation has progressed to clearance or authorization for the planned deployment. | Review conversation data, assessment scores, safety flags, institution reporting, OpenAI/LLM processing, anonymized training and analytics, AWS hosting, fitness-data use, coach or medical-assistant records, and local BAA/DPA terms. | Review product-specific clinical evidence, crisis and safeguarding performance, PHQ-9/GAD-7 handling, user engagement, human escalation quality, and outcomes for the target population before rollout. | Best governed as supervised behavioral-health access and support, with clear exclusions, emergency routing, human escalation, institution reporting boundaries, and periodic clinical safety review. |
| Ellipsis Health Sage | Treat as high-risk patient-facing care-management and behavioral-health support. Verify whether the deployment is operational outreach, clinical assessment support, mental health screening, or decision support, and confirm no workflow implies autonomous diagnosis, treatment, or emergency response without appropriate regulatory and clinical review. | Review BAA and customer terms, call recording consent, audio and transcript redaction, PHI and consumer health data processing, metadata use, deletion rights, service providers, Salesforce or partner data flows, retention, support access, model training, and whether public privacy claims match the contracted deployment. | Use published voice-biomarker studies as starting evidence only. Require local validation for call type, language, population, PHQ-8 or GAD-7 correlation, subgroup performance, escalation accuracy, patient satisfaction, and whether automated outreach improves outcomes rather than only contact volume. | Best governed with care-management, behavioral health, nursing, quality, privacy, legal, and patient-experience owners defining approved scripts, consent language, forbidden clinical advice, escalation queues, clinician review, complaint handling, and post-launch monitoring. |
| Woebot Health | Treat as high-risk behavioral-health software. Breakthrough Device Designation for WB001 is not the same as FDA clearance, and Woebot's own AI principles page identifies W-DISC-MVP as investigational and not FDA evaluated, cleared, or approved. | Review privacy policy, PHI handling, HIPAA posture, partner data sharing, third-party model or service-provider use, data retention, user rights, and whether organization-specific BAA or DPA terms cover the planned workflow. | Separate broad wellness claims from product-specific evidence. Require current trial status, peer-reviewed publications, safety data, population fit, crisis-performance evidence, and outcome measures for the exact product version. | Govern as supplemental mental-health support or clinician-supervised digital-therapeutic access, with explicit crisis routing, excluded-use rules, partner responsibilities, human escalation, and incident review. |
| K Health | Treat as high-risk patient-facing clinical AI, care navigation, and virtual care access. Verify intended use, clinician involvement, regional medical-practice structure, symptom-checker limitations, telehealth rules, and whether any configured workflow creates regulated medical-device obligations. | Review HIPAA/OHCA coverage after account creation, consumer health data notice, AI model-improvement terms, advertising and analytics sharing, partner health-system records, EHR integration, identity verification, retention, and patient-record transfer paths. | Check peer-reviewed and internal validation claims against the exact workflow, acuity mix, patient population, clinician review process, specialty scope, and downstream prescription, referral, or escalation decisions. | Best governed as AI-assisted intake and access with licensed clinician review, explicit emergency exclusions, clear patient messaging, partner-health-system continuity, draft-chart review, and monitoring of unsafe dispositions. |
| MedAware | Treat as high-risk medication clinical decision support; confirm intended use, jurisdiction, and whether the deployed claims or partner integration create regulated software obligations. | Review EHR and prescribing-data access, PHI flow, partner environment controls, BAA terms, audit logs, data retention, and whether local data are used for model refinement. | Validate alert relevance, false positives, missed high-risk orders, clinician behavior change, medication-error outcomes, and subgroup performance in local medication workflows. | Best deployed with pharmacy, informatics, medication safety, prescriber governance, and monitored escalation paths rather than unfiltered alerts to frontline clinicians. |
| DrFirst Clinical-Grade AI | Treat as medication safety and reconciliation decision support; verify intended use, EHR integration, safety-check claims, and whether any deployed workflow requires clinical, legal, or regulated software review. | Review prescription, payer, medication-history, EHR, support, and integration data flows plus BAA terms, audit logs, role access, retention, and any AI training or model-improvement rights. | Validate sig translation, inferred detail safety, medication-history completeness, allergy or interaction alert triggering, false normalization, and downstream medication-error outcomes locally. | Best deployed with pharmacy and clinical informatics ownership, reconciliation review, exception queues for low-confidence data, and monitoring of overrides or missed medication risks. |
| DoseMeRx | Treat as high-risk medication dosing decision support and verify local clearance, intended use, drug-model scope, and clinician accountability before production use. | Review patient demographics, lab data, medication levels, genotype fields, EHR integration, hosting, HITRUST evidence, BAA terms, retention, and access controls. | Validate drug-model fit, lab-timing assumptions, local patient mix, outcome claims, and dosing recommendations against stewardship or pharmacy protocols. | Best used inside pharmacist-led dosing programs with documented review, lab-quality checks, escalation rules, and dose-change signoff. |
| InsightRX Nova | Treat as high-risk precision dosing clinical decision support; verify exact regulatory, quality, and intended-use claims for the deployment country and workflow. | Review EHR, lab, dosing, demographics, and life-sciences data flows plus security certifications, access controls, BAA or DPA terms, retention, and auditability. | Validate model implementation, local drug-level timing, uncertainty, drug-library fit, and outcome monitoring before changing dosing protocols. | Best used with clinical pharmacy or pharmacology ownership, protocol alignment, dose-review documentation, lab coordination, and ongoing model-performance review. |
| Arine | Treat as medication management and population-health decision support unless configured for direct clinical decisions; align use with pharmacist, care-team, quality, and plan obligations. | Review claims, pharmacy, clinical, SDoH, outreach, language, and member-contact data flows plus BAAs, consent posture, subcontractors, retention, and audit controls. | Validate program-level outcomes, recommendation acceptance, adherence and hospitalization claims, subgroup performance, and causal assumptions against local or plan data. | Best used with pharmacist and care-team review, defined outreach scripts, prescriber engagement rules, quality-measure ownership, and continuous monitoring. |
| Bluesight Prism | Treat as pharmacy operations and compliance decision support, not a final determination engine; diversion investigations require policy, HR, legal, and clinical governance. | Review controlled-substance, PHI, employee, audit, prompt, and model-provider data handling plus BAA terms, role permissions, retention, and investigation access controls. | Validate that summaries trace back to source records, preserve context, avoid unsupported accusations, and improve review time without increasing false escalations. | Best deployed with compliance-approved prompts, investigation checklists, source-record review, escalation rules, and periodic audit of AI-assisted findings. |
| EveryDose Provider | Treat as medication management, adherence, education, and remote monitoring support unless configured for clinical decision support; medication decisions remain with licensed staff. | Review patient app, provider portal, EHR, claims, pharmacy, survey, outreach, and analytics data flows plus BAA terms, hosting, encryption, access, retention, and audit controls. | Validate adherence, med-list accuracy, adverse-event surveillance, readmission, quality-measure, patient satisfaction, and workload claims against local populations and workflows. | Best used with defined outreach queues, medication-concern escalation, pharmacist or clinician review, patient education ownership, and EHR documentation rules. |
| DreaMed endo.digital | Treat as high-risk, regulated diabetes clinical decision support. Verify the exact cleared device version, indications, patient population, insulin regimen, device compatibility, and clinician-review requirements before use. | Review diabetes device data, patient app data, EHR integration, PHI, audit logs, SOC 2 and HIPAA claims, BAA terms, retention, support access, and any data use for product improvement. | Validate FDA summaries, clinical evidence, local patient mix, unsupported-regimen exclusions, clinician agreement, override rates, glycemic outcomes, and adverse-event monitoring. | Best deployed with endocrinology and pharmacy governance, clear insulin-change signoff, device-data quality checks, remote-monitoring protocols, and documentation of accepted or rejected recommendations. |
| GenXys TreatGx | Treat as pharmacogenomic clinical decision support and verify local CDS, laboratory, privacy, and prescribing obligations for the intended use and jurisdiction. | Review genomic, medication, condition, allergy, EHR, pharmacy, lab, and user-action data flows plus BAA terms, hosting, access, retention, and auditability. | Validate source-guideline currency, PGx phenotype handling, interaction prioritization, condition coverage, alert burden, and recommendation acceptance in local pilots. | Best governed through prescriber, pharmacist, informatics, lab, and precision medicine review with explicit responsibility for final prescribing decisions. |
| FDB Meducation | Treat as medication education and adherence support unless local configuration turns it into medication decision support; validate instructions before patient-facing use. | Review EHR, pharmacy, MAR, portal, print, and language-preference data flows plus BAA/license terms, access, retention, and patient-delivery controls. | Check readability, translation quality, patient comprehension, medication-error reduction, adherence outcomes, and validation of AI/NLP-transformed sig instructions. | Best used as a clinician-reviewed education layer embedded in discharge, MAR, pharmacy, or ambulatory workflows with counseling and escalation still owned by staff. |
| AiCure | Treat as medication adherence, trial monitoring, and patient engagement support; verify whether the local use affects clinical trial endpoints, regulated evidence generation, remote patient monitoring, or patient-care decisions. | Review captured video, facial images, biometric matching, medication-event data, PHI, sponsor/provider access, retention, encrypted storage, country filings, consent, and child or vulnerable-population notices before use. | Validate adherence detection, missed-dose alerts, participant burden, equity across devices and populations, site intervention timing, and how adherence data changes trial or care decisions. | Best governed with study-team or care-team review queues, participant support scripts, escalation paths, consent language, data-monitoring plans, and audit trails for every adherence intervention. |
| Medisafe Maestro | Treat as medication adherence and patient engagement support; verify whether local configuration triggers adverse-event reporting, regulated patient support, remote monitoring, or clinical program obligations. | Review medication lists, health information, caregiver contacts, app telemetry, voice interactions, pharma and provider data sharing, AI insight generation, consent, retention, and patient rights. | Validate adherence and persistence outcomes by therapy, population, channel, and language, and test false-positive or overmessaging risk before scaling. | Best governed with approved patient-support content, documented escalation paths, adverse-event intake rules, program analytics review, and clinician or pharmacist ownership for medication decisions. |
| Synapse Medication Shield | Verify the exact module and jurisdiction because Synapse materials reference pharmacovigilance automation, e-prescribing, CE-marked medical-device components, HAS certification, and ONC-certified Synapse Prescribe disclosures. | Review anonymization, HDS hosting, GDPR posture, PHI export, adverse-event report content, patient identifiers, integration logs, retention, and cross-border transfer constraints. | Check published validation of adverse-event coding, local MedDRA mapping performance, severity prioritization, expert override rates, and downstream reporting quality. | Best governed as expert-reviewed pharmacovigilance or prescribing-safety support with clear queues, override documentation, regulatory reporting ownership, and post-deployment performance monitoring. |
| RxLogix PV Signal | Treat as regulated life-sciences pharmacovigilance infrastructure; validate against GxP, FDA, EMA, local authority, SOP, inspection, and safety reporting requirements before production use. | Review safety case data, adverse-event narratives, patient identifiers, reporter information, literature and database connectors, role access, audit logs, hosting model, and cross-border processing. | Evaluate signal detection sensitivity, false positives, literature mining quality, data-source coverage, validation workflow, audit evidence, and safety physician acceptance before relying on automation. | Best governed as a PV operations platform with safety expert review, SOP-aligned signal lifecycle states, documented decisions, inspection-ready audit trails, and periodic model and data-source review. |
| ArisGlobal LifeSphere Safety | Treat as regulated pharmacovigilance infrastructure; confirm GxP validation, local health-authority reporting obligations, SOP alignment, and module-specific intended use before production automation. | Review safety narratives, patient and reporter identifiers, multilingual intake, email or document ingestion, literature feeds, translation flows, role access, audit logs, vendor support, retention, and cross-border transfers. | Validate extraction accuracy, duplicate handling, MedDRA or WHODrug coding support, signal quality, translation quality, false negatives, false positives, and reviewer acceptance against local case data. | Best governed as safety expert-reviewed automation with documented queues, exception handling, manual fallback, versioned SOPs, inspection-ready audit evidence, and ongoing PV quality monitoring. |
| Oracle Safety One Argus | Treat as life-sciences safety and regulatory reporting infrastructure; validate configuration, reporting rules, records controls, and SOPs against FDA, EMA, ICH, and local authority requirements. | Review adverse-event source documents, patient and reporter identifiers, attachments, partner distributions, gateway submissions, audit logs, role access, hosting model, and retention. | Pilot extraction, duplicate detection, coding, workflow prioritization, case quality, reporting timeliness, false-negative risk, and user override patterns against representative safety cases. | Best deployed with clear case-owner responsibilities, medical review checkpoints, regulatory submission controls, validation evidence, manual fallback, and periodic PV quality review. |
| IQVIA Vigilance Detect | Treat as safety intake and PV operations infrastructure; confirm validation, SOP alignment, inspection support, and regional reporting obligations before using automation in production. | Review call recordings, emails, documents, chats, patient and reporter identifiers, product complaint data, translations, service access, hosting, retention, and cross-border transfer controls. | Measure extraction sensitivity, field-level accuracy, missed adverse events, seriousness classification, language performance, duplicate handling, follow-up burden, and reviewer acceptance locally. | Best governed as intake acceleration with source-linked review queues, low-confidence escalation, quality sampling, medical review boundaries, and documented overrides. |
| Veeva Vault Safety AI | Treat as pharmacovigilance system-of-record infrastructure; validate against GxP, ICH, FDA, EMA, local authority, sponsor oversight, and outsourced PV process requirements. | Review adverse-event case data, patient and reporter identifiers, attachments, partner distributions, safety documents, signal workspaces, AI processing, role access, retention, and support access. | Validate automation accuracy, case quality, submission timeliness, signal workflow quality, documentation control, user overrides, and inspection evidence with representative safety operations. | Best governed with sponsor and CRO role clarity, SOP-aligned queues, medical review checkpoints, controlled signal decisions, audit exports, and periodic quality monitoring. |
| Prenosis Sepsis ImmunoScore | Treat as prescription AI/ML-based medical-device software and match use to FDA De Novo DEN230036, including suspected sepsis context, adult ED or hospital patients, blood-culture workflow, and clinician-review requirements. | Review EHR, lab, biomarker, and cloud algorithm-suite data flows; PHI transfer; retention; access controls; security certifications; audit logs; and BAA or data-processing terms before production use. | Validate local performance against sepsis prevalence, laboratory workflows, demographics, comorbidities, SEP-1 objectives, false-positive burden, and missed-sepsis risk rather than relying on authorization alone. | Best governed through emergency medicine, hospital medicine, infectious disease, nursing, lab, quality, and informatics teams with clear escalation, override, monitoring, and downtime procedures. |
| Cytovale IntelliSep | Treat as a regulated in vitro diagnostic tied to the Cytovale System, labeled specimen handling, adult ED suspected-infection population, and FDA 510(k) intended use; do not generalize clearance to autonomous diagnosis, organism identification, pediatric triage, or unsupported care settings. | Review lab-result, instrument, LIS, EHR, support, service, and analytics data flows, plus Cytovale privacy, security, customer-contract, retention, access-control, and covered-entity obligations before implementation. | Compare FDA decision materials, pooled analysis results, local sepsis prevalence, ED triage criteria, Band 1 false-reassurance risk, Band 3 escalation burden, antibiotic stewardship goals, and post-launch outcome monitoring before scaling. | Best governed through a joint ED, lab, nursing, infectious disease, pharmacy, quality, and informatics protocol with clear ordering criteria, result interpretation, escalation paths, override documentation, and routine safety review. |
| Anumana ECG-AI | Match each deployment to the exact cleared algorithm and intended use, including K232699 for low ejection fraction and K252360 for pulmonary hypertension; do not generalize clearance across future or investigational cardiac conditions. | Review ECG, EHR, result-routing, audit-log, customer-support, and integration data flows; Anumana says the pulmonary hypertension algorithm runs within the health-system environment, but contract and architecture review still matter. | Evaluate local performance by ECG source, patient mix, prevalence, care setting, downstream echo or referral pathway, false-positive burden, and whether published sensitivity and specificity match the intended workflow. | Best governed as clinician-reviewed cardiac detection support with defined ECG-system integration, result display, referral criteria, cardiology escalation, monitoring, and patient communication rules. |
| Eko Health SENSORA | Treat as regulated cardiac detection support tied to specific Eko devices, algorithms, adult-use labeling, and FDA-cleared indications; do not generalize one algorithm clearance to unsupported arrhythmias, pediatric workflows, diagnosis, or treatment decisions. | Review ECG, phonocardiogram, audio, patient identifier, app, dashboard, EHR, support, and analytics data flows, plus BAA, HIPAA, encryption, access control, retention, deletion, and secondary-use terms. | Check FDA records, Eko's clinical-study references, algorithm-specific validation, acquisition protocol, patient mix, structural murmur and AFib performance, low-EF evidence, false-positive burden, and whether results match local screening goals. | Best governed as clinician-reviewed point-of-care cardiac screening support with trained acquisition staff, documented provider over-read, clear referral thresholds, conventional diagnostic backup, and monitoring for over-referral or missed disease. |
| AliveCor Kardia 12L | Treat as regulated ECG hardware and algorithmic cardiac interpretation support; match use to the current FDA-cleared Kardia 12L and KAI 12L labeling rather than broad AliveCor or Kardia device claims. | Review device, app, KardiaPro, API, cloud, NPI, patient-profile, ECG recording, support, and telehealth data flows, plus BAA, HIPAA, SOC 2, ISO 27001, HITRUST, retention, and deletion terms. | Check FDA clearance materials, IFU limits, validation population, operator workflow, comparison with conventional 12-lead ECG, false positives, false negatives, and local follow-up outcomes. | Best governed as clinician-reviewed ECG acquisition and interpretation support with trained operators, clear escalation pathways, conventional ECG backup, cardiology review, and monitoring for over-reliance. |
| Philips Cardiologs Holter | Match the deployment to the exact Cardiologs Holter Platform or Philips Holter Analysis System record, including K250569 for Cardiologs Holter Platform and K241890 for Philips Holter Analysis System, plus geography, patient-age, ECG-source, and intended-use limits. | Review cloud hosting, ECG upload, API integration, ECG management-system transfers, patient identifiers, report exports, audit logs, technician and physician access, support access, data residency, retention, deletion, BAA, HIPAA, and GDPR terms. | Validate arrhythmia detection and review efficiency in the local ambulatory ECG population, including AF false-positive burden, ventricular ectopy, pacemaker cases, pediatric or adult eligibility, technician edit time, physician overread quality, and downstream follow-up. | Best governed as clinician-reviewed ECG interpretation support with defined technician queues, cardiologist overread, advisory-output labeling, report signoff, escalation rules, QA sampling, and conventional review fallback. |
| Tempus | Separate molecular assays, companion-diagnostic claims, EHR assistants, imaging algorithms, trial matching, and care-pathway notifications because each workflow can carry different regulatory and clinical accountability. | Review whether data is handled under website privacy, notice-of-privacy-practices, customer contract, research agreement, or de-identified data program before connecting EHR, genomic, imaging, or real-world datasets. | Require product-level validation for the disease area, data type, model output, and care setting rather than relying on broad precision-medicine platform positioning. | Map how outputs enter tumor boards, EHR workflows, trial screening, imaging review, care-gap closure, or life-sciences analysis, and define who approves downstream actions. |
| Tempus One | Treat as high-risk precision-medicine decision support and workflow automation; separate clinical reference, documentation, prior authorization, trial matching, cohort research, and order-related use because each can carry different regulatory, contractual, and clinician-accountability obligations. | Review Tempus privacy and compliance terms, customer agreements, EHR integration scope, PHI flows, support access, retention, audit logging, cross-product data use, and whether custom agents can access institution-specific procedures or repositories. | Validate every guideline, biomarker, trial, patient-history, and cohort output against the underlying Tempus report, EHR note, guideline source, source excerpt, or research dataset before relying on it clinically. | Best governed as clinician- or researcher-reviewed assistive infrastructure with local rules for source checking, note editing, prior-authorization review, trial-screening confirmation, patient communication, and custom-agent change control. |
| SOPHiA GENETICS | Confirm the exact SOPHiA DDM module, Dx-mode status, IVDR claim, local lab validation path, and whether the workflow is diagnostic, research, or exploratory before clinical use. | Review data-protection flyers, hosting model, anonymization, sample control, cross-institution insight sharing, HIPAA/GDPR commitments, and the customer agreement for genomic or imaging data. | Validate the assay, scanner, sequencing, and module performance against the lab's specimen type, disease area, population, and local quality-management requirements. | Map sample preparation, sequencing or imaging, data upload, interpretation, LIMS/EHR transfer, clinician review, and exception handling before relying on outputs. |
| Guardant InfinityAI | Separate exploratory cohort analytics, biomarker discovery, testing-value analysis, and any patient-specific use because each can carry different clinical, regulatory, or submission expectations. | Review consent, de-identification, data-use agreements, partner access, longitudinal clinical-genomic linkage, and any customer-data upload before using oncology datasets. | Check data provenance, completeness, cohort definitions, molecular-pattern methods, external validation, and whether insights are hypotheses, real-world evidence, or clinically actionable findings. | Use with oncology, bioinformatics, regulatory, privacy, and commercial review paths before applying outputs to trials, testing strategy, or patient-care workflows. |
| ArteraAI Prostate | Verify the exact ArteraAI Prostate version and indication against FDA De Novo DEN240068, CLIA/CAP lab status, scanner compatibility, NCCN-referenced use, CE/IVDR status, and partner-specific implementations before clinical use. | Review the HIPAA notice, privacy policy, ordering workflow, lab data handling, de-identification, retention, report access, and payer or partner data flows because the test uses pathology images and clinical information. | Check validation cohorts, Phase 3 trial evidence, population representation, endpoint definitions, scanner or specimen constraints, and whether the report output supports the intended decision in the local tumor board workflow. | Use as a clinician-ordered precision-oncology input with urology, radiation oncology, pathology, and patient shared-decision review before treatment intensification, active surveillance, salvage therapy, or metastatic prostate workflows are changed. |
| Avenda Unfold AI | Treat as regulated radiological computer-assisted diagnostic software and match use to K221624 labeling, trained physician use, prostate oncological workflow scope, and any reimbursement-specific requirements. | Review MRI, biopsy, pathology, PSA, report, and provider-ordering data flows along with privacy-policy terms, BAA coverage, support access, retention, and whether patient data is used for analytics or product improvement. | Inspect validation evidence for cancer extent mapping, encapsulation confidence, focal therapy planning, MRI-visible and MRI-invisible disease, and performance across local scanners, biopsy approaches, and patient populations. | Best governed as physician-reviewed prostate cancer decision support with documented image review, biopsy/pathology reconciliation, treatment-planning discussion, patient shared decision-making, and outcomes monitoring. |
| Unlearn | Treat as clinical trial methodology and evidence-generation infrastructure that needs protocol, SAP, ethics, sponsor, and regulator review before affecting enrollment or analysis. | Review trial-participant data flows, baseline-variable scope, consent, de-identification, retention, transfers, automated-decision disclosures, and sponsor agreements. | Inspect disease-model validation, calibration, external generalizability, uncertainty intervals, bias testing, and whether assumptions match the endpoint and population. | Best used with biostatistical governance where digital-twin outputs are versioned, auditable, and reconciled with trial operations and regulatory commitments. |
| Owkin K Pro | Treat K Pro as biomedical research and drug-development support unless a deployment links outputs to patient-specific care or regulated-development decisions that need formal controls. | Confirm whether data enters Owkin K, a customer environment, or the patient-data network, then review GDPR, ISO, data-transfer, de-identification, and access-control terms. | Require visible source data, reproducible methods, statistical assumptions, uncertainty, and expert review for target, biomarker, subgroup, or report-generation claims. | Best used inside governed R&D workflows where domain scientists review generated analyses before they influence experiments, trial design, or translational strategy. |
| Caris Life Sciences | Review the selected assay, laboratory status, report language, AI signature, and molecular tumor board use separately instead of treating Caris as one uniform AI product. | Confirm patient consent, molecular-data handling, data-use permissions, portal access, retention, and whether research, biopharma, or clinical workflows have different terms. | Check the biomarker, signature, and treatment-association evidence for the cancer type and report context before using outputs in clinical recommendations. | Route AI insights through oncologist, molecular pathology, genetic counseling, payer, and tumor board review as appropriate for the test and patient context. |
| Flatiron Assist | Treat as high-governance oncology clinical decision support; verify how pathways, NCCN content, local preferences, biomarkers, and prior-authorization workflows affect clinical accountability. | Review EHR integration, user permissions, patient-data exchange, reporting exports, pathway analytics, and contractual PHI terms before enabling point-of-care use. | Validate guideline currency, custom pathway governance, biomarker fit, trial matching, concordance reporting, and denial impact against local oncology practice. | Best governed through oncology pathway committees, EHR build review, clinician override tracking, prior-authorization monitoring, and periodic pathway updates. |
| Truveta | Treat Truveta as research, analytics, and evidence infrastructure, not clinical decision software, unless a deployment changes patient care or supports a regulated submission that needs study-specific controls. | Review de-identification, data-use agreements, linked-data scope, trusted research environment controls, HITRUST/SOC/ISO materials, and whether any customer-provided data changes obligations. | Validate cohort definitions, code sets, source traces, assumptions, missingness, confounding, and reproducibility artifacts before using outputs for regulatory, clinical, or commercial decisions. | Best used with defined research protocols, analyst review, versioned methods, and governed export paths rather than ad hoc natural-language answers. |
| Deep 6 AI | Treat as research operations and trial-matching infrastructure; confirm IRB, recruitment, consent, and clinical-trial obligations before using matches for patient contact. | Review EHR data access, PHI handling, site agreements, role permissions, audit trails, data retention, and whether sponsor-facing workflows expose identifiable data. | Validate extraction accuracy against local charts, especially for nuanced inclusion and exclusion criteria, temporality, biomarkers, medications, and comorbidities. | Best used with study-team review loops where AI-ranked candidates are confirmed by trained staff before outreach, enrollment, or protocol decisions. |
| Dyania Health Synapsis | Treat as research operations, chart review, and evidence infrastructure unless a deployment directly changes patient care; confirm IRB, protocol, registry, and sponsor obligations before use. | Review BAA terms, EHR access, PHI handling, role permissions, audit trails, retention, and whether sponsor-facing workflows expose identifiable or re-identifiable records. | Validate extraction and matching accuracy against local charts, especially for nuanced criteria, dates, negation, biomarkers, medications, disease status, and missing data. | Best used with explicit human confirmation steps before trial outreach, registry submission, protocol decisions, or real-world evidence conclusions. |
| TriNetX | Treat as clinical research, feasibility, and real-world evidence infrastructure unless a deployment directly affects patient care; align use with protocol, IRB, sponsor, and regional research rules. | Review federation model, data rights, de-identification or pseudonymization, site-level patient re-identification workflow, audit logs, retention, and cross-border data controls. | Validate cohort counts, criteria logic, ontology mappings, missing-data assumptions, site performance signals, and diversity metrics against known local or sponsor trial data. | Best used as decision support for study teams, with documented human confirmation before protocol amendments, site selection, patient outreach, or RWE conclusions. |
| Medidata AI | Treat as regulated clinical research infrastructure; protocol changes, external controls, synthetic data, and trial-risk actions need statistical, clinical, sponsor, and regulatory review. | Review trial-data rights, RWD linkage, patient-level data handling, synthetic data controls, role permissions, auditability, retention, and trust documentation. | Validate recommendations against the study protocol, therapeutic area, geography, enrollment history, endpoint definitions, safety signals, and statistical analysis plan. | Best deployed inside formal clinical operations governance, with traceable human decisions before protocol optimization, site actions, data queries, or external comparator use. |
| ConcertAI | Treat as oncology RWE, trial, and analytics infrastructure unless a specific workflow is used in patient care or a regulated submission; align each use with protocol, sponsor, IRB, and regulatory expectations. | Review de-identification, data rights, oncology network agreements, biomarker data handling, customer-data uploads, role access, retention, and whether sponsor-facing outputs expose site or patient-level information. | Validate cohort definitions, real-world data completeness, biomarker capture, model assumptions, source traceability, and study reproducibility before relying on outputs for evidence or trial decisions. | Best used with oncology research, biostatistics, trial operations, privacy, and clinical governance so AI-generated insights are reviewed before trial, commercial, or quality programs change. |
| Aetion Evidence Platform | Treat as evidence-generation infrastructure; regulatory, payer, safety, or HTA use needs protocol, data, methods, versioning, and review controls matched to the decision. | Review data-source agreements, cloud deployment, de-identification, synthetic data generation, user permissions, audit exports, and whether linked or customer-provided data changes obligations. | Check study design, cohort logic, outcome definitions, confounding control, sensitivity analyses, reproducibility, and whether AI-assisted steps are transparent enough for review. | Best used by epidemiology, HEOR, safety, regulatory, and analytics teams with reusable study components and explicit signoff before evidence leaves the research workflow. |
| nference nSights | Treat as research and evidence infrastructure unless outputs are linked to patient-specific care, diagnostics, or regulated submissions that require formal controls. | Review de-identification, federated or licensed-data access, institution data rights, modality add-ons, exports, retention, and user permissions before using sensitive cohorts. | Validate cohort logic, source-data completeness, AI curation methods, modality coverage, missingness, and reproducibility for the intended drug, diagnostic, or research question. | Best used with clinical research, informatics, biostatistics, privacy, and domain-science review before insights feed experiments, publications, models, or development programs. |
| Dandelion Health | Treat as research, validation, and evidence infrastructure unless a project supports a regulated submission or a patient-care workflow; align each study with protocol, SaMD, FDA, sponsor, and IRB expectations. | Review de-identification, expert-determination claims, data-use agreements, hospital-system source rights, secure-computing controls, exports, retention, and whether any customer-provided data changes HIPAA or contractual obligations. | Validate cohort definitions, modality coverage, label quality, algorithm performance, subgroup bias, provenance, missingness, and reproducibility before using outputs for development, regulatory, payer, or commercial decisions. | Best used by clinical research, data science, biostatistics, privacy, regulatory, and domain experts who approve protocols and review AI-derived evidence before action. |
| KidneyIntelX.dkd | Treat as a regulated in vitro diagnostic and match deployment to the FDA De Novo intended use, ordering requirements, lab status, and any local diagnostic governance before clinical use. | Review specimen handling, LIMS data flows, EHR integration, laboratory access, ISO/IEC 27001 scope, retention, payer data exchange, and BAA or covered-entity terms. | Check FDA decision materials, validation population, biomarker and clinical-variable inputs, real-world performance, reimbursement evidence, and local outcome tracking before scaling. | Best governed as a clinician-reviewed kidney-risk pathway where results trigger documented follow-up, medication or referral review, patient counseling, and post-deployment monitoring. |
| Healthy.io Minuteful Kidney | Treat as a regulated in vitro diagnostic home-use workflow; match the exact app, kit, analytes, prescription pathway, FDA 510(k), state availability, and intended use before deployment. | Review app account data, health-plan or provider sharing, telehealth partners, support access, retention, state availability, consent, and whether the contracting party needs a BAA or data-processing agreement. | Verify FDA decision materials, clinical-grade claims, adherence data, ACR measurement performance, abnormal-result follow-up, and whether local users can complete testing with supported phones. | Best governed as a population-health testing and follow-up workflow where results are shared with clinicians, abnormal findings trigger outreach, and patients are told the test is not a standalone diagnosis. |
| Roche Kidney Klinrisk Algorithm | Treat as regulated IVD software and verify CE/IVDR status, region, outpatient use, intended population, non-diagnostic boundaries, algorithm version, and whether local deployment needs additional medical-device governance. | Review navify Algorithm Suite hosting, LIS/EMR integration, lab-result data flow, role access, audit logs, retention, cloud region, processor terms, and cross-border transfer controls. | Check validation cohorts, performance metrics, CKD stages, diabetes and hypertension subgroups, eGFR and ACR input quality, external validation, and local calibration before relying on risk tiers. | Best governed as clinician-reviewed CKD risk stratification that supports monitoring frequency, treatment review, and referral planning while keeping patient-management decisions with qualified professionals. |
| Swift Medical | Treat as high-risk wound assessment and documentation support; verify intended use, jurisdiction, and whether local deployment claims make it clinical decision support or device software. | Review PHI in wound images, mobile capture, cloud storage, consent, user permissions, audit logs, data retention, BAA terms, and model-improvement data use. | Validate measurement consistency, tissue classification, healing predictions, documentation completeness, escalation accuracy, and subgroup performance in the intended care setting. | Best deployed with wound-care protocols that define image capture standards, specialist review, escalation, reimbursement documentation, and ongoing quality monitoring. |
| Net Health Tissue Analytics | Clarify whether the deployment is documentation support, measurement support, analytics, or clinical decision support, and verify any device or software claims for the intended setting. | Review PHI in wound photos, mobile capture workflow, cloud processing, access controls, retention, EHR interfaces, audit logs, and BAA terms. | Test measurement accuracy, tissue classification, pressure injury analytics, workflow time savings, and false reassurance risks against local wound-care standards. | Best used with clinician-reviewed wound rounds, standardized photography, escalation rules, and documented ownership for updating the care plan. |
| eKare inSight | Verify the exact inSight device and software status, intended use, wound types, and measurement claims for the country and care setting. | Review wound image storage, telehealth access, mobile-device controls, patient identifiers, EHR export, BAA terms, and retention. | Validate wound-area, depth, and tissue measurements against local standards and monitor variability by camera workflow, lighting, and anatomy. | Best used with repeatable capture protocols, wound-specialist review, telehealth handoff rules, and documentation workflows that preserve an audit trail. |
| Healthy.io Minuteful for Wound | Verify FDA registration or local device status, country availability, intended use, and whether the workflow is measurement support, documentation, or decision support. | Review mobile capture, image upload, remote consultation access, consent, identity controls, retention, BAA terms, and patient-facing communication. | Validate smartphone wound measurements, tissue assessment, remote-review reliability, adherence, equity, and follow-up outcomes in the care model being used. | Best deployed with staff training, calibration supplies, remote expert coverage, escalation thresholds, and documentation rules for longitudinal wound monitoring. |
| MolecuLight | Match the device model and intended use to FDA-cleared indications and avoid treating fluorescence as a standalone infection diagnosis. | Review image transfer, Wi-Fi, local device storage, EHR integration, HIPAA/SOC 2 materials, user controls, and retention. | Assess clinical studies, detection limitations, false negatives from blood or workflow issues, impact on antimicrobial use, and local wound-care outcomes. | Best used as adjunctive imaging during wound assessment with training, room setup, interpretation rules, documentation, and escalation pathways. |
| Spectral AI DeepView | Treat as regulated medical-device software and match use to the FDA De Novo indication, labeling, trained users, and burn-care setting. | Review imaging data flow, device connectivity, support access, storage, retention, BAA terms, and whether research or commercial deployments use different data terms. | Review pivotal and post-market evidence for healing prediction, false reassurance risk, timing after injury, skin tone, burn depth, and effect on grafting decisions. | Best governed as burn-specialist decision support with documented imaging timing, interpretation, escalation, treatment planning, and outcome monitoring. |
| ModelOp Center | Use for governance orchestration, not as proof that a model is safe or cleared; still map each AI system to intended use, medical-device status, payer policy, privacy law, and local review board requirements. | Review PHI exposure in model inventories, validation datasets, monitoring telemetry, evidence uploads, user comments, audit exports, integrations, retention, and BAA or data-processing terms. | Check whether validation evidence, model-change records, monitoring thresholds, fairness tests, and incident reviews are complete enough for high-risk clinical or payer workflows. | Best deployed as the central AI governance register and approval workflow for health systems or life-sciences teams, with named clinical, compliance, security, and model-owner responsibilities. |
| Credo AI Platform | Use to organize governance controls and evidence, while separately verifying medical-device status, health-data law, institutional review, and clinical-safety requirements for each AI system. | Review whether PHI, prompts, system cards, vendor evidence, control results, and audit exports are stored in Credo AI and how access, retention, and integrations are governed. | Confirm the registry and policy mapping capture validation evidence, monitoring results, human oversight, bias checks, incident review, and retirement decisions for high-risk systems. | Best governed as an enterprise intake and control layer for AI systems, with healthcare-specific review gates before clinical, payer, or patient-facing deployment. |
| Mendel Redact | Treat as privacy and data-governance infrastructure, not proof that a dataset is legally de-identified; confirm HIPAA, expert-determination, IRB, contractual, state, and cross-border obligations for each data use. | Review original document ingestion, PHI masking categories, redacted file outputs, JSON coordinates, audit trails, user access, support access, retention, hosting, BAAs, DPAs, and downstream data-sharing agreements. | Validate sensitivity, false negatives, over-redaction, clinical-context preservation, OCR performance, and re-identification risk on local document types before using outputs for research or commercial analytics. | Best governed as a privacy-review step inside a clinical-data pipeline, with quality sampling, exception queues, expert review, approval gates, and documentation before data export or reuse. |
| Fiddler AI Observability | Treat as monitoring and risk-control infrastructure, not a substitute for regulated-device validation or clinical-governance approval of the underlying AI system. | Review trace capture, prompt and output logging, PHI detection, redaction, retention, access controls, integrations, and BAA or enterprise security terms. | Validate that metrics detect the failure modes that matter locally, including drift, missing context, hallucination, inequitable performance, unsafe agent actions, and alert fatigue. | Best used after AI deployment with incident queues, monitoring owners, risk thresholds, retraining/change control, and documented escalation paths. |
| Arize AI Observability | Use as technical monitoring and evaluation infrastructure while separately documenting intended use, clinical validation, regulatory status, and governance approval for the AI application itself. | Review telemetry design, PHI handling, redaction, hosted versus self-managed deployment, retention, user access, audit trails, and BAA/security documentation. | Require task-specific eval sets, clinician-reviewed labels, drift checks, regression gates, and outcome monitoring before using observability dashboards as governance evidence. | Best suited to teams that can instrument models and agents, maintain eval datasets, triage alerts, and feed findings into release and incident processes. |
| Monitaur | Use to document governance and compliance controls, while separately verifying healthcare, payer, insurance, medical-device, and health-data obligations for the specific AI use case. | Review claims or health-data ingestion, model telemetry, validation artifacts, user permissions, evidence exports, retention, subcontractors, and BAA or data-processing terms. | Check that validation protocols and performance reports reflect real local populations, payer rules, fairness expectations, and post-deployment changes. | Best used with model risk committees, compliance owners, technical model owners, and operational teams that act on validation and monitoring findings. |
| Saidot | Use for EU-oriented AI governance workflow support while separately confirming medical-device, health-data, clinical, procurement, and national regulatory obligations for each AI system. | Review how system records, evidence, health-data references, prompts, outputs, vendors, and audit materials are stored, accessed, retained, and exported. | Confirm whether policy templates, inherited evidence, and risk suggestions are backed by system-specific validation, monitoring, human oversight, and incident evidence. | Best suited to organizations that need a live AI inventory and cross-functional approval process spanning compliance, product, clinical, privacy, and technical teams. |
| Chryso.ai | Use as governance and compliance evidence infrastructure; separately verify medical-device status, clinical validation, security review, and local approval for every AI system it tracks. | Review whether PHI, staff records, prompts, outputs, telemetry, screenshots, audit artifacts, or vendor evidence are stored in the platform and under what BAA, access, retention, and export controls. | Confirm that automated evidence packages reflect real validation, monitoring, fairness, incident, training, and policy-review activity rather than unchecked template completion. | Best governed as a compliance operations layer for healthcare AI programs, with named owners for policy updates, training completion, evidence review, and monitored-agent incidents. |
| ALIGNMT AI | Use as governance and monitoring infrastructure while separately classifying every AI system by intended use, medical-device status, HTI-1 or other transparency obligations, local policy, and clinical approval path. | Review service agreements, BAA terms, patient-data handling, de-identified data claims, validation datasets, monitoring telemetry, third-party analytics, retention, access controls, and report-card publication rules. | Require product-specific validation plans, subgroup or fairness results, benchmark provenance, real-world monitoring definitions, and documented remediation for identified risks. | Best governed as a cross-functional oversight layer spanning clinical, legal, compliance, product, data science, and executive owners for AI intake, assessment, monitoring, and mitigation. |
| Risk Meridian | Treat as governance documentation support; legal, compliance, and clinical owners still need to classify each AI use case, validate evidence, and approve disclosures or regulatory submissions. | Check whether health data, vendor records, AI-system details, incidents, board reports, control evidence, and user activity are stored, exported, or shared, and whether healthcare contracts cover required safeguards. | Verify that risk scores, controls, reports, and certifications are backed by actual validation, monitoring, incident, privacy, and human-review evidence instead of questionnaire completion alone. | Best used to establish a repeatable AI intake, risk-review, control-tracking, incident, re-assessment, and board-reporting cadence for healthcare AI programs. |
| Censinet RiskOps AI Governance | Treat as governance and risk-management infrastructure; each AI system still needs intended-use classification, FDA or local regulatory review, privacy/security assessment, and accountable clinical ownership. | Review vendor-risk evidence, questionnaire answers, AI inventory details, clinical-function mappings, support access, benchmarking participation, retention, exports, and BAA or data-processing terms before loading sensitive data. | Require that AI risk scores, NIST AI RMF mappings, AI governance assessments, benchmarking outputs, and recommended controls trace back to product-specific evidence and local validation. | Best used as a cross-functional operating layer for AI intake, third-party review, enterprise-risk alignment, exception tracking, and ongoing committee reporting. |
| Trase OS | Classify each agent by workflow, intended use, clinical impact, and human-review boundary; governed runtime controls do not by themselves establish medical-device status or clinical safety. | Review deployment topology, EHR connections, PHI handling, prompt and output retention, audit trails, SDK integrations, support access, HIPAA documentation, SOC 2 scope, and customer security controls. | Validate agent accuracy, escalation rates, failure handling, cost claims, productivity claims, and clinical-operation impact against local workflows before expanding beyond a narrow pilot. | Best piloted with one bounded workflow, explicit policy gates, human review, service-line owners, and post-deployment monitoring before allowing agents to act across systems. |
| ShadowIQ for Healthcare | Treat as an AI governance, enforcement, and evidence layer; each downstream clinical, payer, or SaaS AI use case still needs intended-use classification, HTI-1 or FDA SaMD review when applicable, and accountable human oversight. | Review BAA availability, DPA terms, PHI detection limits, redaction or tokenization behavior, subprocessor/model routing, tenant keys, retention periods, evidence exports, and access controls. | Validate claims about zero PHI egress, signed decision receipts, policy enforcement, registry completeness, and FDA lifecycle artifacts against a representative local workload before production use. | Best governed as an AI traffic-control and audit-evidence layer with change control for policies, approved model routes, exception queues, incident review, and periodic governance committee reporting. |
| Harness.health | Use to maintain oversight of AI tools, but still evaluate each product's intended use, FDA or local regulatory status, clinical validation, and institutional approval pathway. | Review EHR integrations, safety-event records, metrics, contracts, vendor documentation, user accounts, audit logs, retention, and whether a BAA or equivalent agreement is required. | Require local evidence that monitored metrics and safety-event workflows detect meaningful documentation, imaging, CDS, and access-tool issues rather than just deployment counts. | Best deployed as a health-system governance registry and monitoring surface, with formal committee review, service-line owners, and safety-event feedback loops. |
| SAIGE | Use as healthcare AI governance workflow support while separately classifying each AI system by intended use, medical-device status, privacy law, procurement terms, and clinical governance requirements. | Review whether registry data, vendor submissions, risk assessments, validation artifacts, comments, and monitoring data include PHI or confidential security information. | Confirm that risk scores and prioritization decisions are supported by system-specific validation, monitoring, bias, incident, and change-control evidence. | Best suited to organizations standardizing AI intake, vendor evidence collection, risk review, policy alignment, and ongoing reassessment in one shared workflow. |
| Grid Health | Treat as monitoring and governance infrastructure; separately classify every tracked AI tool by intended use, device status, clinical-risk tier, and local approval requirements. | Review data connectors, read-only implementation claims, EHR or vendor telemetry, PHI exposure, role access, retention, audit trails, and BAA or security documentation. | Confirm that drift, adoption, editing, cost, and utilization metrics are mapped to clinically meaningful thresholds and reviewed against original validation baselines. | Best used by cross-functional AI governance teams that can start with one workflow, interpret monitoring signals, and decide whether to expand, retrain, restrict, or retire AI tools. |
| Asher Informatics | Use as healthcare AI governance infrastructure while separately classifying each AI tool by intended use, FDA or local medical-device status, institutional policy, and state or federal AI requirements. | Review DICOM, EHR, signal, text, policy, monitoring, and model-output integrations for PHI exposure, access control, hosting model, retention, BAA coverage, and audit exports. | Confirm that monitoring metrics, utility modeling, and governance controls map to local validation baselines, real workflow outcomes, subgroup performance, and post-deployment change management. | Best piloted with one high-value AI service line where governance, compliance, clinical, operational, and informatics owners can compare monitoring outputs with real-world performance. |
| Integral Privacy Engine | Treat as privacy and data-governance infrastructure. Confirm how HIPAA Expert Determination, Safe Harbor, state privacy laws, consent, IRB requirements, contractual data-use terms, and AI training permissions apply to each dataset and recipient. | Review deployment model, PHI processing, linkage-token handling, synthetic replacement, audit reports, retention, user access, subprocessors, BAA terms, and whether customer data remains inside the organization's network boundary. | Ask for sample expert reports, validation methods, quasi-identifier analysis, false-negative PHI checks, utility-preservation evidence, and change-monitoring process for the data modalities being used. | Best governed as a privacy gate in data acquisition, data product, AI training, annotation, clean-room, or research workflows, with documented approval before datasets leave the controlled environment. |
| Cognome ExplainerAI | Use for governance evidence and model transparency while independently confirming FDA, HIPAA, medical-device, security, procurement, and institutional review requirements for each AI use case. | Review cloud versus on-premise hosting, HL7/EHR feeds, endpoint scanning, public-LLM detection, PHI handling, access controls, retention, and business-associate terms. | Require local validation that explanation, fairness, bias, drift, and outcome dashboards reflect clinically meaningful measures rather than generic model metrics. | Best suited to mature analytics or informatics teams that can connect models, monitor real-world behavior, review alerts, and feed findings into formal AI governance workflows. |
| Qualified Health | Treat as enterprise AI infrastructure and workflow automation. Classify each deployed agent or solution separately by intended use, clinical risk, medical-device or CDS status, operational impact, human-review boundary, and local governance policy. | Review EHR and enterprise data connectors, prompts, outputs, user actions, logs, dashboards, PHI, support access, retention, encryption, role permissions, BAA terms, subprocessors, and whether customer data can be used for model improvement. | Require workflow-level validation for accuracy, safety, hallucinations, source traceability, model drift, subgroup effects, user adoption, ROI, clinician burden, and patient-safety or operational outcomes before scaling beyond pilots. | Best governed through a central AI intake and monitoring process with named clinical, operational, technical, privacy, and executive owners for each use case, plus incident review and periodic value reassessment. |
| Caresyntax | Classify each deployed module by intended use, jurisdiction, device status, analytics scope, human-review boundary, and whether output influences intraoperative decisions, postoperative management, quality review, training, or operations. | Review OR video, audio, patient and staff identifiers, procedure data, device feeds, EHR/PACS integration, regional hosting, retention, role access, audit logs, subcontractors, BAA or DPA terms, and model-improvement rights. | Ask for procedure-specific validation, implementation references, analytics accuracy, safety-event review, surgeon acceptance, quality-improvement outcomes, and evidence that each dashboard or alert improves the targeted local workflow. | Best piloted with a defined surgical service line, surgeon reviewers, perioperative operations, privacy, IT, quality, and governance owners plus explicit rules for video review, coaching, dashboards, escalation, and operational decisions. |
| Theator | Confirm intended use for video analysis, documentation, quality improvement, and any clinical decision support before treating outputs as operational or care-affecting evidence. | Review video capture, case linkage, user accounts, data retention, model-improvement rights, privacy notice terms, EHR integration, and access controls for surgical footage. | Validate against local procedure types and surgeon-written documentation, tracking missed events, inaccurate steps, edit burden, coding impact, and inter-reviewer disagreement. | Best used with surgeon signoff, quality-team review, and explicit limits around operative reports, training libraries, and performance dashboards. |
| Proximie | Distinguish collaboration, training, workflow analytics, and any real-time surgical intelligence from regulated intraoperative guidance before deployment. | Review patient and staff video, audio, data-region choices, cloud hosting, customer controller/processor roles, support access, retention, and customer agreements. | Measure case delays, throughput, training value, remote-support quality, privacy incidents, staff workload, and whether AI insights are accurate for each service line. | Best governed as connected-OR infrastructure with patient notice, credentialing rules, defined escalation paths, and review of every AI-derived operational recommendation. |
| Medtronic Touch Surgery ecosystem | Confirm product labeling, country availability, intended use, and whether any analytics affect care, documentation, training, or credentialing decisions. | Review Medtronic privacy terms, surgical video handling, patient identifiers, device metadata, hosting, retention, user access, and customer agreement requirements. | Pilot with representative procedure videos and track capture quality, analytic accuracy, educator acceptance, surgeon edit burden, and training or quality-improvement outcomes. | Best used with explicit postoperative review and education workflows, not as a substitute for surgeon judgment or local credentialing governance. |
| Moon Surgical Maestro | Verify exact cleared indications, software version, ScoPilot status, procedure scope, geography, and hospital medical-device governance before clinical use. | Review security, device telemetry, intraoperative data, analytics, cloud or edge processing, retention, support access, and privacy-notice terms. | Assess local procedure times, setup burden, conversion risk, surgeon ergonomics, safety events, and whether insights improve outcomes or workflow without introducing distraction. | Best governed like a surgical device plus AI-enabled workflow: credentialing, training, emergency fallback, surgeon control, and biomedical engineering oversight are central. |
| Activ Surgical ActivSight | Confirm product labeling, clearance, country availability, compatible use cases, and whether AI-enabled modes are investigational or cleared for the planned workflow. | Review device data, video, image capture, support access, retention, security, and whether case data leaves the OR or hospital environment. | Pilot under surgeon oversight and track visualization accuracy, missed findings, false positives, setup burden, adverse events, and whether outputs change decisions safely. | Best evaluated as intraoperative adjunctive visualization with explicit surgeon control, training, failure-mode planning, and procedure-specific governance. |
| Apella | Treat as perioperative operations and documentation intelligence unless a deployment uses predictions or event detection to drive care decisions; review medical-device, safety, and institutional governance boundaries for each workflow. | Map ceiling cameras, live video, patient privacy blurring, staff images, event timelines, SMS notifications, Epic write-back, historical video review, retention, access controls, and support access before room installation. | Validate event detection, predicted delays, case-duration forecasts, staffing recommendations, and utilization metrics against local OR data, procedure types, and staffing practices. | Best governed as an OR operations layer with named owners for event correction, schedule decisions, staffing escalation, privacy review, and post-deployment performance monitoring. |
| Surgical Safety Technologies OR Black Box | Separate quality improvement, education, risk management, analytics, and any care-affecting use because the platform's governance obligations change when outputs influence clinicians or credentialing. | Review de-identification, audio and video capture, patient and staff images, clinical-environment data, retention, quality-review protections, access logs, and contractual data-use terms before installation. | Require local validation that captured events, analytics, and trend reports reflect meaningful safety and efficiency signals rather than artifacts of procedure mix or camera placement. | Best piloted with a formal safety culture plan, surgeon and staff communication, protected review process, incident escalation rules, and limits on punitive or unsupported use. |
| Cydar Maps | Verify the exact product name, software version, indications, FDA or local authorization, and instructions for use before clinical deployment, especially for expanded vascular procedure coverage. | Review CT and fluoroscopy data flow, cloud hosting, live collaboration, support access, authentication, retention, image sharing, and hospital data-processing terms. | Validate planning measurements, map registration, overlay accuracy, radiation and contrast claims, procedure time effects, and post-operative assessment against local endovascular cases. | Best governed as image-guided surgery support with surgeon confirmation, standard-imaging fallback, biomedical engineering involvement, and post-case review of guidance accuracy. |
| Asensus Intelligent Surgical Unit | Confirm authorization, labeling, intended use, software version, geography, and enabled features because robotic-surgery systems require device governance and procedure-specific credentialing. | Review procedure-data capture, video, telemetry, analytics, service access, cybersecurity controls, retention, and whether data leaves the hospital or device environment. | Assess setup burden, camera-control accuracy, surgeon ergonomics, visual-guidance reliability, conversion planning, adverse events, and procedure-specific outcomes during local adoption. | Best evaluated as a surgeon-controlled robotic surgery adjunct with formal training, biomedical engineering oversight, fallback procedures, and post-deployment device monitoring. |
| Proprio Paradigm | Confirm the exact Paradigm System 510(k), software version, indications, geography, instrument compatibility, and training requirements before clinical use because this is high-risk surgical navigation. | Review OR video and sensor capture, CT image handling, system logs, structured case data, support access, retention, cloud or local processing, cybersecurity controls, and customer privacy terms. | Validate registration accuracy, instrument placement guidance, alignment measurements, radiation and workflow claims, adverse-event handling, and procedure-specific outcomes against local spine cases. | Best governed as surgeon-controlled spinal navigation with biomedical engineering oversight, credentialing, standard-navigation fallback, post-case discrepancy review, and device performance monitoring. |
| PathKeeper System | Treat as high-risk surgical navigation and verify K222355, software version, labeling, geography, procedure eligibility, accessory setup, and hospital medical-device governance before clinical use. | Review preoperative CT handling, optical 3D images, workstation data transfer, system logs, support access, cybersecurity controls, retention, website/contact-data terms, and whether any case data leaves the hospital environment. | Validate registration, instrument-tracking accuracy, setup burden, radiation-reduction claims, screw-placement workflow, false reassurance risk, and discrepancy handling against local spine cases before wider rollout. | Best governed as surgeon-controlled spine navigation with biomedical engineering oversight, trained setup staff, registration confirmation, standard-imaging fallback, and post-deployment monitoring of accuracy and workflow impact. |
| ZEISS Surgery Optimizer | Treat as surgical video review and education support unless local labeling or use changes; confirm non-medical-device status, country availability, compatible systems, and intended-use limits before using outputs in quality programs. | Review surgical-video upload, patient and biometry data, ZEISS Health Data Platform terms, Microsoft cloud relationship, mobile access, retention, account roles, and cross-border data handling. | Validate AI phase segmentation and KPI dashboards against local cataract cases, surgeons, equipment, and teaching objectives before relying on benchmark comparisons. | Best governed as postoperative cataract video review with surgeon oversight, explicit teaching or quality-improvement boundaries, consent/notice review, and documented limits on performance interpretation. |
| SurgeryView.ai | Treat as retrospective surgical video review, education, quality-improvement, or research support unless local use turns analytics into care, credentialing, or clinical decision support. | Review the no-PHI upload rule, AI PII detection limits, user access, staff support access, video retention, public-posting warnings, institutional agreements, and whether consent or de-identification workflows are adequate. | Validate phase segmentation, procedure support, benchmark relevance, and longitudinal metrics against local cases before using analytics for training or quality programs. | Best piloted as a post-case review layer with surgeon approval, protected quality-review rules, explicit de-identification checks, and non-punitive use boundaries. |
| Stryker SurgiCount+ with Triton | Treat as a high-risk medical-device software workflow and verify the exact cleared SurgiCount+ System software configuration, labeling, accessories, geography, indications, and hospital device-governance requirements before clinical use. | Review device images, RFID sponge records, user-entered patient hemoglobin values, reports, EMR integration, cloud connectivity, offline behavior, access controls, retention, vendor support access, and customer security documentation. | Validate blood-loss estimates, sponge-count reconciliation, missing-item alerts, charting accuracy, hemorrhage-response timing, false reassurance risk, staff workload, and protocol adherence with local OR and obstetric cases. | Best implemented as an adjunct to established nursing, anesthesia, surgical, and obstetric hemorrhage workflows, with clear responsibility for confirming estimates, documenting discrepancies, and escalating patient-safety events. |
| Intuitive da Vinci 5 Surgical Insights | Treat as high-risk surgical robotic medical-device software and match use to da Vinci 5 labeling, FDA 510(k) records, software version, procedures, instruments, region, and trained users. | Review system connectivity, procedure data, surgeon training data, local video replay behavior, remote software-update pathways, support access, My Intuitive services, retention, and customer privacy terms. | Validate vendor-cited force, efficiency, and learning claims against local procedures, surgeon experience, complications, downtime, procedure duration, and post-market safety signals. | Best governed as surgeon-controlled intraoperative information and robotic-platform software with biomedical engineering oversight, credentialing, cybersecurity approval, update control, and fallback procedures. |
| TrackiMed | Treat as high-risk perioperative safety software until current regulatory status, intended use, item classes, alert claims, and clinical deployment boundaries are verified. | Require a hospital-grade data-flow review for OR video, audio, staff images, patient exposure, transcripts, item records, integrations, retention, analytics, subprocessors, access controls, and BAA or DPA terms. | Use public pilot claims as preliminary only; run local shadow-mode validation for item detection, count discrepancy alerts, documentation accuracy, time savings, staff workload, and safety outcomes. | Best piloted as staff-supervised OR support with formal count-policy alignment, nurse and surgeon override rules, discrepancy escalation, quality review, downtime procedures, and non-punitive analytics governance. |
| Osso VR | Treat as procedural education and competency-support software, not intraoperative guidance or autonomous credentialing; verify whether any device-specific training module carries separate regulatory, manufacturer, or institutional requirements. | Review learner identifiers, performance analytics, headset and session telemetry, supervisor access, recordings, retention, subprocessors, security terms, and whether any local deployment involves PHI-like scenario data. | Match published or vendor-cited research to the specific procedure, learner type, endpoint, and assessment rubric, then compare VR metrics with faculty-observed skill and local competency standards. | Best governed as a simulation and assessment layer with educator review, documented remediation paths, clear limits on credentialing decisions, and feedback loops into existing surgical, nursing, or device-training curricula. |
| Radformation AutoContour | Treat as high-risk radiological image processing software for radiation therapy and verify the exact 510(k), version, modality, anatomy, region, and intended-use labeling before production use. | Review image routing, DICOM metadata, support access, cloud or local processing, authentication, retention, audit logs, BAA terms, and whether patient data contributes to model updates. | Commission site-by-site performance against local CT, MR, CBCT, scanner protocols, artifacts, abnormal anatomy, physician edits, plan dosimetry, and interobserver variation. | Best governed as a planning accelerator with documented human review, contour editing, physicist/dosimetrist QA, fallback manual contouring, and monitoring for drift in edit burden. |
| MIM Contour ProtegeAI | Confirm the exact FDA 510(k), product version, supported modality, structure set, intended use, and deployment geography because auto-segmentation claims vary by release. | Review MIM workflow hosting, local or cloud deployment, DICOM and PHI handling, support access, retention, security controls, and contractual data-use language. | Evaluate validation by anatomy and cancer site, local scanner performance, contour edit time, false contour risk, plan-quality effects, and physician acceptance. | Best deployed with radiation oncologist review, dosimetry editing, physicist commissioning, structured exception handling, and documented fallback to manual contouring. |
| Siemens Healthineers DirectORGANS | Verify region-specific authorization, supported CT simulator, software version, cancer site, and instructions for use because embedded simulation workflows may differ by market. | Review CT simulator data flow, DICOM export, on-premises versus connected service processing, support access, logs, retention, and cybersecurity documentation. | Commission by cancer site, scanner protocol, artifacts, contrast, anatomy, edit burden, physician acceptance, and downstream treatment-planning quality before relying on time-savings claims. | Best used as CT-simulation workflow support with radiation oncologist and dosimetrist review, clear edit accountability, and manual-contouring fallback for unsupported or poor-quality cases. |
| MVision Contour+ | Treat as high-risk radiotherapy image-analysis software and verify the exact FDA record, version, CT/MR scope, anatomy, intended users, and real-time adaptive planning exclusions. | Review cloud versus local deployment, DICOM transfer, pseudonymization, TLS encryption, support access, retention, BAA terms, and whether images or contours are reused for model development. | Commission by cancer site, scanner, CT and MR protocol, contouring guideline, outlier anatomy, edit burden, and plan-quality impact before relying on vendor time-saving claims. | Best governed as an initial contour-template generator with radiation oncologist review, dosimetrist editing, physicist QA, exception handling, and fallback manual contouring. |
| TheraPanacea Annotate | Verify exact ART-Plan module, FDA or CE status, intended-use labeling, geography, supported structures, and whether tumor or adaptive modules carry separate authorization. | Review GDPR and HIPAA claims, cloud processing, DICOM metadata, retention, support access, user permissions, audit logs, and contractual PHI protections before sending radiotherapy images. | Commission site-specific segmentation quality, contour edit burden, interobserver variability, anatomy-specific performance, guideline fit, and downstream treatment-plan effects. | Best used as supervised contouring support with radiation oncologist validation, dosimetry editing, physicist QA, batch-workflow monitoring, and manual fallback for unsupported cases. |
| Mirada DLCExpert | Verify current regulatory status, software version, anatomy, modality, deployment geography, and whether older DLCExpert clearance or CE materials apply to the purchased configuration. | Review image routing, remote-reporting deployment, support access, user permissions, retention, audit logs, and contractual data-processing terms for radiotherapy images and contours. | Commission contour quality by anatomy and site, compare edit burden against local standards, review clinical-acceptability studies, and monitor downstream plan-quality impact. | Best governed as a zero-click initial contouring workflow with physician and dosimetrist review, documented edits, physicist oversight, and manual fallback. |
| RayStation Deep Learning Segmentation | Treat as high-risk radiation oncology treatment-planning software and verify the exact RayStation release, 510(k) or local authorization, enabled model, modality, anatomy, and market restriction before production use. | Review RayStation deployment architecture, image and contour storage, support access, scripting, logs, connected services, retention, BAA or data-processing terms, and whether model updates use customer data. | Commission DLS performance by cancer site, scanner, protocol, contouring guideline, physician edit burden, abnormal anatomy, artifacts, and treatment-plan impact rather than relying only on vendor time-savings claims. | Best governed as an integrated contouring and planning accelerator with radiation oncologist review, dosimetrist editing, physicist QA, documented exceptions, and manual fallback for unsupported cases. |
| GE HealthCare Critical Care Suite | Match the deployed module to the exact FDA 510(k), device version, patient population, view type, and notification or triage indication; do not generalize pneumothorax clearance to unsupported diagnosis, tube-position, pediatric, or non-chest workflows. | Review on-device processing, DICOM routing, PACS flags, secondary-capture images, device logs, service access, retention, network segmentation, and any cloud or support data flows under the health system's GE contract. | Use the FDA summary, GE materials, and local pilot data to check sensitivity, specificity, small-pneumothorax performance, ET tube measurement accuracy, false alerts, missed cases, and turnaround-time impact in the target sites. | Best governed as radiologist-reviewed chest X-ray triage and acquisition-support software with clear rules for technologist notifications, worklist priority, secondary captures, downtime, and post-deployment quality monitoring. |
| Imbio Lung Density Analysis | Match deployment to the exact Imbio module, 510(k) K141069 or local authorization, CT protocol, intended user, report wording, and region; do not generalize lung-density clearance to autonomous diagnosis or unsupported lung-disease workflows. | Review CT image routing, DICOM metadata, portal or partner delivery, uploaded-data responsibility, support access, retention, anonymization, international transfers, security controls, BAA or DPA terms, and patient-facing LungMap use. | Evaluate Imbio's publication claims and FDA record against local low-dose CT, COPD, asthma, BOS, scanner, reconstruction, threshold, and reporting workflows, then track report edits and downstream clinical actions. | Best governed as radiologist- and pulmonologist-reviewed quantitative CT support with documented thresholds, exception handling, patient counseling boundaries, smoking-cessation handoff, and post-deployment monitoring. |
| icometrix icobrain | Treat icobrain as regulated medical image-processing software and match each deployment to the exact 510(k), software version, measured brain structures, disease module, intended user, region, and clinical workflow before using outputs in care decisions. | Review DICOM pseudonymization, retained demographics, transfer encryption, remote icobridge access, cloud or local processing, support access, retention, audit logs, HIPAA/GDPR claims, ISO27001 scope, BAA or DPA terms, and re-identification controls. | Evaluate icometrix publications and FDA summaries against the local scanner mix, MRI protocols, disease population, longitudinal interval, lesion and volume thresholds, ARIA workflow, false positives, false negatives, and specialist interpretation process. | Best governed as quantitative MRI support for radiologists and neurologists, with explicit report-review responsibility, escalation rules for new activity or ARIA findings, treatment-decision boundaries, and post-deployment performance monitoring. |
| Behold.ai red dot | Treat each red dot module and geography separately. K191556 supports adult chest X-ray pneumothorax prioritization, not a blanket authorization for lung cancer rule-out, CT head triage, autonomous reporting, or unsupported indications. | Review DICOM routing, image-copy handling, anonymization, identifiers, support access, audit logs, retention, international transfer, customer privacy terms, and whether the available privacy notice is only website/cookie-oriented rather than a clinical data processing agreement. | Validate vendor-reported chest X-ray performance, 510(k) performance data, NHS case-study claims, local scanner and population mix, alert precision, missed-case review, normal-reporting thresholds, and radiologist workload impact. | Best governed as a radiologist-supervised imaging triage service with explicit exception queues, indication-specific reporting language, downtime paths, post-deployment monitoring, and separate approval for any autonomous normal-reporting workflow. |
| Biobeat Cuffless Blood Pressure Monitoring | Match each deployment to the exact FDA-cleared device, 510(k) number, measured parameter, intended setting, adult population, calibration requirement, and non-critical-care limitation before using outputs in care workflows. | Review Biobeat's privacy policy and enterprise contract for device data, mobile app data, dashboard access, tokenization, controller versus processor roles, anonymized analytics, geolocation connectivity data, retention, support access, and cross-border transfer controls. | Validate cuffless blood-pressure and physiologic-signal performance against the local patient population, calibration process, wear time, skin and motion artifacts, home connectivity, report quality, and escalation outcomes. | Best governed as clinician-reviewed remote physiologic monitoring with clear onboarding, calibration, patient instructions, report review, escalation, device troubleshooting, downtime, and removal-from-monitoring criteria. |
| Pieces Technologies | Treat as high-impact clinical workflow and documentation support unless a configured use case starts making patient-specific diagnostic, treatment, admission-status, or utilization decisions; review intended use, CDS policy, and local governance before production automation. | Review EHR data flow, voice capture, generated notes, prompts, logs, AWS or other model subprocessors, support access, retention, BAA terms, de-identification, customer data rights, and whether operational analytics can be reused for model or product improvement. | Use Pieces' public safety-review claims and customer metrics as starting points only; validate hallucination, omission, bias, note-quality, length-of-stay, documentation-timeliness, utilization-management, and clinician-workload results with local chart review. | Best governed as clinician-reviewed inpatient automation with explicit chart-verification steps, source traceability, signoff rules, exception queues, downtime fallback, monitoring owners, and periodic review of generated-content safety metrics. |
| PreciseDx PreciseBreast | Treat as high-risk oncology prognostic software or laboratory testing until the exact ordering pathway, laboratory status, FDA or local authorization, intended population, and report claims are confirmed. | Review slide image transfer, clinicopathologic data fields, laboratory ordering, vendor privacy terms, business-associate or data-processing agreements, retention, support access, and whether de-identified data may be used for model improvement. | Compare published analytical and external validation evidence with local breast cancer subtypes, specimen workflow, scanner diversity, follow-up horizon, recurrence endpoint, calibration, and incremental value over existing assays. | Best governed as tumor-board decision support where pathologists and oncologists interpret the AI-derived risk score beside standard pathology, biomarkers, genomic tests, treatment guidelines, and patient-specific preferences. |
| Lunit SCOPE | Separate every SCOPE module, version, geography, study purpose, and intended use before deployment; research-use-only language on SCOPE IO, GP, uIHC, and IHC Suite pages should not be treated as diagnostic authorization. | Review whole-slide image transfer, platform integrations, support access, annotations, study metadata, product-service data, de-identified data handling, retention, international transfers, and customer-contract privacy terms. | Use Lunit's publication library, module-specific validation materials, and local pilot data to test scanner mix, tissue and stain quality, cancer subtype, biomarker endpoint, reproducibility, pathologist agreement, and trial-readout impact. | Best governed as a module-specific digital pathology and biopharma analysis workflow with pathologist, translational science, clinical-trial, privacy, and regulatory review before outputs inform patient selection or reports. |
| Indica Labs HALO AP and HALO AP Dx | Separate HALO AP, HALO AP Dx, HALO AI, and each clinical AI algorithm before procurement. Confirm scanner, display, version, module, country, and intended use against FDA 510(k), CE-IVDR, UKCA, or local requirements before diagnostic deployment. | Review cloud versus on-premise deployment, LIS/LIMS and WSI data flows, patient and case metadata, role permissions, audit logs, support access, AWS-hosted services, deidentified exports, retention, BAA or DPA terms, and whether product-service data can be reused. | Require module-specific validation, scanner and stain compatibility, local case-mix testing, pathologist agreement, quality-control metrics, false-positive and false-negative review, and evidence that the selected AI output supports the intended pathology decision. | Best governed as an enterprise digital pathology platform where pathologists retain diagnostic responsibility, AI modules are released only after local validation, and reports, consults, tumor boards, molecular workflows, and downtime procedures are explicitly mapped. |
| Validic Impact | Treat Validic Impact as clinical operations infrastructure unless a deployment uses AI summaries, alerts, or device data to drive patient-specific triage; review intended use, device status, monitoring obligations, and local clinical decision-support policy before go-live. | Review Validic privacy, security, BAA or data-processing terms, client controller responsibilities, device and app permissions, EHR writes, support access, de-identified analytics, retention, Data Privacy Framework claims, and cross-border transfer controls. | Pilot with the target condition, device mix, patient population, EHR workflow, staffing model, alert thresholds, AI-summary review, and escalation protocol before relying on outcomes, risk-stratification, or workload claims. | Best governed as EHR-embedded remote monitoring infrastructure where clinicians remain responsible for alert review, trend interpretation, outreach, documentation, escalation, downtime, and patient removal from monitoring. |
| Awell | Treat Awell as clinical operations and workflow infrastructure unless a configured care flow or agent begins making patient-specific triage, diagnosis, treatment, or utilization decisions; review each workflow's intended use before production. | Verify customer BAA terms, HIPAA posture, OpenAI BAA coverage for agents, subprocessors, prompt and output retention, access controls, logs, support access, data catalog design, and cross-border transfer terms. | Validate each workflow with representative records, faxes, messages, patient calls, exception cases, staff review metrics, false automation, missed escalations, and post-launch monitoring before relying on efficiency claims. | Best governed as pathway-specific workflow automation with named owners, version control, approval gates, exception queues, human review for consequential steps, and clear rollback or downtime procedures. |
| b.well bailey | Treat bailey as patient-facing health navigation and connected-data assistant infrastructure unless local configuration supports patient-specific diagnosis, treatment, medication, or triage decisions; review intended use and escalation policy carefully. | Verify identity proofing, consent, HIPAA role, BAA terms, FHIR and network connections, data-source permissions, longitudinal record assembly, AI processing, retention, model improvement, subprocessors, and patient revocation workflows. | Pilot with the target population, data-source mix, language, benefits context, care-navigation tasks, unsafe prompts, incomplete records, and handoff rules before relying on engagement or self-service claims. | Best governed as a consumer-facing assistant with approved intents, data-source provenance, human escalation, emergency routing, audit trails, user consent controls, and periodic review of answer quality and task completion. |
| Welldoc BlueStar | Match deployment to the exact FDA-cleared Welldoc Diabetes or BlueStar version, labeling, adult population, prescription status, insulin-support feature, region, and clinical workflow before treating outputs as medication or disease-management support. | Review patient app data, glucose and device feeds, medication data, EHR or payer integrations, clinician reports, HIPAA role, consent, retention, support access, analytics, and customer-contract privacy terms. | Evaluate published Welldoc studies and clearance materials against the local diabetes population, medication regimen, device mix, digital access, adherence, clinician workload, and safety-monitoring requirements. | Best governed as regulated digital therapeutic support with clinician oversight, patient education, escalation rules for abnormal values, medication-change controls, report review, and clear fallback to usual care. |
| Ailva | Treat as high-risk clinician-facing clinical reference and decision-support software; verify intended use, FDA/non-device CDS positioning, and whether local patient-specific use changes governance obligations. | Review the prohibition on patient-identifiable information, Safe Harbor de-identification assumptions, query retention, account data, subprocessors, self-hosted query-processing claim, and whether a BAA is needed for any future PHI workflow. | Sample local clinical questions across specialties, confirm cited papers support each recommendation, inspect flagged unverified citations, and compare outputs against primary guidelines and specialty review. | Best governed as clinician-reviewed evidence lookup with explicit PHI restrictions, citation checking, uncertainty handling, and documentation of final decisions outside the product. |
| Eolas Medical | Treat as local clinical knowledge retrieval and reference support; review any configuration that gives patient-specific recommendations, medication guidance, or protocol automation with clinical governance and regulatory counsel. | Verify PHI prohibitions, user eligibility checks, customer data ownership, analytics, sponsored content handling, trust-center controls, subprocessors, retention, support access, and whether a BAA or local equivalent is required. | Audit source provenance, guideline versioning, answer citations, hallucination-mitigation instructions, clinical safety review, and performance against high-risk local protocol questions before broad rollout. | Best deployed with named guideline owners, document-update workflows, staff training, analytics review, escalation for uncertain answers, and clear rules that AI output does not replace clinical judgment. |
| Aiberry | Treat as high-risk mental health screening or clinical decision-support software. Verify current medical-device status, intended use, jurisdiction, claims, and whether each configured score is wellness, screening, diagnostic support, or clinical assessment. | Review video, audio, transcript, facial-behavior, text, score, and dashboard data flows; confirm consent, BAA/DPA coverage, retention, deletion, program-level reporting, support access, and model-improvement limits before deployment. | Compare the cited validation study with the local population, language, setting, acuity, modality quality, baseline screening process, and follow-up workflow; monitor sensitivity, specificity, calibration, subgroup performance, and staff review burden. | Best governed as supervised mental health screening and monitoring with explicit crisis escalation, clinician or care-team review, patient communication rules, and periodic safety review. |
| Twill Mental Health Sequence | Treat as behavioral-health access and wellness or digital-therapeutic infrastructure until the exact configured modules, claims, population, and clinical responsibilities are reviewed. Separate wellness support, coaching, telebehavioral health, and any prescribed or regulated digital therapeutic workflow. | Review sponsor organization reporting, PHI collection, Taylor chatbot and assessment data, community sharing, coach records, partner handoffs, affiliate sharing, anonymization, consent, BAA terms, and regional privacy obligations. | Validate published and customer evidence against the configured product mix and covered population; monitor symptom scores, engagement, escalation quality, care access, adverse events, and subgroup outcomes. | Best governed as a supervised mental health access layer with explicit module scope, benefit routing rules, crisis escalation, human coaching or clinical handoff paths, and sponsor reporting limits. |
| Cognoa Canvas Dx | Treat as regulated pediatric diagnostic software. Match use to DEN200069, prescription-only status, age range, qualified HCP interpretation, adjunctive role, language/device prerequisites, exclusions, and any current labeling or software-version changes before launch. | Review child videos, caregiver and clinician questionnaires, child demographics, insurance details, HCP portal data, reports, SMS support, service providers, telemedicine partners, FDA or IRB disclosures, retention, de-identification, and customer agreement terms before routing families through the workflow. | Use Cognoa's clinical research and FDA summary as starting evidence, then monitor local eligibility, indeterminate outputs, diagnostic agreement, false reassurance risk, referral burden, equity, family experience, and downstream access to early intervention. | Best governed as a clinician-supervised autism evaluation accelerator with explicit prescribing criteria, family instructions, report interpretation, specialist escalation for indeterminate or complex cases, and documented next-step care planning. |
| Sohar Health | Primarily front-end revenue-cycle and eligibility automation, but review any output that affects patient access, scheduling, payment expectations, benefit interpretation, or payer communication with compliance and operations leaders. | Verify BAA/customer-contract coverage for PHI and PII, approved subprocessors, API authentication, logging, retention, data transfer, support access, and whether payer or patient data is used beyond the contracted service. | Validate payer coverage, benefit accuracy, latency, manual-resolution outcomes, carve-out handling, inactive-plan detection, and webhook reliability against local staff workflows and downstream denials. | Best deployed as a staff-supervised intake or RCM API with clear status handling, recheck cadence, payer-outage paths, patient-facing disclosure rules, and exception queues for ambiguous eligibility. |
| Adonis Intelligence | Treat as revenue-cycle analytics and operational automation, but review any claim, coding, appeal, payment, underpayment, or patient-billing action that could affect reimbursement, compliance, or payer communication. | Verify contracted PHI processing rather than relying only on website privacy language; confirm BAA, encryption, RBAC, auditability, retention, subprocessors, support access, and data-use boundaries for RCM datasets. | Validate vendor-reported denial, ROI, and productivity claims against local payer mix, specialty, EHR/PM data quality, alert precision, underpayment recovery, and staff action rates. | Best deployed with explicit ownership across billing, coding, finance, compliance, IT, and operations so alerts become reviewed work queues rather than unsupervised claim or collection actions. |
| Plenful | Treat as administrative pharmacy and revenue-cycle automation unless a deployment changes medication therapy decisions or patient-facing clinical guidance; review 340B, payer, prior-authorization, and reimbursement outputs with pharmacy compliance leaders. | Verify contracted PHI handling rather than relying only on public website language, including BAA, Service Data rights, anonymized model-training terms, retention, role access, audit logs, subprocessors, support access, and connected-system permissions. | Validate vendor efficiency and revenue-recapture claims against local pharmacy volume, payer mix, 340B policy, referral pathways, authorization criteria, and staff-reviewed exception outcomes. | Best deployed as a staff-supervised pharmacy operations layer with documented exception queues, compliance review, payer communication rules, dashboard ownership, and audit evidence before actions affect claims or therapy access. |
| Innovaccer Gravity | Classify each deployed agent separately because the platform spans administrative automation, payer operations, care management, clinical summaries, clinical pathway guidance, early warning, lab interpretation, and quality workflows with different regulatory and clinical-risk profiles. | Verify contracted PHI processing, BAA terms, data residency, support access, audit logs, retention, subprocessors, model-training restrictions, identity controls, and data-lineage evidence rather than relying only on public privacy notices. | Require use-case-specific validation because broad platform claims do not prove local performance; measure data quality, recommendation precision, drift, bias, staff adoption, documentation quality, RCM outcomes, and patient-safety exceptions by workflow. | Best governed as an enterprise AI control plane with named owners for each agent, documented human review, kill-switch or rollback paths, monitoring dashboards, change control, and audit-ready evidence before outputs affect care or reimbursement. |
| Anterior | Treat as high-impact payer utilization-management infrastructure; verify CMS prior-authorization rules, state UM and appeal obligations, plan medical-policy governance, delegated-entity responsibilities, FHIR/DTR implementation, and whether automation changes authorization, denial, delay, or care-modification decisions. | Review health-plan PHI processing under customer agreements rather than public website privacy alone, including BAA terms, member and provider data, clinical records, faxes, call or communication content, audit logs, subprocessors, retention, support access, and model-training limits. | Require local validation beyond vendor benchmarks: approval accuracy, missed approvals, inappropriate escalations, clinical-review burden, turnaround time, demographic error-rate monitoring, appeal reversals, policy-version drift, and reviewer override patterns. | Best governed with explicit auto-approval thresholds, clinician review queues, cited policy evidence, audit-ready reasoning logs, appeal handoffs, quality sampling, kill-switches, and medical-director ownership before production decisions affect members or providers. |
| SmarterNotes | Treat SmarterNotes as medium-risk documentation, CDI, coding, and revenue-integrity support rather than autonomous diagnosis; classify any patient-specific prompt, diagnosis-completeness suggestion, quality metric, or reimbursement recommendation separately. | Do not rely only on public website privacy language for PHI terms because SmarterDx says enterprise customer data may be governed by customer agreements; review BAA, EHR permissions, retention, support access, audit logs, subprocessors, and data-use restrictions. | Pilot with representative inpatient services and measure unsupported note content, omitted facts, CDI/coding suggestion accuracy, physician query volume, discharge-summary timing, edit burden, denial outcomes, and compliance audit findings. | Best governed as clinician-reviewed inpatient note drafting with explicit handoffs among physicians, CDI, coders, quality, revenue integrity, privacy, and AI governance teams before outputs affect signed notes or claims. |
| SamaCare | Treat as revenue-cycle and patient-access infrastructure rather than medical advice, while still reviewing prior-authorization, payer, market-access, sponsored support, interoperability, and state or CMS policy obligations for each workflow. | Review the customer BAA and data-use terms in detail because SamaCare's public policy references PHI, patient demographics, insurance, diagnosis, medication, EMR or practice-management pulls, health-plan sharing, action replay, de-identification, aggregate use, and U.S. hosting. | Validate vendor benchmark and outcome claims against local specialty, payer mix, therapy type, documentation quality, prior-authorization volume, denial reasons, policy changes, and staff-reviewed exceptions before relying on projected approval or time-to-resolution gains. | Best governed as staff-supervised prior-authorization automation with explicit checkpoints, submission approval, escalation ownership, payer follow-up queues, audit sampling, integration monitoring, and sponsor-program transparency before scaling. |
| Aiva Health | Treat as patient-access, staff-workflow, communication, documentation-support, and smart-room infrastructure; classify any symptom handling, EHR writeback, clinical education, or care-escalation workflow separately before allowing patient-facing automation. | Verify contracted PHI terms rather than relying only on public web language, including BAA, Alexa configuration, voice assistant data flows, room identifiers, EHR access, retention, de-identified reuse, subprocessors, audit logs, and support access. | Pilot with representative units and measure request-routing accuracy, missed urgent requests, documentation accuracy, device-command failure rates, patient satisfaction, nurse workload, response times, accessibility, and multilingual performance. | Best deployed with explicit nurse, virtual-care, IT, biomedical-device, privacy, patient-experience, and clinical-governance ownership so voice or chat requests route to accountable staff and do not become unsupervised triage. |
| Sunoh.ai | Treat as documentation support unless local use expands into clinical decision support, patient triage, order execution, or coding/billing automation; classify order-entry capture and EHR writeback controls separately. | Confirm the contracted BAA and data-processing terms, including consent workflow, audio and transcript retention, PHI handling, EHR extension permissions, mobile device controls, support access, subprocessors, Azure region, and whether any data are used for model improvement. | Run a specialty-specific pilot with paired transcripts, draft notes, finalized notes, and edit logs to measure missing facts, hallucinations, section placement, terminology errors, order-entry capture, and clinician review time. | Best governed as clinician-reviewed draft documentation: providers should review, edit, approve, and sign notes before import, with explicit escalation for ambiguous audio, multiple speakers, consent exceptions, and failed EHR sync. |
| Tandem Health | Treat as regulated documentation and coding-support software in Europe; verify the exact MDR Class IIa certificate, UKCA or country-specific status, intended use, clinician-approval boundary, and whether coding suggestions affect reimbursement or clinical decisions. | Review the processor agreement and local privacy materials for health data, including consent, EU hosting, audio deletion, transcript and note retention, support access, subprocessors, audit logs, security certifications, and model-training exclusions. | Use vendor compliance claims as diligence inputs, then run specialty-specific validation against final signed notes, coding selections, edit logs, failed transfers, and local patient-safety or billing quality measures. | Best governed as clinician-reviewed documentation and coding assistance with explicit approval before medical-record transfer, clear consent scripts, integration testing, exception queues, and periodic audit of unsupported note or code content. |
| Honey Health | Treat as operational, access, documentation-support, and revenue-cycle automation rather than autonomous clinical decision support, while classifying refill, order, prior-authorization, device-data, and patient-message workflows separately before deployment. | Review contracted PHI terms and trust-center materials before relying on public marketing claims, with special attention to BAA scope, EHR and portal credentials, customer-specific agent training, support access, retention, subprocessors, audit logs, and whether data are used to improve shared models. | Validate vendor-reported ROI and case-study claims locally by measuring queue volume, completion accuracy, staff overrides, exception routing, turnaround time, wrong-field writeback, denial or approval quality, patient-safety events, and revenue-cycle reconciliation. | Best governed as multi-workflow back-office automation with named owners for each agent, staff approval points for consequential actions, audit sampling, payer and portal-change monitoring, and explicit rollback plans when automation quality drifts. |
| Sword Health AI Care | Separate wellness navigation, telehealth services, digital therapy, device-supported biofeedback, surgery-risk prediction, and mental-health support because each workflow can carry different clinical, device, and state telehealth obligations. | Review the signed plan or employer agreement plus public privacy and HIPAA notices for PHI, claims data, wearable/calendar signals, mental-health data, support access, retention, subprocessors, member rights, and whether data are used to improve shared AI systems. | Treat vendor outcome claims as diligence inputs, then validate published studies, actuarial analyses, engagement, pain, surgery intent, mental-health, cardiometabolic, and savings metrics against the enrolled population and benefit design. | Best governed as clinician-supervised virtual care with explicit escalation, crisis, complaint, program-change approval, device-support, and handoff rules before using AI outputs in care navigation or member-facing coaching. |
| Clairity Breast | Treat as prescription-use Class II radiological software for future risk prediction, not detection or diagnosis; match local use to DEN240047 labeling, compatible mammography systems, output timing, and post-market obligations. | Review mammography image routing, DICOM metadata, HL7 return path, cloud or on-prem processing, access controls, retention, support access, BAA terms, cybersecurity documentation, audit logs, and model-change governance. | Use the FDA decision summary and vendor validation claims as starting points, then validate calibration, discrimination, subgroup performance, implant limitations, high-score overestimation, and downstream screening changes in the local population. | Best governed as radiologist- and clinician-reviewed risk stratification after screening interpretation, with explicit counseling scripts, enhanced-screening criteria, threshold review, equity monitoring, and exception handling. |
| CancerIQ | Treat as clinical decision support and precision oncology workflow infrastructure unless a specific deployment makes diagnostic, testing, or treatment claims; verify risk-model logic, guideline basis, clinician oversight, and local genetics governance. | Review platform privacy and contracted BAA terms for PHI, family-history, genetic-risk, test-ordering, EHR, navigator, analytics, support, subprocessors, retention, de-identified data use, and patient-rights handling. | Use vendor research and published workflow studies as starting points, then measure local eligibility capture, genetic counseling or testing uptake, patient comprehension, equity, adherence, false positives, and missed high-risk patients. | Best governed as provider-directed cancer-risk navigation with documented patient consent, genetics review pathways, EHR integration testing, result reconciliation, referral queues, guideline-update monitoring, and patient communication controls. |
| Nanox.AI HealthCCSng | Treat as regulated radiological post-processing software; match use to the exact cleared HealthCCSng version, patient age, CT study type, output type, radiologist review boundary, and non-standalone decision language. | Review DICOM routing, cloud processing, PACS and EMR interfaces, PHI and metadata retention, support access, audit logging, cybersecurity materials, BAA terms, and model-update governance before routing production scans. | Validate against local CT protocols, scanner vendors, calcium prevalence, radiology reporting patterns, cardiology follow-up capacity, false-positive burden, missed disease, and patient outcomes rather than relying only on clearance or vendor case studies. | Best governed as opportunistic imaging detection feeding radiologist-reviewed reports and predefined cardiovascular follow-up pathways, with ownership across radiology, cardiology, primary care, quality, privacy, and IT. |
| PeriGen PeriWatch Vigilance | Treat as regulated perinatal monitoring software and high-risk clinical decision support; match local use to the exact cleared algorithm, gestational-age scope, intended-use statement, warning language, and clinician-adjunct boundary. | Review EMR and central-monitor data flows, fetal tracings, maternal vitals, mobile access, identity provider integration, PHI retention, support access, audit logging, BAA terms, cybersecurity documentation, and model-change controls. | Use the FDA summary, vendor responsible-AI materials, research pages, and local pilot data to test performance across tracing quality, monitor vendors, preterm cases, alert burden, clinician response, and maternal-fetal safety outcomes. | Best governed as continuous L&D situational awareness with predefined nurse, OB, anesthesia, triage, postpartum, command-center, escalation, downtime, and incident-review workflows rather than as a standalone interpretation tool. |
| Nuvo INVU | Treat as FDA-cleared maternal-fetal monitoring software and hardware; match local use to the exact 510(k), gestational-age, singleton-pregnancy, prescription-use, antepartum-surveillance, home-or-facility, and non-preterm-prevention labeling. | Review patient app, clinician app, EMR API, monitoring-session data, sensor and shipping data, support recordings or transcripts, cloud processing, retention, subprocessors, BAA or provider agreement terms, and cross-border data handling before launch. | Use FDA summaries, labeling, vendor materials, and a local pilot to test signal quality, patient setup, clinician review burden, missed sessions, false reassurance, escalation timing, and subgroup performance before relying on remote monitoring. | Best governed as clinician-ordered remote antepartum surveillance with explicit patient instructions, monitoring windows, review queues, escalation paths, after-hours rules, downtime plans, and conversion-to-in-person-care criteria. |
| Spacelabs Rothman Index | Treat as regulated high-risk clinical decision-support and patient-surveillance software; match use to FDA 510(k) K172959, intended-use language, software version, care setting, warnings, and clinician-adjunct boundaries. | Review contract-specific privacy and security terms because the workflow depends on EHR, lab, nursing-assessment, warning-state, dashboard, and integration data that may contain PHI and operationally sensitive information. | Use FDA documentation, Spacelabs resources, peer-reviewed literature, and local silent-mode or supervised pilots to validate calibration, alert thresholds, response pathways, outcome impact, and subgroup performance. | Best governed as hospital-wide early-warning infrastructure with explicit owners for score review, rapid-response routing, unit-level thresholds, clinician education, escalation, downtime, and post-deployment monitoring. |
| Azra AI | Treat as oncology operations, registry, research, and patient-management workflow software unless a configured use makes diagnostic, treatment-selection, or regulated clinical decision-support claims; validate intended use separately for each module. | Review contract-specific PHI handling because workflows may ingest pathology reports, radiology reports, notes, PDFs, EMR data, registry data, patient proximity, trial criteria, navigator actions, and operational analytics. | Use vendor materials and partner announcements as diligence inputs, then run local silent-mode or supervised validation for case finding, extraction accuracy, eligibility matching, workflow timeliness, missed cases, and subgroup performance. | Best governed as a closed-loop oncology operations layer with explicit registrar, navigator, tumor-board, research, radiology, oncology, compliance, and IT ownership for every AI-surfaced task. |
| Clarify Meridian | Treat primarily as operational referral, patient activation, network intelligence, and performance analytics software unless configured to make clinical triage, medical-necessity, or patient-specific care-routing recommendations that require additional clinical and legal review. | Review BAA and customer agreement terms because the workflow can involve PHI, provider data, scheduling transactions, CRM records, claims or contract data, outreach content, user activity, retention settings, integrations, and de-identified analytics. | Use vendor-stated ROI and performance claims only as diligence inputs; measure local referral completion, leakage, wait times, patient experience, quality thresholds, provider capacity, equity, and attribution before tying incentives to outputs. | Best governed as supervised operational intelligence with access, referral, service-line, finance, compliance, privacy, and clinical leaders agreeing on which referral opportunities can be acted on and how patients are informed and scheduled. |
| Freenome SimpleScreen CRC | Treat as a high-risk screening and laboratory workflow. Verify FDA clearance or approval status, CLIA and state laboratory requirements, local medical policy, and whether early-access or commercial use is permitted for the exact population and clinical pathway. | Review clinical-trial, laboratory, patient, provider, research, commercial-relationship, genomic, proteomic, website, cookie, third-party service-provider, retention, de-identification, international-transfer, and security terms before sharing identifiable data. | Use PREEMPT CRC and the JAMA publication as core diligence inputs, but evaluate sensitivity, specificity, advanced adenoma performance, population fit, follow-up adherence, comparison to existing screening methods, and real-world implementation outcomes locally. | Best governed as a supervised screening-access program with primary care, GI, laboratory, oncology prevention, privacy, compliance, payer, scheduling, and navigation teams defining eligibility, ordering, result disclosure, colonoscopy follow-up, and monitoring. |
| GRAIL Galleri | Treat as a high-risk screening and laboratory workflow. Verify the current FDA PMA status, CLIA and CAP laboratory scope, state requirements, prescription-use boundaries, guideline status, and whether any local use is clinical care, employer benefit, research, or population-health pilot. | Review HIPAA notice, privacy terms, HIE participation, genetic information handling, laboratory results, provider and patient portal access, billing, business associates, research disclosures, de-identification, retention, and whether PHI or genomic-derived data can support product improvement. | Use published performance studies, PATHFINDER results, NHS-Galleri topline data, FDA submission materials, and local pilots to evaluate sensitivity by stage and cancer type, false-positive burden, PPV, diagnostic workup completion, stage shift, mortality evidence, patient anxiety, and equity. | Best governed as a supervised screening-access program with primary care, oncology, genetics, radiology, laboratory, privacy, payer, navigation, and scheduling teams defining eligibility, ordering, result interpretation, diagnostic confirmation, follow-up ownership, and incident review. |
| Median eyonis LCS | Treat as high-risk radiology SaMD. Verify the exact cleared version, FDA 510(k) letter and intended use, local jurisdiction status, reimbursement assumptions, model-change controls, and whether any planned workflow extends beyond assisted detection and characterization on LDCT screening studies. | Review DICOM routing, PACS connectivity, metadata handling, cloud or on-premise processing, retention, support access, audit logs, data-protection terms, subprocessors, and whether a BAA or equivalent clinical data-processing agreement is available. | Use FDA clearance, manufacturer performance testing, pivotal-study materials, and local retrospective validation to assess sensitivity, specificity, false-positive load, false-negative risk, subgroup performance, workflow impact, follow-up completion, and patient outcomes. | Best governed as radiologist-supervised lung cancer screening support with radiology, pulmonology, thoracic oncology, imaging IT, privacy, compliance, and navigation teams defining output review, follow-up routing, exception handling, and post-deployment monitoring. |
| Teton AI | Treat as high-impact patient or resident monitoring and operations software. Verify whether local use is safety monitoring, fall-risk support, workflow analytics, remote observation, or clinical decision support, and confirm any medical-device or care-home regulatory obligations in the deployment jurisdiction. | Review consent, room-level sensing, local processing, anonymized animation claims, event exports, dashboards, AI-agent queries, retention, access controls, support access, cloud processing, BAA terms, and whether website privacy language differs from the clinical deployment agreement. | Use vendor-reported falls, workload, response-time, and sleep metrics as directional only; run local validation across units and resident groups for missed events, false alarms, response times, staff adoption, and unintended surveillance burden. | Best governed as supervised ambient monitoring with nursing, patient safety, privacy, legal, IT, facilities, and operations teams defining consent, alert thresholds, escalation paths, documentation, downtime procedures, and post-deployment review. |
| RapidClaims | Treat as revenue cycle, coding, and documentation-support software with compliance impact. Verify specialty scope, payer-policy fit, direct-to-bill rules, coder accountability, physician-query controls, and whether any output affects clinical documentation or claims without human review. | Review the customer agreement and BAA for PHI handling, AWS hosting, U.S. data residency, upload/download controls, model-training exclusions, access logs, incident response, subprocessors, retention, and security certifications rather than relying only on public website claims. | Require chart-level evidence for every generated code, CDI suggestion, payer-rule action, denial appeal, or recovery recommendation, then compare accuracy, denial rates, audit results, and equity metrics against local baselines. | Best governed through explicit direct-to-bill thresholds, mandatory review queues for complex or high-risk claims, coder override logging, compliance sampling, payer-policy updates, and post-payment audit feedback. |
| Covera Health | Treat as radiology quality, network, and diagnostic-pathway intelligence rather than an image-reading device unless a specific deployment includes regulated detection or diagnosis software. Review patient-steering, credentialing, payer, PSO, peer-review, and claims-use implications before launch. | Verify clinical data-use agreements, provider and payer data sharing, de-identification, PSO protections, service-provider access, cookies or session replay for web services, retention, audit logs, and whether business partners can independently use personal information. | Require methodology transparency for quality insights, patient-journey linkage, outcome claims, imaging-center variation, and cost impact, then validate local findings against radiologist peer review, claims, outcomes, and access metrics. | Best governed with radiology, quality, legal, privacy, payer relations, network management, and patient-access teams defining who can see quality signals, how they are acted on, and how access or equity effects are monitored. |
| Bunkerhill Carebricks | Treat each Bunkerhill algorithm as a separate high-risk imaging SaMD workflow. Match the deployed feature, anatomy, CT acquisition type, age range, output, 510(k), and physician-review language before connecting it to outreach or care-coordination automation. | Review DICOM routing, EHR integration, edge versus cloud processing, re-identification, patient outreach data, scheduling messages, support access, retention, audit logs, BAA terms, security certifications, and whether public privacy language differs from contracted clinical data terms. | Use FDA summaries, vendor validation materials, and local retrospective pilots to assess algorithm performance, incidental finding burden, false-positive and false-negative risk, follow-up completion, equity, and whether downstream interventions improve care rather than only increasing work. | Best governed by radiology, cardiology, primary care, bone health, vascular, imaging IT, privacy, and patient-access teams defining review queues, signoff requirements, patient communication, referral ownership, downtime procedures, and post-launch monitoring. |
| Riverain ClearRead CT | Treat as high-risk radiology SaMD. Separate cleared ClearRead CT functions from research-use lung tissue analysis, match local use to FDA indications, and review any CAC reporting or reimbursement workflow before production launch. | Review PACS routing, DICOM metadata, prior-study access, generated series and reports, web API or HL7 exports, user logs, retention, support access, hosting, BAA/security documentation, and any external AI platform distribution path. | Assess module-specific evidence for nodule detection, comparison accuracy, vessel suppression, reading time, missed-nodule reduction, CAC scoring accuracy, follow-up outcomes, and performance on local scanners and screening populations. | Best governed as radiologist-supervised chest CT support with clear rules for nodule follow-up, CAC result communication, report insertion, failed-study handling, incidental finding ownership, and post-deployment quality monitoring. |
| Carenostics | Treat as high-impact transplant operations support rather than a standalone clinical decision system, but review whether extracted findings, readiness alerts, committee packets, or outreach workflows could influence transplant eligibility, listing, organ-offer, or follow-up decisions. | Verify BAA terms, HITRUST report scope, EHR partner responsibilities, outside-record ingestion, patient-file storage, generated-summary retention, support access, audit logs, subprocessors, model-training boundaries, and deletion or correction workflows. | Validate extraction and summarization on local transplant records, including 300-page outside files, missing tests, stale clearances, contradictory data, specialty-specific forms, and downstream effects on coordinator workload and patient progression. | Best governed with transplant coordinators, surgeons, nephrology or organ-specific clinical leaders, quality, privacy, and informatics defining review queues, escalation thresholds, patient-contact rules, downtime procedures, and monitoring metrics. |
| Rune Labs StrivePD | Treat the Apple Watch symptom-data workflow as FDA-cleared software under the cited 510(k), but review StrivePD Guardian, coaching, clinician dashboards, payor programs, and trial workflows separately for intended use, clinical claims, patient instructions, and local medical-device obligations. | Verify controller versus processor role, BAA terms, Apple Health and wearable data flows, PHI and consumer-health data handling, research sharing, AI companion transcript retention, coaching access, subprocessors, deletion rights, audit logs, and whether patient-facing privacy terms differ from provider or payor agreements. | Require evidence for tremor and dyskinesia measurement reliability, clinician-dashboard usefulness, medication and symptom interpretation, Guardian guidance quality, trial-readiness claims, and any outcome or cost claims before using it for care management decisions. | Best governed as supervised Parkinson's disease management support: clinicians define what data is reviewed, patients know when to seek urgent care, AI guidance stays within safe education and coaching boundaries, and medication or treatment changes remain clinician-owned. |
| Microsoft Healthcare Agent Service | Treat as configurable healthcare agent infrastructure until the exact scenario is known. Reassess risk when the agent handles symptom triage, patient-specific clinical information, care-routing decisions, medical knowledge, or integrations that can affect access to care. | Verify Microsoft BAA coverage, HIPAA-eligible service scope, Azure tenant settings, data residency, transcript retention, Azure OpenAI data handling, authentication, connected data sources, and downstream integrations for the exact bot. | Validate answers against approved sources, medical protocols, customer content, and escalation rules. Test source citation quality, language support, hallucinations, stale content, unsafe reassurance, and staff handoff quality before patient-facing launch. | Best governed as a configurable digital front door or staff copilot with named intents, allowed data sources, explicit emergency routing, human escalation, monitoring, and change-control review. |
| Salesforce Agentforce for Healthcare | Treat as healthcare workflow and service automation unless an agent is configured to make clinical recommendations, triage symptoms, modify records, or perform decisions that require clinical governance, medical-device, payer, or public-health review. | Verify BAA coverage, HIPAA-ready feature scope, Shield or Government Cloud needs, Health Cloud and Data Cloud configuration, voice and transcript retention, EHR connector permissions, audit logs, and prompt or tool data exposure. | Test each agent action against real access, provider, claims, EHR, and service scenarios. Measure wrong-patient risk, incorrect eligibility, provider mismatch, hallucinated policy explanations, failed handoffs, and unsafe answers before expansion. | Best governed through approved actions, least-privilege tool permissions, clear human handoff, audit trails, service-line ownership, prompt change review, and monitoring by access, compliance, security, and clinical owners. |
| Google Cloud Agent Search for Healthcare | Treat as configurable healthcare data search and generative summary infrastructure, not a cleared medical device by default. Review each application built on it for intended use, CDS boundaries, patient-specific recommendations, local policy, and any medical-device or clinical governance obligations. | Verify BAA execution, HIPAA-eligible service scope, IAM, VPC Service Controls, audit logging, encryption, regional controls, Healthcare API configuration, PHI in prompts and outputs, generated-answer retention, support access, and downstream integrations. | Validate retrieval and answer quality against local records, including FHIR mapping, document references, images, PDFs, clinical notes, provenance, citation alignment, missing documents, duplicate data, and clinician acceptance before clinical reliance. | Best governed as an enterprise clinical search and summarization layer with informatics, compliance, privacy, security, and clinical owners defining allowed queries, review steps, escalation paths, and monitoring for each use case. |
| AskTrip | Treat as clinical evidence search and summarization unless configured or marketed for patient-specific diagnosis or treatment recommendations. Review local CDS, medical-device, and professional-use policies before point-of-care deployment. | Verify whether real patient details may be entered, whether Trip offers institutional privacy terms, how prompts and answer history are stored, whether data is used for service improvement, and what deletion or export controls exist. | Check every important answer against the cited guideline, review, or paper. Track citation relevance, source age, conflict handling, and whether the answer misses local guidelines or special populations. | Best governed as a source-backed evidence lookup aid: users ask focused questions, read the linked sources, document the evidence used, and keep final clinical decisions with qualified clinicians. |
| Techcyte Fusion | Treat as high-risk pathology AI and digital pathology infrastructure. Match each module to the exact geography, specimen type, scanner, intended use, and current regulatory status before clinical deployment. | Review BAA terms, image hosting, DICOM metadata, LIS integration, user access, audit logs, support access, retention, deletion, subprocessors, and whether model-development or partner workflows use customer images. | Require module-specific validation on local slides, stains, scanners, sample prep, and lab populations. Measure pathologist override rates, missed findings, false positives, turnaround time, and drift after launch. | Best governed through pathologist-supervised review, laboratory validation, quality management, IT/security review, LIS integration testing, downtime procedures, and clear rules for AI output in final reports. |
| Artisight Smart Operating Room | Treat as high-impact perioperative workflow intelligence and documentation support unless a specific clinical decision, safety, or monitoring function creates additional regulatory obligations. Review intended use and local surgical safety policy before go-live. | Verify video/audio processing, whether recordings are stored, RTLS data handling, EHR writes, access controls, audit logs, BAA terms, staff and patient notice, retention, support access, and facility-specific privacy requirements. | Pilot against local OR data and measure prediction accuracy, turnover time, start-time performance, documentation corrections, alert fatigue, staff trust, safety-check capture, and whether workflow pressure affects clinical judgment. | Best governed with perioperative leadership, surgeons, anesthesia, nursing, privacy, security, informatics, and quality teams defining review steps, alert ownership, downtime process, correction rights, and monitoring metrics. |
| Scopio Full-Field Digital Cell Morphology | High-risk in vitro diagnostic lab workflow. Match K201301, K220013, later clearances, IVDR, CE, and local requirements to the exact application, software version, specimen type, and professional-user setting. | Review digital slide images, sample IDs, remote viewer access, hospital-network setup, distributor support access, audit logs, retention, exports, and any cloud or browser-based collaboration features. | Compare AI pre-classification and morphology support against local manual review, abnormal smear mix, rare-cell cases, scanner performance, false classifications, and technologist/pathologist override patterns. | Best governed as technologist- and pathologist-reviewed digital morphology support with documented review, exception handling, LIS result release rules, downtime plans, and quality monitoring. |
| Sysmex DI-60 | Treat as a high-risk laboratory device workflow. Verify current local registration, recalls, field corrections, intended use, specimen type, and analyzer integration before clinical release. | Review LIS links, barcodes, sample identifiers, image storage, remote service access, user audit trails, retention, exports, and whether any cloud or distributor support access is enabled. | Validate pre-classification and operator workflow against local smear quality, abnormal flags, rare cells, body-fluid use if claimed, turnaround time, and manual differential reference practice. | Best governed with trained technologist verification, barcode safeguards, quality-control review, LIS reconciliation, recall monitoring, and laboratory director oversight. |
| CellaVision DC-1 | Treat as a regulated laboratory morphology workflow. Verify CE, 510(k), local registration, specimen claims, and distributor terms for the exact analyzer and software version. | Review slide image storage, sample identifiers, networked installation, support access, LIS export, audit logs, retention, and user permissions across standalone and lab-network configurations. | Validate pre-classification and review performance using local smear quality, abnormal case mix, low-volume staffing patterns, manual comparison, and quality-control acceptance criteria. | Best governed as a technologist-reviewed digital morphology aid with laboratory director oversight, training, correction workflow, LIS release checks, and periodic competency review. |
| Sight OLO | Treat as a regulated in vitro diagnostic hematology analyzer. Verify K190898, K211840, current labeling, CLIA complexity, sample type, age range, and local market status before use. | Review sample identifiers, barcode handling, instrument connectivity, result transmission, quality-control records, support access, retention, and any cloud or distributor data flow. | Validate CBC and differential results against local reference analyzers across capillary, venous, pediatric, abnormal, and flagged samples before clinical reliance. | Best governed through point-of-care or laboratory oversight, operator training, QC procedures, abnormal-result escalation, LIS reconciliation, and medical director review. |
| PixCell HemoScreen | Treat as a regulated point-of-care in vitro diagnostic analyzer. Verify K180020, K222148, current labeling, CLIA complexity, IVDR or CE status, sample type, and patient age before use. | Review instrument connectivity, sample identifiers, LIS middleware, QC records, service access, result storage, audit logs, and whether any remote support or cloud data flow exists. | Validate CBC and 5-part differential results locally against reference analyzers, including capillary collection variability, abnormal flags, pediatric use, low-volume settings, and operator competency. | Best governed through POCT committee or laboratory director oversight, QC procedures, cartridge controls, operator training, abnormal-result escalation, LIS reconciliation, and periodic proficiency review. |
| Mindray MC-80 | Treat as a high-risk in vitro diagnostic morphology workflow. Verify current local registration, intended use, software version, specimen claims, and whether the deployed workflow is cleared or registered in the target market. | Review slide image storage, sample identifiers, remote-review configuration, LIS connectivity, service access, user permissions, audit logs, exports, and retention across standalone and networked deployments. | Validate pre-classification against local manual microscopy and abnormal case mix, including immature cells, platelet clumps, rare findings, smear quality, turnaround time, and correction patterns. | Best governed as technologist- and hematopathologist-reviewed digital morphology support with documented review rules, exception handling, QC monitoring, LIS reconciliation, downtime procedures, and competency checks. |
| HORIBA Yumizen D20 | Treat as a high-risk IVD laboratory morphology workflow. Confirm the exact local authorization, specimen claims, software version, cloud features, and whether blood and urine workflows are covered in the intended market. | Review cloud storage, remote access, sample identifiers, image retention, LIS connections, user roles, audit logs, support access, exports, and data-transfer terms before enabling networked review. | Validate pre-classified blood and urine reports against local reference microscopy, abnormal case mix, sample quality, operator correction rates, turnaround time, and quality-control acceptance criteria. | Best governed with laboratory director oversight, trained technologist approval, specimen-specific review rules, LIS reconciliation, QC monitoring, downtime planning, and periodic competency review. |
| Noul miLab | Treat as a high-risk IVD diagnostic workflow. Confirm the exact module, cartridge, software version, specimen type, geography, malaria species or morphology claim, and local authorization before clinical use. | Review device connectivity, image and result storage, identifiers, cloud or local processing, support access, user accounts, export controls, retention, and public-health data-sharing terms. | Validate malaria and morphology performance against local microscopy, PCR or reference methods, parasite prevalence, species distribution, smear quality, operator workflow, and quality-control requirements. | Best governed with laboratory director oversight, trained operator review, confirmed QC procedures, escalation for discordant or high-risk findings, LIS/reporting mapping, and fallback microscopy. |
| SigTuple AI100 with Shonit | Confirm FDA K221309, local registration, software version, specimen type, and user labeling before clinical deployment. Treat any workflow beyond cleared peripheral blood smear use as a separate validation and regulatory question. | Review image storage, sample identifiers, LIS integration, user accounts, remote support, audit logs, retention, exports, encryption, and any cloud processing or service-access terms. | Validate WBC differential and morphology pre-classification against local manual microscopy, abnormal case mix, rare findings, smear quality, technologist correction patterns, and turnaround-time targets. | Best governed as technologist-reviewed AI microscopy support with documented review thresholds, hematopathologist escalation, QC monitoring, LIS reconciliation, and downtime procedures. |
| CellaVision DM1200 and DM9600 | Verify the exact CellaVision system, software, application, distributor configuration, and specimen claim against FDA, CE/IVDR, and local labeling before using outputs in clinical reporting. | Review local and network image storage, remote-review access, LIS integration, audit logs, role permissions, service access, exports, backups, and retention policies. | Validate each application against local manual microscopy, body-fluid protocols, abnormal cell mix, RBC findings, specimen quality, technologist corrections, and hematopathologist review requirements. | Best governed as professional digital morphology support with trained technologist verification, hematopathologist escalation, competency review, QC documentation, LIS reconciliation, and downtime planning. |
| Roche cobas m 511 | Verify current FDA 510(k), CE/IVDR, country availability, software version, specimen types, and intended use before procurement because older clearance does not guarantee active market availability. | Review viewing station storage, LIS interfaces, image retention, user access, service connectivity, audit logs, backups, cybersecurity, and data-export policies. | Validate performance against local analyzers and manual morphology for normal, abnormal, venous, capillary, and high-risk samples, with QC and review-station workflow metrics. | Best governed as an integrated hematology analyzer workflow with technologist review, manual classification for exceptions, QC acceptance rules, LIS reconciliation, reagent management, and downtime plans. |
| Copan PhenoMATRIX | Verify FDA K251511, exact package, media, organism workflow, auto-release status, TAG functionality, software version, and local authorization before using AI outputs for clinical culture reporting. | Review WASPLab and PhenoMATRIX image storage, LIS-linked context, patient identifiers, access controls, audit logs, support access, retention, backups, exports, and data-processing terms. | Validate against local plate media, incubation timing, specimen sources, organism prevalence, colony morphology, negative-rate assumptions, technologist review patterns, and downstream ID/AST workflow. | Best governed as qualified-laboratory culture plate triage with lab-defined rules, documented validation, human review for consequential results, exception queues, and periodic performance monitoring. |
| BD Kiestra Urine Culture Application | Verify local authorization for the exact urine culture application, BD Kiestra hardware, ReadA, BD Synapsys workflow, media, specimen type, and intended use before clinical result workflow changes. | Review BD Synapsys and LIS data flows, plate-image retention, patient identifiers, access controls, audit logs, service access, cybersecurity, backups, and data-processing agreements. | Validate against local urine culture protocols, media, incubation times, organism prevalence, negative-rate assumptions, significant-growth rules, technologist review, and discrepancy handling. | Best governed as AI-assisted microbiology imaging support where qualified staff interpret results, review exceptions, maintain culture protocols, reconcile LIS reporting, and monitor post-deployment performance. |
| APAS Independence | Verify FDA K183648 or relevant local authorization, module, media, specimen type, clinical versus environmental-monitoring use, and distributor labeling before relying on APAS outputs. | Review plate image retention, patient or sample identifiers, APAS Web User Interface, LIMS/LIS integration, audit logs, user roles, remote review, backup options, service access, and data-transfer terms. | Validate APAS performance with local media, specimen mix, incubation protocols, organism prevalence, colony counts, negative-release rules, microbiologist review, and quality or clinical reporting requirements. | Best governed as AI culture plate triage with qualified laboratory review, documented validation, controlled auto-release rules where authorized, data-integrity controls, and ongoing performance monitoring. |
| Product | Workflow | Risk | Regulatory snapshot | Best fit | First verification check |
|---|---|---|---|---|---|
| OpenEvidence Clinical evidence and questions |
Evidence-backed clinical questions and medical literature synthesis | High | Verify current status from official sources | Clinicians who need fast answers grounded in medical literature and source partnerships. | Whether your user type and region are eligible. |
| ClinicalKey AI Clinical evidence and questions |
Generative AI clinical question answering grounded in licensed medical reference content | High | Verify current status from official sources | Health systems and clinicians that want a governed alternative to general-purpose AI for point-of-care clinical reference questions. | Whether your institution's license covers the intended user group and country. |
| UpToDate Expert AI Clinical evidence and questions |
Conversational clinical question answering grounded in UpToDate content, assumptions, source links, and clinician review | High | Verify current status from official sources | Clinicians and health systems that want AI-assisted clinical reference answers inside an established UpToDate evidence workflow. | Whether Expert AI is available for your country, subscription tier, professional role, and enterprise account. |
| Dyna AI Clinical evidence and questions |
AI-assisted evidence retrieval and clinical question answering inside EBSCO clinical decision-support content | High | Verify current status from official sources | Clinical teams that already rely on EBSCO evidence products and want AI-assisted retrieval with direct source links and clinician control. | Which host product is licensed: DynaMed, DynaMedex, Dynamic Health, or Dyna AI Mode. |
| Glass Health Clinical evidence and questions |
AI-powered clinical decision support, ambient scribing, real-time encounter insights, differential diagnosis drafts, assessment and plan drafts, evidence-backed answers, documentation generation, and developer API workflows | High | Verify current status from official sources | Clinicians or clinical software teams that want evidence-backed reasoning support embedded into visits, documentation, EHR context, or product workflows with explicit human review. | Which workflow is in scope: web CDS, ambient scribing, EHR integration, developer API, triage, record summarization, diagnostic support, treatment planning, documentation, or patient-facing handouts. |
| Atropos Health Clinical evidence and questions |
Real-world evidence generation, clinical evidence agents, and EHR-connected evidence support | Medium to high | Verify current status from official sources | Organizations that need source-backed real-world evidence for clinical questions, policy, research, or precision-medicine workflows. | Which data network or local data source will answer the clinical question. |
| Doximity Ask Clinical evidence and questions |
HIPAA-compliant clinician assistant for clinical questions, patient education, chart note templates, translation, and document drafting | Medium to high | Verify current status from official sources | Clinicians already using Doximity who want a PHI-capable assistant for first-draft clinical reference, correspondence, education, and workflow writing. | Whether your clinician role, country, and Doximity verification status are eligible. |
| Medwise AI Clinical evidence and questions |
AI-assisted clinical information search across trusted sources, guidance, literature, UK drug references, and uploaded or recorded context | Medium to high | Verify current status from official sources | UK clinicians who need fast clinical information lookup with source review, especially when local guidance or UK drug references matter. | Whether the intended users are UK healthcare professionals covered by the current terms and subscription path. |
| AvoMD Clinical evidence and questions |
AI-assisted clinical decision support, local guideline workflows, medical calculators, pathways, and clinician-facing care algorithms | Medium to high | Verify current status from official sources | Organizations that want locally governed clinical pathways and calculators embedded into clinician workflows with reviewable source logic. | Which pathway, calculator, Ask Avo workflow, or EHR integration is being deployed. |
| VisualDx Clinical evidence and questions |
Visual clinical decision support, differential diagnosis building, dermatology image analysis, medical image reference, and AI-assisted clinical education workflows | Medium to high | Verify current status from official sources | Clinicians and educators who need image-rich differential diagnosis support, skin-of-color representation, patient education visuals, and supervised dermatology decision support. | Which workflow is in scope: diagnosis search, differential builder, image library, DermExpert, API integration, medical education, or patient education. |
| Isabel DDx Companion Clinical evidence and questions |
Differential diagnosis generation, symptom-to-disease matching, EMR-integrated clinical feature extraction, and evidence-linked diagnostic reasoning support | High | Verify current status from official sources | Clinicians and educators who need a second-check differential diagnosis list, red-flag prompts, and evidence-linked next-step references inside or alongside the EMR. | Which Isabel workflow is in scope: DDx Companion, Self-Triage, Clinical Educator, Active Intelligence, API, Cerner App Gallery, or Epic info-button access. |
| Causaly Clinical evidence and questions |
Agentic biomedical research, evidence retrieval, knowledge-graph exploration, target assessment, and scientific workflow automation | Medium to high | Verify current status from official sources | Teams that need traceable biomedical evidence, internal-data research workflows, target or indication assessment, and repeatable scientific decision support. | Which Causaly module is in scope: Agentic Research, Discover, Bio Graph, Pipeline Graph, or private-data workflows. |
Tools for clinicians, researchers, and students asking medical questions, searching literature, or building evidence-backed summaries.
Ambient scribes and documentation assistants that capture encounters, draft notes, support coding, or prepare visit context.
AI for radiology, cardiology imaging, pathology imaging, triage, detection, reporting, and care coordination around images.
AI-enabled pathology viewers, algorithms, and diagnostic support for whole-slide images and lab workflows.
AI-enabled surgical video, operating-room intelligence, procedural analytics, robotic assistance, and intraoperative visualization workflows.
AI for clinical insights, coding, revenue cycle, report drafting, and operational workflows that affect care delivery or reimbursement.
Symptom checkers, intake tools, patient navigation, post-discharge outreach, and healthcare-specific AI agents.
AI and decision-support tools for medication safety monitoring, precision dosing, pharmacy analytics, adherence, and patient-specific medication education.
AI-enabled hematology, cell morphology, CBC, and diagnostic laboratory systems that support lab professionals with image analysis, pre-classification, and point-of-care testing.
AI platforms for genomics, oncology, real-world data, multimodal clinical data, and personalized medicine workflows.
Platforms for inventorying, governing, monitoring, validating, and auditing AI systems used by healthcare, payer, life-sciences, or clinical operations teams.
Tools for clinicians, researchers, and students asking medical questions, searching literature, or building evidence-backed summaries.
| Product | Primary use case | First verification check | Official sources |
|---|---|---|---|
| OpenEvidence | Evidence-backed clinical questions and medical literature synthesis | Whether your user type and region are eligible. | 3 official sources |
| ClinicalKey AI | Generative AI clinical question answering grounded in licensed medical reference content | Whether your institution's license covers the intended user group and country. | 4 official sources |
| UpToDate Expert AI | Conversational clinical question answering grounded in UpToDate content, assumptions, source links, and clinician review | Whether Expert AI is available for your country, subscription tier, professional role, and enterprise account. | 3 official sources |
| Dyna AI | AI-assisted evidence retrieval and clinical question answering inside EBSCO clinical decision-support content | Which host product is licensed: DynaMed, DynaMedex, Dynamic Health, or Dyna AI Mode. | 4 official sources |
| Glass Health | AI-powered clinical decision support, ambient scribing, real-time encounter insights, differential diagnosis drafts, assessment and plan drafts, evidence-backed answers, documentation generation, and developer API workflows | Which workflow is in scope: web CDS, ambient scribing, EHR integration, developer API, triage, record summarization, diagnostic support, treatment planning, documentation, or patient-facing handouts. | 7 official sources |
| Consensus | Medical research discovery, study snapshots, and evidence-backed answers | Which databases and journals are searched. | 2 official sources |
| Elicit | Systematic-review search, screening, extraction, and research-backed reports | Database coverage and deduplication process. | 3 official sources |
| Scite | Citation-context search, paper evaluation, and AI research synthesis | Citation coverage for your specialty. | 2 official sources |
| Atropos Health | Real-world evidence generation, clinical evidence agents, and EHR-connected evidence support | Which data network or local data source will answer the clinical question. | 4 official sources |
| Doximity Ask | HIPAA-compliant clinician assistant for clinical questions, patient education, chart note templates, translation, and document drafting | Whether your clinician role, country, and Doximity verification status are eligible. | 3 official sources |
| Medwise AI | AI-assisted clinical information search across trusted sources, guidance, literature, UK drug references, and uploaded or recorded context | Whether the intended users are UK healthcare professionals covered by the current terms and subscription path. | 4 official sources |
| AvoMD | AI-assisted clinical decision support, local guideline workflows, medical calculators, pathways, and clinician-facing care algorithms | Which pathway, calculator, Ask Avo workflow, or EHR integration is being deployed. | 4 official sources |
| VisualDx | Visual clinical decision support, differential diagnosis building, dermatology image analysis, medical image reference, and AI-assisted clinical education workflows | Which workflow is in scope: diagnosis search, differential builder, image library, DermExpert, API integration, medical education, or patient education. | 5 official sources |
| Isabel DDx Companion | Differential diagnosis generation, symptom-to-disease matching, EMR-integrated clinical feature extraction, and evidence-linked diagnostic reasoning support | Which Isabel workflow is in scope: DDx Companion, Self-Triage, Clinical Educator, Active Intelligence, API, Cerner App Gallery, or Epic info-button access. | 3 official sources |
| Causaly | Agentic biomedical research, evidence retrieval, knowledge-graph exploration, target assessment, and scientific workflow automation | Which Causaly module is in scope: Agentic Research, Discover, Bio Graph, Pipeline Graph, or private-data workflows. | 5 official sources |
| AMBOSS AI Mode | AI-assisted clinical evidence search, medical question answering, study support, trusted-content navigation, and practice-focused reference workflows | Which workflow is enabled: clinical AI Mode, AI Mode Learning, LiSA, semantic search, AMBOSS GPT, or another institutional AI feature. | 4 official sources |
| Ailva | Clinical intelligence search, evidence-backed question answering, cross-specialty reasoning, citation verification, and clinician-reviewed reference support | Whether your role, specialty, region, and NPI status are eligible for the same product described on the public site. | 4 official sources |
| Eolas Medical | Healthcare knowledge management, guideline search, protocol access, retrieval-augmented AI answers, staff education, and content-use analytics | Which content sources are approved, who owns guideline updates, and how stale or conflicting documents are handled. | 5 official sources |
| AskTrip | AI-powered clinical question answering inside Trip Database that helps users explore evidence, guidelines, reviews, and source-linked answers for clinical questions | Whether AskTrip is being used for background evidence lookup, point-of-care reference, teaching, guideline surveillance, or patient-specific decision support. | 4 official sources |
Ambient scribes and documentation assistants that capture encounters, draft notes, support coding, or prepare visit context.
| Product | Primary use case | First verification check | Official sources |
|---|---|---|---|
| Abridge | Ambient clinical documentation and clinician-reviewed note drafts | BAA, audio, transcript, and training-data terms. | 3 official sources |
| Ambience Healthcare | Real-time clinical documentation, coding, and CDI support | Specialty coverage for your service lines. | 3 official sources |
| Nuance DAX Copilot | Ambient clinical documentation automation for EHR workflows | EHR support for your system. | 2 official sources |
| Microsoft Dragon Copilot | Role-based clinical AI assistant for documentation, information surfacing, reporting, coding suggestions, and workflow automation | Which role experience is in scope: physician, nurse, radiologist, or developer-kit integration. | 6 official sources |
| Oracle Health Clinical AI Agent | EHR-connected clinical AI agent for chart review, documentation, scheduling, patient access, care coordination, and operational workflows | Which agent or module is live in your licensed environment versus planned: chart review, documentation, scheduling, referrals, patient self-service, or financial transparency. | 3 official sources |
| AWS HealthScribe | API-based ambient transcription, clinical note drafting, and transcript-linked evidence mapping | Whether your workflow uses HealthScribe batch jobs, streaming, Amazon Connect Health Ambient, or a partner application built on the API. | 3 official sources |
| DeepScribe | Ambient AI scribing, specialty-specific clinical notes, pre-visit chart synthesis, EHR synchronization, and coding-support workflows | Which module is in scope: AI Medical Scribe, SmartPrep, AI Coding, Customization Studio, E/M coding, ICD-10, HCC, or a specific specialty workflow. | 6 official sources |
| Suki | Ambient documentation, coding support, clinical reasoning, and Q&A | Supported EHRs and specialty settings. | 2 official sources |
| Nabla | AI scribe, live transcript, note drafts, and EHR-connected documentation | No-audio-storage default and data-training terms. | 3 official sources |
| Epic Art for Clinicians | EHR-native AI charting, note summarization, draft documentation, ambient ordering, discharge summaries, level-of-service suggestions, and prior-authorization answer drafting | Which Epic AI workflow is in scope: Art, AI Charting, note summarization, inpatient insights, discharge summaries, ambient ordering, prior authorization, or level-of-service suggestions. | 4 official sources |
| Freed | AI scribe for SOAP notes and visit documentation | BAA and HIPAA terms for your workflow. | 2 official sources |
| Heidi Health | AI medical scribe, clinical note generation, evidence search, and patient communications support | Which Heidi product is in scope: Scribe, Evidence, Comms, or a combined workflow. | 3 official sources |
| ModMed Scribe | Ambient clinical documentation, structured note suggestions, billing code suggestions, and downstream EHR workflow automation | Whether your specialty and EMA workflow are supported. | 3 official sources |
| Augmedix | Ambient medical documentation, live note support, after-visit documentation, and EHR-connected clinical workflow support | Which product is in scope: Augmedix Go, Live, Assist, or another documentation workflow. | 4 official sources |
| Commure Ambient AI | Ambient AI documentation, clinician assistant workflows, care cues, macros, coding support, and EHR-connected clinical operations | Which Commure tier or workflow is in scope: Ambient AI, Ambient AI Scribing, AI Assistant, CareCues, Macros, autonomous coding, or a broader RCM integration. | 4 official sources |
| Tali AI | AI ambient scribe, medical dictation, note generation, and clinician-reviewed documentation | Whether the U.S., Canadian, or enterprise deployment path matches your privacy, data residency, and contracting requirements. | 5 official sources |
| Twofold Health | AI medical scribe for structured clinical notes, therapy notes, and encounter documentation | Whether your specialty templates, note formats, and therapy documentation needs are supported. | 3 official sources |
| Nabla Copilot | Ambient AI documentation, dictation, real-time encounter summaries, patient instructions, coding-support workflows, and EHR-embedded note generation | Which workflow is in scope: Copilot web app, mobile app, Chrome extension, Nabla Connect, API, dictation, coding support, patient instructions, or EHR-embedded ambient AI. | 5 official sources |
| Eleos Health | Behavioral health ambient documentation, progress-note drafting, compliance review, care operations automation, session insights, and note-quality improvement | Which Eleos workflow is in scope: Documentation, Compliance, workflow agents, ambient scribe, text summary input, session insights, or EHR-embedded behavioral health documentation. | 5 official sources |
| TORTUS | AI medical scribe for consultation notes, transcripts, codes, and NHS-aligned documentation workflows | Whether the product, site, and workflow are covered by current NHS DTAC, clinical-safety, cyber-security, and data-protection approvals. | 3 official sources |
| NextGen Clinical AI | Ambient visit capture, structured SOAP-note generation, patient summaries, ICD-10, medication, lab, imaging, and order suggestions inside the NextGen mobile and EHR workflow | Which edition is in scope: NextGen Clinical AI, NextGen Ambient Assist, or NextGen Office Ambient Assist, and whether it supports your EHR, specialty, mobile, and template workflow. | 4 official sources |
| SmarterNotes | AI-generated inpatient clinical notes that combine chart context, clinician editing, documentation completeness prompts, coding/CDI signals, and revenue-cycle intelligence | Whether the deployment is SmarterNotes alone, a combined SmarterDx revenue-cycle workflow, or a migration from the former Pieces Technologies platform. | 5 official sources |
| Sunoh.ai | Ambient medical scribe for visit transcripts, progress-note drafts, summaries, order-entry details, and approved-note sync into browser-based EHRs | Which Sunoh surfaces are in scope: ambient listening, dialogue transcript, progress-note draft, visit summary, order-entry detail capture, EHR Sync extension, mobile app, web browser, or specialty templates. | 5 official sources |
| Tandem Health | Regulated AI medical scribe and coding assistant for consultation capture, draft notes, related documents, clinical codes, and one-click transfer to medical record systems | Whether the deployment uses the AI Scribe, Coding Assistant, integrations, personalization, wireless audio capture, or another country-specific Tandem workflow. | 6 official sources |
AI for radiology, cardiology imaging, pathology imaging, triage, detection, reporting, and care coordination around images.
| Product | Primary use case | First verification check | Official sources |
|---|---|---|---|
| Aidoc | Radiology triage, scan analysis, care-team activation, and enterprise AI orchestration | FDA-cleared algorithms that match your exact modality and use case. | 6 official sources |
| AIRS Medical SwiftMR | FDA-cleared AI MRI image enhancement, denoising, super-resolution, and scan-time reduction workflow for DICOM MRI studies | Current FDA 510(k), CE, or local authorization for the exact SwiftMR version, body region, sequence, field strength, scanner vendor, and OEM deep-learning reconstruction combination in scope. | 8 official sources |
| Viz.ai | AI-powered care coordination around suspected disease detection and specialist activation | Which algorithms are FDA-cleared for your use case. | 6 official sources |
| Ferrum Health | Clinical AI governance suite for deploying, monitoring, validating, and managing imaging and other clinical AI models across existing infrastructure | Which models, service lines, PACS/RIS/EHR connections, deployment fabric, and governance modules are included in the scope. | 4 official sources |
| Blackford Platform | Enterprise radiology AI orchestration, relevancy routing, curated marketplace access, deployment monitoring, and AI application management | Which Blackford Platform functions and marketplace applications are in scope. | 4 official sources |
| CARPL.ai | Enterprise radiology AI marketplace, DICOM image viewing, PACS-integrated algorithm orchestration, pre-deployment validation, clinical deployment, and post-deployment monitoring | Current FDA 510(k) status, CARPL software version, included viewer and workflow-management functions, geography, and whether the planned use matches the cleared intended use. | 6 official sources |
| deepcOS | Vendor-neutral radiology AI operating system for evaluating, integrating, orchestrating, monitoring, and scaling multiple imaging AI solutions | Which deepcOS modules, AI marketplace applications, and clinical indications are included in the deployment. | 3 official sources |
| Enlitic Curie / ENDEX | AI-enabled medical imaging data standardization, DICOM description normalization, de-identification, anonymization, routing support, and imaging-data quality management | Which Enlitic modules are in scope: Curie platform, ENDEX data standardization, ENCOG de-identification, migration services, ENSIGHT data management, GE-integrated workflow, or research data preparation. | 6 official sources |
| Brainomix 360 Stroke | AI-enabled CT, CTA, MRI, and mobile stroke workflow support for suspected acute stroke assessment and transfer decisions | Which Brainomix 360 Stroke modules are in scope, such as e-ASPECTS, e-CTA, Triage Stroke, core-volume, e-MRI, or mobile notifications. | 6 official sources |
| Avicenna.AI CINA-ASPECTS | AI-assisted ASPECTS scoring and heat-map support on non-contrast head CT for suspected acute ischemic stroke assessment | Whether CINA-ASPECTS clearance, software version, age limits, scanner manufacturers, and geography match the planned stroke workflow. | 6 official sources |
| Qure.ai | Chest X-ray, CT, lung cancer, tuberculosis, and stroke imaging workflows | Product-specific clearance and local regulatory status. | 4 official sources |
| Qure.ai qXR | AI-assisted chest X-ray pre-read, worklist prioritization, abnormality detection, reporting support, and screening workflows | Which qXR module, finding set, software version, and geography are in scope for the planned chest X-ray workflow. | 6 official sources |
| Oxipit ChestLink | Autonomous reporting of high-confidence normal chest X-ray studies, chest radiograph triage, and radiologist workload reduction | Whether ChestLink is available and authorized for the intended country, institution, CXR workflow, software version, and autonomous-reporting mode. | 5 official sources |
| Rad AI | Radiology report drafting, impression generation, consensus-guideline insertion, and reporting workflow automation | Whether Rad AI Reporting supports the modalities, templates, macros, consensus guidelines, hardware, and reporting styles used by the radiology group. | 5 official sources |
| Rad AI Continuity | AI-assisted detection, categorization, communication, dashboard tracking, and resolution of follow-up recommendations from radiology reports | Which report types, incidental-finding categories, anatomy groups, consensus guidelines, and follow-up timeframes are detected and tracked. | 3 official sources |
| Sirona RadOS | Cloud-native PACS, worklist, viewer, reporting, and AI-powered radiology workflow automation | Which RadOS modules are contracted, including PACS archive, viewer, worklist, reporting, AI automation, business continuity, and any prospective features under regulatory review. | 4 official sources |
| Bayer Calantic Digital Solutions | Cloud-hosted radiology AI platform for curated imaging applications, PACS-integrated viewing, triage, detection, quantification, and workflow orchestration | Which Calantic applications are available in the intended country, service line, modality, body region, and regulatory pathway. | 4 official sources |
| Cleerly | AI-enabled coronary CT angiography and plaque analysis | Regulatory status and intended use in your country. | 7 official sources |
| Elucid PlaqueIQ | AI-enabled coronary CTA plaque composition and lesion-level plaque analysis | FDA 510(k) indication, software version, and whether the intended coronary CTA workflow matches the clearance. | 5 official sources |
| LumineticsCore | Autonomous AI diabetic retinopathy detection from retinal images at the point of care | FDA De Novo authorization, indications for use, contraindications, and exact eligible patient population. | 5 official sources |
| Eyenuk EyeArt | Autonomous AI diabetic retinopathy screening from color retinal fundus images | FDA 510(k) record, current EyeArt version, supported camera models, intended-use language, and eligible patient population. | 5 official sources |
| AEYE-DS | Autonomous point-of-care diabetic retinopathy screening from tabletop or portable non-mydriatic fundus-camera images | Current FDA 510(k) record, supported camera model, software version, indication, contraindications, and adult diabetes eligibility rules. | 4 official sources |
| RETINA-AI Galaxy | Autonomous detection of moderate-or-worse diabetic retinopathy from supported retinal fundus cameras in primary care settings | FDA-cleared indication, compatible cameras, contraindications, warnings, and patient eligibility before purchase. | 3 official sources |
| RetInSight Fluid Monitor | AI-based OCT retinal-fluid segmentation, quantification, visualization, follow-up charts, and nAMD monitoring support | Current CE/MDR status, country availability, version, indication, OCT device compatibility, and whether U.S. clinical use is supported. | 3 official sources |
| RetinAI Discovery | Ophthalmology image and data platform with OCT/image management, AI enrichment, trial data collection, and retinal-disease analytics | Which Discovery product, AI module, disease area, and region are in scope for clinical use versus research use only. | 5 official sources |
| Cercare Medical Neurosuite | Automated CT, MRI, and cone-beam CT perfusion post-processing for stroke, neuro-oncology, and neurovascular assessment workflows | Which module is in scope: CMN Capillary Function, Virtual Expert, CT perfusion, MRI perfusion, CBCT Perfusion, oncology, or stroke workflow support. | 5 official sources |
| RapidAI | AI-powered imaging triage, quantification, disease detection, and care-team workflow support | Which RapidAI module is in scope and whether its clearance matches the exact modality, anatomy, and intended use. | 6 official sources |
| Heartflow | AI-powered coronary CTA analysis, FFRCT physiology analysis, plaque analysis, and coronary roadmap workflows | Which Heartflow product is being used: FFRCT, Plaque Analysis, Roadmap Analysis, or another module. | 7 official sources |
| Caristo CaRi-Plaque and CaRi-Heart | AI-assisted coronary CTA plaque analysis, stenosis quantification, coronary inflammation assessment, and cardiovascular risk reporting | Which module is in scope: FDA-cleared CaRi-Plaque, CaRi-Heart FAI-Score, CaRi-Heart Risk Score, a research workflow, or a combined regional report. | 5 official sources |
| Ultromics EchoGo | AI-assisted echocardiography analysis for HFpEF detection support and cardiac workflow reporting | Whether the selected EchoGo Heart Failure version and 510(k) clearance match the intended echocardiography workflow. | 4 official sources |
| Us2.ai | Automated transthoracic echocardiography analysis, measurement extraction, disease-detection support, and structured echo reporting | Which Us2.ai software version and market authorization apply to the planned echo workflow. | 6 official sources |
| Gleamer BoneView | AI-assisted fracture detection and trauma X-ray second-reader workflow support | FDA K222176 intended use, covered anatomy, patient age limits, warnings, and region-specific availability. | 4 official sources |
| iCAD ProFound AI | AI-assisted breast cancer detection, mammography case scoring, density assessment, and short-term risk workflow support | Which module is in scope: ProFound Detection, ProFound AI for DBT, density assessment, risk scoring, or another breast-health workflow. | 5 official sources |
| GI Genius | Real-time computer-aided polyp detection support during standard white-light colonoscopy | FDA De Novo authorization, current labeling, software version, contraindications, prescription-use requirements, and geography-specific availability. | 4 official sources |
| SKOUT | Real-time AI-assisted colorectal polyp location support during adult screening or surveillance colonoscopy | FDA 510(k) record, current labeling, intended adult screening or surveillance population, white-light requirement, and compatible SKOUT system components. | 4 official sources |
| Fujifilm CAD EYE | AI-assisted real-time detection of colonic mucosal lesions during colonoscopy with Fujifilm endoscopy systems | FDA 510(k) status for the exact CAD EYE or EW10-EC02 software version, intended use, compatible Fujifilm hardware, and current U.S. availability. | 4 official sources |
| Olympus CADDIE | Cloud-connected computer-aided detection support for suspected colorectal polyps during standard white-light colonoscopy | FDA 510(k) records such as K240044 or K252586, current U.S. labeling, standard white-light limitation, software version, and any hardware or OLYSENSE Hub dependencies. | 6 official sources |
| MammoScreen | AI-assisted mammography reading, suspicious-lesion scoring, pre-check workflow, priors-informed review, and breast-density support | Whether the exact MammoScreen version and module are cleared or available for the intended country, modality, and mammography system. | 5 official sources |
| Kheiron Mia | AI-supported breast screening triage, reader workflow support, image-quality review, and mammography pathway optimization | Which Mia module is in scope: Mia Triage, Mia Reader, Mia IQ, RSViP, or another local workflow. | 5 official sources |
| ScreenPoint Transpara | AI-assisted breast cancer detection, density assessment, temporal comparison, and mammography workflow support | Which Transpara module is in scope: Detection, Density, Temporal Comparison, or another breast AI workflow. | 4 official sources |
| Koios DS Breast | AI-assisted risk assessment and computer-aided diagnosis support for breast ultrasound lesions | Whether Koios DS Breast, Koios DS, or another module/version matches the intended breast ultrasound workflow. | 4 official sources |
| Subtle Medical | AI-powered MRI and PET image enhancement, denoising, acceleration, and synthetic imaging workflow support | Which tool is in scope: SubtleMR, SubtlePET, SubtleHD, SubtleSYNTH, SubtleALIGN, or an integrated partner workflow. | 6 official sources |
| Lunit | AI cancer screening, breast imaging, chest X-ray, precision oncology, and pathology biomarker workflows | Which module is in scope: INSIGHT MMG, INSIGHT DBT, INSIGHT CXR, SCOPE IO, SCOPE IHC, SCOPE GP, or a Volpara-derived workflow. | 3 official sources |
| annalise.ai | Chest X-ray, non-contrast head CT, radiology triage, decision support, worklist prioritization, and draft reporting support | Which product is being evaluated: Annalise Enterprise CXR, Enterprise CTB, Annalise Triage, Reporting, or a regional Harrison.ai-branded workflow. | 4 official sources |
| CureMetrix | AI-assisted mammography worklist triage and breast-screening workflow prioritization | Whether the exact CureMetrix module is cmTriage, cmAssist, or another breast-imaging workflow. | 3 official sources |
| Hologic Genius AI Detection | Deep-learning computer-aided detection and case scoring for breast tomosynthesis exams | Which version is being evaluated: Genius AI Detection, Genius AI Detection 2.0, CC-MLO Correlation, or another local package. | 4 official sources |
| GE HealthCare Caption AI | AI-guided cardiac ultrasound acquisition and automated ejection-fraction support on compatible GE HealthCare ultrasound systems | Which GE ultrasound system, Caption Guidance feature, or Caption Interpretation AutoEF workflow is in scope. | 4 official sources |
| UltraSight Guidance | Real-time AI guidance and image-quality feedback for acquiring adult two-dimensional transthoracic echocardiography views on compatible ultrasound systems | FDA 510(k), regional authorization, software version, compatible ultrasound systems, intended users, adult 2D-TTE scope, and supported cardiac views. | 6 official sources |
| Butterfly iQ3 | Handheld point-of-care ultrasound with AI-enabled workflow software and gestational-age AI tooling in eligible settings | Which probe generation, software plan, AI feature, and clinical workflow is being deployed. | 4 official sources |
| Sonio Detect | AI-assisted fetal ultrasound acquisition support, view detection, anatomical-structure detection, and quality-criteria verification during routine prenatal exams | Which Sonio Detect version, Sonio Pro workflow, ultrasound manufacturer, country, and gestational-age range are in scope. | 7 official sources |
| DeepHealth Breast Suite | AI-supported mammography detection, density assessment, workflow triage, risk assessment, and breast imaging worklist support across modular Breast Suite applications | Which Breast Suite module is in scope: Saige-Dx, density assessment, safeguard review, risk assessment, viewer, breast ultrasound, or another DeepHealth component. | 6 official sources |
| Pearl Second Opinion | AI-assisted dental radiograph review, pathology detection, patient education, and 2D or 3D dental image analysis | Which Pearl module is in scope: Second Opinion 2D, Second Opinion 3D, bone-level features, claims review, or another workflow. | 5 official sources |
| Overjet | FDA-cleared dental X-ray analysis, caries support, bone-level measurement, image enhancement, and dental workflow automation | Which product is being used: Vision AI, Dental Assist, Caries Assist, IRIS, image enhancement, payer review, voice, or insurance verification. | 6 official sources |
| VideaAI | Dental X-ray AI for clinical assist, patient education, caries and periodontal findings, and practice workflow insights | Which Videa product is in scope: Clinical Assist, Patient View, Daily Dashboard, Voice Notes, Clean Claims, AutoVerify, or another platform module. | 4 official sources |
| Denti.AI | AI-assisted dental radiograph detection, auto-charting, voice perio charting, dental scribe documentation, and PMS-connected workflow support | Which module is in scope: Denti.AI Detect, Auto-Chart, Voice Perio, Scribe, Receptionist, Voice Assistant, or PMS integration. | 6 official sources |
| Diagnocat | AI-assisted CBCT review, radiological reports, 3D visualization, tooth charts, segmentation, and second-read support for dental professionals | Whether the deployment uses Diagnocat Viewer, Radiological Report, CBCT second read, 3D modeling, or another module. | 6 official sources |
| DentalMonitoring | AI-powered remote orthodontic monitoring from smartphone scans, treatment-progress tracking, workflow alerts, and patient-practitioner communication | Which product and region are in scope: DentalMonitoring, DM Intelligent Platform, ScanBoxpro, ScanAssist, SmartSTL, app workflow, or analytics. | 5 official sources |
| DermaSensor | AI-assisted optical spectroscopy for adjunctive skin cancer risk assessment and dermatologist referral decisions | FDA De Novo DEN230008, prescription-use limits, patient age, lesion exclusions, and whether the intended users match the cleared non-dermatologist physician workflow. | 4 official sources |
| Skin Analytics DERM | AI as a medical device for skin lesion assessment, urgent suspected skin cancer triage, and dermatology pathway prioritization | Class III CE mark, MHRA status, U.S. investigational status, intended pathway, imaging requirements, and whether local use is autonomous triage or clinician-reviewed support. | 4 official sources |
| FotoFinder Moleanalyzer pro | Dermoscopy image analysis, lesion comparison, AI score, heatmap support, and second-opinion workflow | Which version, device, magnification, FotoFinder Hub account, online or offline AI score, heatmap, and second-opinion workflow are included. | 3 official sources |
| DermEngine | Dermatology image capture, storage, analytics, mole mapping, visual search, evolution tracking, and teledermatology workflow management | Which modules are included: DermEngine web platform, MoleScope capture, full-body imaging, visual image search, mole matching, evolution tracker, analytics, or referral network. | 4 official sources |
| Model Dermatol | AI-assisted dermatology image search that returns relevant skin disease information and reference links for review | Whether the intended workflow is patient self-education, clinician education, medical information retrieval, or clinical decision support because the vendor states it must not be used as a diagnostic medical device. | 3 official sources |
| Swift Medical | AI-supported wound imaging, measurement, documentation, analytics, reimbursement documentation, and care-team coordination | Which Swift modules are being deployed: image capture, wound measurement, documentation, analytics, reimbursement support, or remote review. | 3 official sources |
| Net Health Tissue Analytics | AI-powered mobile wound imaging, segmentation, measurement, tissue classification, analytics, and EHR-integrated wound documentation | Which imaging, measurement, classification, analytics, and EHR-interface capabilities are included in the contracted workflow. | 2 official sources |
| eKare inSight | 3D wound imaging, measurement, tissue analysis, documentation, telehealth workflow, and wound healing analytics | Which inSight device, application, analytics, and research or clinical workflow are included. | 4 official sources |
| Healthy.io Minuteful for Wound | Smartphone-based wound scanning, 3D wound imaging, automatic measurement, tissue distribution, documentation, and remote review | Whether the U.S., EU, or local Minuteful for Wound service and app version matches the intended care setting. | 3 official sources |
| MolecuLight | Point-of-care fluorescence wound imaging, elevated bacterial-load detection support, wound measurement, and longitudinal wound monitoring | Which device model, fluorescence, thermal, measurement, reimbursement, and EHR capabilities are included. | 3 official sources |
| Spectral AI DeepView | AI-enabled multispectral wound imaging for burn wound healing assessment and treatment-planning support | FDA De Novo DEN250028, indication, labeling, contraindications, user training, and commercial availability for the intended burn-care setting. | 3 official sources |
| Radformation AutoContour | Deep-learning auto-contouring, organ-at-risk segmentation, treatment-planning structure generation, DICOM workflow integration, and radiation oncology planning acceleration | Current FDA 510(k), local regulatory status, AutoContour version, supported CT/MR/CBCT inputs, structure library, and whether Limbus-derived features are included. | 4 official sources |
| MIM Contour ProtegeAI | AI auto-segmentation for radiation oncology contours, CT and MR structure generation, molecular radiotherapy contour support, and MIM workflow automation | FDA clearance records, software version, supported structures, CT/MR scope, molecular radiotherapy features, and whether local deployment or cloud deployment is licensed. | 4 official sources |
| Siemens Healthineers DirectORGANS | CT-simulator-integrated AI autocontouring, organ-at-risk structure generation, optimized reconstruction, and radiation therapy simulation workflow support | Current product availability, region, regulatory status, SOMATOM go.Sim or SmartSimulator requirements, supported cancer sites, and software version. | 4 official sources |
| MVision Contour+ | AI-powered auto-contouring, guideline-based organ-at-risk and lymph-node segmentation, CT and MR contour templates, and treatment-planning workflow acceleration | Current FDA 510(k), CE or local regulatory status, Contour+ version, supported CT and MR models, structure library, and geography. | 4 official sources |
| TheraPanacea Annotate | AI-enhanced contouring for organs-at-risk, lymph nodes, treatment-planning segmentation, batch contouring, and radiotherapy preparation workflows | Current FDA, CE, local regulatory status, ART-Plan module name, supported OAR, CTV, lymph-node, TumorBox, and modality scope. | 4 official sources |
| Mirada DLCExpert | Deep-learning contouring for organs-at-risk, zero-click autocontouring workflows, CT treatment-planning structures, and radiotherapy contour quality support | Current FDA, CE, UK, or local regulatory status, DLCExpert version, Workflow Box or RTx configuration, anatomy coverage, and modality scope. | 4 official sources |
| RayStation Deep Learning Segmentation | Deep-learning organ segmentation inside RayStation, radiation therapy contour generation, automated planning support, and treatment-planning workflow consistency | Current RayStation release, licensed machine-learning modules, FDA or local regulatory status, DLS model catalogue date, supported CT/MR scope, and market restrictions. | 5 official sources |
| GE HealthCare Critical Care Suite | On-device chest X-ray AI for pneumothorax notification, worklist prioritization, image-quality checks, and endotracheal tube position measurement | Which Critical Care Suite version, X-ray device, PACS/workstation integration, geography, and FDA-cleared intended use are in scope. | 3 official sources |
| Imbio Lung Density Analysis | AI-assisted chest CT lung-density quantification, emphysema visualization, COPD component mapping, low-dose CT screening support, and patient LungMap reporting | Which Imbio module is in scope: inspiration-only Lung Density Analysis, functional LDA, Lung Texture Analysis, CAC, airway analysis, partner-delivered workflow, or research use. | 6 official sources |
| icometrix icobrain | FDA-cleared AI brain MRI quantification, longitudinal lesion and volume tracking, ARIA monitoring support, and disease-specific neurology imaging reports | Which icobrain module is in scope: MS, dementia and Alzheimer's, ARIA, traumatic brain injury, epilepsy, Parkinson's disease, brain tumor, or another disease-specific report. | 6 official sources |
| Behold.ai red dot | AI-assisted chest X-ray triage, high-confidence-normal rule-out workflows, suspected lung cancer prioritization, pneumothorax notification, and RIS/PACS worklist support | Which red dot module is in scope: FDA-cleared pneumothorax triage, lung cancer detection, high-confidence-normal chest X-ray reporting, CT head triage, or another Behold.ai service. | 6 official sources |
| Clairity Breast | FDA-authorized AI risk prediction from bilateral screening mammograms to estimate five-year future breast cancer risk after radiologist interpretation | Whether the deployed product is Clairity Breast/Allix5 under De Novo DEN240047 and the exact intended-use, prescription-use, labeling, warning, and contraindication language. | 6 official sources |
| Nanox.AI HealthCCSng | FDA-cleared AI post-processing of routine non-gated, non-contrast CT studies to identify coronary artery calcium and add CAC scoring or category output to radiology and follow-up workflows | Whether the deployed version is HealthCCSng V2.0 or another Nanox.AI cardiac solution, with the exact FDA 510(k), CE, intended-use, age, CT protocol, output, and radiologist-workflow language. | 4 official sources |
| Median eyonis LCS | AI-enabled CADe/CADx software that analyzes low-dose CT lung cancer screening studies to help radiologists detect, localize, and characterize pulmonary nodules suspicious for malignancy | Current FDA 510(k), CE, local regulatory, version, reimbursement, and intended-use status for eyonis LCS before clinical use. | 5 official sources |
| Covera Health | Clinical intelligence platform that applies AI-powered quality insights to radiology networks, diagnostic pathways, peer learning, patient outcomes, and value-based imaging programs | Whether the workflow is provider peer learning, health-plan quality management, employer benefit design, imaging network steering, diagnostic pathway feedback, or value-based care analytics. | 4 official sources |
| Bunkerhill Carebricks | Generative workflow platform and FDA-cleared CT algorithms that surface actionable incidental findings such as coronary artery calcium, aortic valve calcification, abdominal aortic enlargement, mitral annular calcification, and low bone density for clinician review and care coordination | Which Bunkerhill algorithm is in scope, such as iCAC, BMD, AVC, Contrast AVC, AAQ, MAC, or another Carebricks workflow, and which FDA 510(k) and intended-use statement applies. | 7 official sources |
| Riverain ClearRead CT | Cardiothoracic CT AI suite for vessel suppression, pulmonary nodule detection and comparison, reporting support, coronary artery calcium scoring on ungated non-contrast chest CT, and research-use lung tissue analysis | Which ClearRead CT module is enabled, including vessel suppression, nodule detection, compare, CAC scoring, reporting integration, or any research-use lung tissue analysis. | 5 official sources |
AI-enabled pathology viewers, algorithms, and diagnostic support for whole-slide images and lab workflows.
| Product | Primary use case | First verification check | Official sources |
|---|---|---|---|
| Paige | AI-assisted digital pathology and prostate cancer detection support | FDA authorization and exact intended use for the selected product. | 3 official sources |
| PathAI | FDA-cleared digital pathology image management, whole-slide viewing, LIS-connected case workflow, AI algorithm access, quality control, and lab collaboration | Whether the deployment is AISight, AISight Dx, AISight Link, an AI Product Solution, ArtifactDetect, TumorDetect, or another workflow with a different intended use. | 8 official sources |
| Hologic Genius Digital Diagnostics | Digital cytology imaging, AI-assisted cervical cytology review, image management, and local or remote review-station workflow | Whether the exact Genius Digital Diagnostics System, Genius Cervical AI algorithm, imager, server, and review station match the cleared intended use. | 5 official sources |
| Ibex Medical Analytics | AI-powered pathology workflows for cancer detection, grading, biomarker support, and structured reporting | Which Ibex module, tissue type, and workflow is being evaluated. | 6 official sources |
| Deep Bio DeepDx Prostate | AI diagnostic-support workflow for prostate H&E whole-slide images, cancer detection, Gleason-pattern localization, quantification, and pathologist review | Exact DeepDx Prostate module, specimen type, scanner, viewer, geography, CE or MFDS status, and whether the U.S. workflow is research-use-only. | 4 official sources |
| Proscia | Digital pathology image management, AI application deployment, model development, and lab workflow orchestration | Whether Concentriq AP, Dx, LS, or another deployment model fits the lab setting. | 6 official sources |
| Aiforia | AI-assisted digital pathology suites for cancer diagnostics, quantitative image analysis, and case-level pathology reporting | Which Aiforia clinical suite and AI models match the tissue, stain, and diagnostic workflow. | 6 official sources |
| Mindpeak | AI-assisted tissue image analysis for breast biomarkers, PD-L1, HER2, tumor detection, and pathology workflow support | Which Mindpeak suite or module is in scope: breast IHC, PD-L1, HER2, prostate, onychomycosis, lymphocyte quantification, peakDissect, or a biopharma workflow. | 4 official sources |
| Aignostics | Research-use digital pathology foundation-model analysis for H&E tumor microenvironment profiling and quantitative spatial metrics | Research-use-only status and whether any workflow is explicitly excluded from diagnostic procedures. | 3 official sources |
| Lumea | Integrated digital pathology workflow with tissue-handling tools, FDA-cleared viewer, LIS-enabled case management, AI ecosystem access, and molecular test ordering | Which Lumea component is in scope: Viewer+, BxLink, tissue-handling tools, specialty workflow, AI marketplace, or molecular ordering. | 5 official sources |
| Visiopharm | AI-driven precision pathology image analysis, biomarker scoring, diagnostic decision support APPs, research analysis, and workflow integrations | Which Visiopharm platform or APP is in scope: diagnostic decision support, Discovery, Phenoplex, Qualitopix, or a partner integration. | 5 official sources |
| Tribun Health | CaloPix image management, digital slide viewing, AI app integration, telepathology, archive workflow, and pathology platform modernization | Which module is being purchased: CaloPix, CaloPix Archive, AI Apps, TeleSlide, MacroCam, or a partner integration. | 4 official sources |
| Roche navify Digital Pathology | Digital pathology case workflow, whole-slide image viewing, multi-slide review, collaboration, LIS/PACS integration, cloud or on-prem deployment, and access to AI-based image analysis algorithms | Which deployment is in scope: cloud navify Digital Pathology, on-prem software, Roche Digital Pathology Dx, scanners, navify Pathology Lab Hub, analytics, or algorithm access. | 6 official sources |
| PathPresenter | Digital pathology image management, FDA-cleared clinical viewing, remote consultations, education, biorepository workflows, and access to third-party AI models | Whether the purchase covers Clinical Viewer, ConsultConnect, education, biorepository management, AI integrations, or a combination of modules. | 8 official sources |
| DoMore Diagnostics Histotype Px Colorectal | AI-powered digital biomarker for stage II and stage III colorectal cancer outcome prediction from routine H&E histology slides | Whether Histotype Px Colorectal is cleared or CE-marked for the intended country, cancer stage, specimen, scanner, and diagnostic or research workflow. | 4 official sources |
| PreciseDx PreciseBreast | AI-enabled digital pathology prognostic testing for early-stage invasive breast cancer recurrence risk using H&E whole-slide images and clinical factors | Whether PreciseBreast is available and authorized for the intended country, specimen type, breast cancer subtype, stage, and diagnostic or research workflow. | 5 official sources |
| Lunit SCOPE | AI-powered digital pathology analysis for tumor microenvironment profiling, IHC quantification, PD-L1 scoring support, genotype prediction research, and biomarker development workflows | Which module is in scope: SCOPE IO, IHC Suite, uIHC, HER2, PD-L1, GP, or another Lunit precision-oncology product. | 6 official sources |
| Indica Labs HALO AP and HALO AP Dx | AI-ready digital pathology case management, primary-diagnosis viewing where cleared, remote review, LIS/LIMS integration, clinical AI module deployment, and whole-slide-image quality or biomarker analysis workflows | Which product and module are in scope: HALO AP, HALO AP Dx, HALO Clinical AI, Prostate AI, Breast IHC AI, Lung PD-L1 AI, SlideQC BF, macrodissection tools, HALO AI, or third-party algorithms. | 5 official sources |
| Techcyte Fusion | Unified digital pathology platform with AI-assisted workflows for anatomic pathology, clinical pathology, image management, custom AI tools, reporting, and LIS integration | Which Fusion product or module is in scope: Fusion AP, Frozen Section Suite, SureView Cervical Cytology, Parasitology, Bacteriology, Hematology, Organ Donation, DICOM, viewer, storage, or partner AI workflow. | 5 official sources |
AI-enabled surgical video, operating-room intelligence, procedural analytics, robotic assistance, and intraoperative visualization workflows.
| Product | Primary use case | First verification check | Official sources |
|---|---|---|---|
| Caresyntax | Connected operating-room integration, surgical video and device data capture, AI-powered multi-modal analytics, quality improvement, workflow optimization, and perioperative performance monitoring | Which modules are in scope, including Caresyntax ORI, ORION Multi-Modal Analytics, video routing, case documentation, performance dashboards, training, or industry-partner analytics. | 4 official sources |
| Theator | Surgical video capture, AI analysis, procedure mapping, operative-report support, quality review, training, and OR intelligence | Supported specialties, procedures, video sources, capture hardware, and EHR or operative-report integrations. | 3 official sources |
| Proximie | Connected operating-room platform, remote collaboration, surgical video library, workflow orchestration, and AI-powered surgical intelligence | Which Platform, Intelligence Suite, Surgical Suite, and hardware capabilities are included in the deployment. | 2 official sources |
| Medtronic Touch Surgery ecosystem | AI-enabled surgical video management, postoperative review, performance assessment, education, and procedural insight workflows | Which Touch Surgery ecosystem components, video sources, devices, specialties, and analytics features are available in your country. | 3 official sources |
| Moon Surgical Maestro | Collaborative robotic assistance, laparoscope control, intraoperative data capture, and procedure-level insights for minimally invasive surgery | Current FDA, EU, or local authorization for Maestro, ScoPilot, procedure types, instruments, and intended use. | 4 official sources |
| Activ Surgical ActivSight | Intraoperative surgical visualization, perfusion-related visual insight, AI-enabled case support, and augmented-reality surgical intelligence | Current ActivSight indications, clearance status, geography, compatible procedures, and whether AI-enabled modes are commercially available. | 3 official sources |
| Apella | Ambient operating-room intelligence, real-time OR monitoring, automated case-event documentation, delay prediction, capacity optimization, and perioperative analytics | Which ORs, cameras, EHR fields, event types, dashboards, and automated write-back workflows are in scope. | 4 official sources |
| Surgical Safety Technologies OR Black Box | AI-driven multimodal OR data capture, de-identified procedure review, safety analytics, quality improvement, team training, and operating-room performance insights | Which data streams are captured, such as intracorporeal video, room video, audio, device data, workflow events, and perioperative context. | 3 official sources |
| Cydar Maps | AI-enhanced endovascular procedure planning, 3D surgical maps, intraoperative image guidance, automatic registration, volume assessment, and post-operative analysis | Current regulatory status, indications for use, geography, procedure scope, and whether Plan+, Guide, AVA, or collaboration features are included. | 4 official sources |
| Asensus Intelligent Surgical Unit | Augmented-intelligence support for robotic surgery, machine-vision camera control, digital tools, visual guidance, and procedure-data insights with the Senhance Surgical System | Current FDA, CE, PMDA, or local authorization for the Senhance system, Intelligent Surgical Unit, software version, and procedure indication. | 4 official sources |
| Proprio Paradigm | AI-powered spine-surgery navigation, real-time 3D surgical guidance, light-field computer vision, intraoperative measurement, and structured surgical data capture | Current 510(k) record, indications for use, software version, anatomy, surgical approach, vertebral levels, and procedure eligibility. | 5 official sources |
| PathKeeper System | AI-driven 3D optical spine navigation, preoperative CT-based planning, intraoperative registration, instrument tracking, and radiation-free pedicle-screw guidance workflow | Current 510(k) record, indications for use, software version, supported spinal region, procedure type, and whether the planned case matches posterior approach open spine fusion labeling. | 4 official sources |
| ZEISS Surgery Optimizer | AI-assisted cataract surgical video library, phase segmentation, case review, benchmarking, teaching, and performance-improvement workflow | Whether Surgery Optimizer is available in your country and connected to the exact CALLISTO eye, ARTEVO, FORUM, IOLMaster, and DICOM workflow in use. | 4 official sources |
| SurgeryView.ai | Post-procedure surgical video library, AI PII detection, phase segmentation, longitudinal analytics, benchmarking, case review, and training workflow | Which analytics level is included, including video library, editing, AI PII detection, phase segmentation, longitudinal analytics, and benchmarking. | 4 official sources |
| Stryker SurgiCount+ with Triton | AI-assisted surgical blood-loss estimation, sponge counting, retained-sponge prevention workflow, EMR-connected charting, and perioperative hemorrhage response support | Current FDA 510(k) status, software configuration, validated sponges or absorbent items, compatible hardware, and indications for the planned surgical service line. | 4 official sources |
| Intuitive da Vinci 5 Surgical Insights | Robotic surgery platform software for real-time force visualization, intraoperative video replay, remote software updates, surgeon learning, and procedural analytics | Exact da Vinci 5 system, software version, instruments, Force Gauge, In-Console Video Replay, Network CCM, regional availability, and FDA 510(k) labeling. | 5 official sources |
| TrackiMed | Vision and voice AI for live OR item counting, instrument tracking, sponge and needle workflow support, voice documentation, usage analytics, and retained-item prevention | Current product stage, ORKing and Tracki modules, supported instruments, needles, sponges, disposables, cameras, microphones, room setup, and integration roadmap. | 2 official sources |
| Osso VR | Virtual reality procedural training, skill assessment, scenario-based onboarding, structured debriefing, learner dashboards, supervisor analytics, and surgical or nursing workflow rehearsal | Which Osso workflow is in scope: surgical residency, medical-device procedure training, nursing onboarding, collaborative VR practice, supervisor dashboards, or assessment modules. | 3 official sources |
| Artisight Smart Operating Room | Ambient OR intelligence for case progress tracking, predictive scheduling, RTLS-enabled coordination, procedural milestones, Epic-connected operative-note support, and performance analytics | Which modules are enabled: OR coordination, predictive scheduling, asset and staff tracking, systemwide visibility, operative-note support, timeout/debrief capture, video timeline review, Epic integration, or remote collaboration. | 4 official sources |
AI for clinical insights, coding, revenue cycle, report drafting, and operational workflows that affect care delivery or reimbursement.
| Product | Primary use case | First verification check | Official sources |
|---|---|---|---|
| Regard | Clinical insights from EHR data, pre-visit documentation, and missed-condition surfacing | EHR integration and data mapping. | 3 official sources |
| Bayesian Health | Real-time EHR-based clinical intelligence, continuous sepsis flagging, patient risk monitoring, care-pathway activation, and performance reporting | Whether the deployment uses the FDA-cleared Bayesian Health Sepsis Flagging Device K250680, another Bayesian module, or a broader clinical pathway workflow. | 7 official sources |
| CLEW ICU | AI-driven clinical surveillance and predictive alerts for adult ICU patient deterioration and hemodynamic instability | FDA 510(k) K233216 intended use, adult critical-care setting, product code, decision date, and any predetermined change-control plan boundaries. | 6 official sources |
| Mednition KATE | Real-time emergency department triage decision support, early sepsis-risk detection, and EHR-derived clinical analytics | Which module is in scope: KATE Triage, KATE Sepsis, Clinical Data Engine, reporting dashboards, or retrospective cohort analytics. | 6 official sources |
| Fathom | Autonomous medical coding and coding automation | Automation rate and accuracy by specialty and claim type. | 3 official sources |
| CodaMetrix | Contextual coding automation and medical coding performance improvement | Service line coverage and payer-rule support. | 3 official sources |
| Apicare AuthAdvisor | AI-powered prior authorization decision support and automated routing for payer utilization-management workflows | Whether AuthAdvisor is still sold, implemented, and supported under Apixio, Datavant, or another contracting entity for your payer segment. | 5 official sources |
| Nym | Autonomous medical coding for emergency medicine, radiology, outpatient surgery, outpatient visits, urgent care, and inpatient professional services | Which service lines are in scope and whether Nym supports the exact encounter types, specialties, payers, and coding systems you need. | 4 official sources |
| SmarterDx | Clinical AI for revenue integrity, prebill diagnosis review, charge validation, denials appeals, and note-level revenue intelligence | Which SmarterDx module is in scope: SmarterPrebill, SmarterDenials, SmarterNotes, SmarterCharges, or a combined Smarter Technologies workflow. | 4 official sources |
| Waystar AltitudeAI | AI-powered healthcare payment and revenue cycle automation across financial clearance, clinical integrity, claims, denials, and reporting | Which Waystar module is in scope: financial clearance, clinical integrity and revenue capture, claim management, denial recovery, payment management, or analytics. | 3 official sources |
| Cedar Intelligence | AI-powered patient financial engagement, billing personalization, bill explanations, agent guidance, and outbound payment support | Which Cedar Intelligence capability is in scope: adaptive patient experience, Bill Navigator, Agent Copilot, Kora Outbound, Cedar Pay, or Cedar Support. | 4 official sources |
| Carta Healthcare Voyager | AI-assisted clinical data abstraction, registry-ready answers, FHIR-connected chart review, quality registry workflow, and data provenance support | Which Carta workflow is in scope: Voyager ingestion, Lighthouse registry questions, Atlas registry abstraction and submission, Navigator analytics, Harbor research, or abstraction services. | 4 official sources |
| Layer Health | AI-powered chart review for clinical registries, custom quality measurement, intelligent clinical pathways, evidence-grounded longitudinal chart questions, and registry abstraction workflows | Which workflow is in scope: clinical registry automation, custom quality measurement, intelligent clinical pathways, cohort identification, or other longitudinal chart-review use case. | 5 official sources |
| Wellsheet Care Team Copilot | AI-powered Smart EHR UI for chart summarization, clinician questions, documentation drafts, clinical pathways, handoff, alerts, and discharge planning | Which capability is in scope: chart summarization, AI Chat, AI Pathways, documentation, handoff, smart alerts, discharge planning, mobile chart review, or EHR-embedded views. | 4 official sources |
| Tennr | Agentic patient-flow automation for referrals, orders, document intake, eligibility, prior authorization, triage, and outreach | Which workflow is in scope: referral intake, order processing, eligibility, prior authorization, intelligent triage, communications coordination, or autopilot completion. | 4 official sources |
| AKASA | Generative AI for revenue cycle, coding optimization, CDI, authorization status, and claim status workflows | Which revenue cycle workflow is in scope: coding, CDI, auth status, claim status, or research. | 4 official sources |
| Forus | Medication prior authorization, appeals, enrollment forms, benefit verification, specialty-pharmacy routing, affordability support, and patient communication | Which medication workflows are in scope: prior authorization, appeal letters, benefit verification, specialty-pharmacy calls, enrollment forms, renewals, or patient updates. | 3 official sources |
| Case Health AI | AI agents for prior authorization intake, clinical abstraction, policy comparison, coverage determination support, outreach routing, and utilization management system integration | Which authorization types and benefit lines are covered and whether the tool approves, recommends, denies, or routes cases for outreach. | 2 official sources |
| Notable | AI-powered healthcare automation for patient access, intake, authorization, scheduling, and administrative workflows | Which workflows are automated and which require staff review. | 4 official sources |
| Qventus | AI-powered healthcare operations automation, inpatient capacity, surgical growth, perioperative coordination, and operational assistants | Which operational workflow is in scope: surgical growth, pre-admission testing, perioperative coordination, inpatient capacity, or assistant-led follow-up. | 3 official sources |
| Caremaze | AI-powered discharge coordination, barrier detection, task orchestration, EMR-integrated transition planning, and Voice AI outreach for routine care-coordination work | Which discharge workflows are enabled: chart ingestion, barrier detection, task assignment, SNF outreach, transportation scheduling, appointment booking, or weekend handoff support. | 2 official sources |
| Laudio | AI-enhanced frontline leader operations, workforce engagement, patient rounding, employee retention workflows, audit tracking, and high-impact action recommendations | Which modules are in scope: employee engagement, voice, time and attendance, professional development, audit and compliance tracking, patient rounding, or executive goal cascade. | 3 official sources |
| LeanTaaS iQueue | AI and machine-learning capacity management for operating rooms, infusion centers, inpatient flow, scheduling, and hospital operations | Which iQueue module is in scope: Operating Rooms, Infusion Centers, Inpatient Flow, or Autopilot-enabled operational workflows. | 5 official sources |
| Iodine AwareCDI | AI-powered clinical documentation integrity, mid-revenue-cycle review, condition capture, coding support, and CDI prioritization | Which Iodine workflow is in scope: AwareCDI, Concurrent, Retrospect, pre-bill, post-bill, or coding support. | 3 official sources |
| Cohere Health | AI-powered prior authorization, utilization management, payment integrity, clinical policy review, and payer-provider collaboration | Which workflow is in scope: prior authorization, delegated utilization, API-based CMS-0057 compliance, payment integrity, appeals, or clinical policy review. | 4 official sources |
| Rhyme | Touchless prior authorization network for preparing, submitting, tracking, observing, and reducing prior authorization work across provider and payer workflows | Which workflow is in scope: procedure prior authorization, medication prior authorization, imaging, outpatient services, payer-provider collaboration, gold carding, dashboards, or Rhyme plus a partner utilization-management platform. | 5 official sources |
| Xsolis Dragonfly | AI-powered utilization management, medical-necessity review, concurrent authorization, discharge planning, denial prevention, and payer-provider collaboration | Whether the workflow is admission review, continued stay, concurrent authorization, discharge planning, appeal support, payment integrity, or payer-provider data sharing. | 5 official sources |
| Navina | AI clinician copilot for value-based care, chart review, care gap surfacing, HCC risk adjustment, quality workflows, visit summaries, and documentation support | Which Navina workflow is in scope: chart review, ambient transcription, visit summaries, HCC recommendations, care gaps, quality management, analytics, or documentation support. | 5 official sources |
| Artisight | Smart hospital platform for virtual nursing, remote patient observation, smart patient rooms, computer vision, voice-enabled workflows, and ambient operational monitoring | Which Artisight modules are in scope: virtual nursing, remote observation, patient room, operating room, command center, voice workflow, or smart hospital platform. | 4 official sources |
| care.ai | Ambient sensing, virtual nursing, smart patient rooms, protocol monitoring, command-center awareness, and AI-assisted hospital operations | Which care.ai workflows are in scope: virtual nursing, patient and protocol monitoring, smart patient rooms, smart ED/OR, command center, workforce optimization, or real-time decision support. | 4 official sources |
| AvaSure Intelligent Virtual Care | AI-enabled virtual nursing, continuous observation, virtual sitting, patient safety monitoring, episodic virtual care, and hospital room workflow automation | Which AvaSure modules are in scope: virtual nursing, continuous observation, virtual sitting, episodic care, environmental sensing, virtual care assistant, analytics, or device deployment. | 5 official sources |
| Caregility Connected Care | Virtual nursing, virtual observation, inpatient telehealth, smart-room devices, AI-enhanced patient safety alerts, contactless vitals trending, and connected care operations | Which Caregility capabilities are in scope: virtual nursing, iObserver continuous observation, iConsult, iNotify, inpatient engagement, smart-room devices, AI capabilities, or analytics. | 4 official sources |
| Oxehealth Oxevision | Contact-free vision-based ward monitoring, spot vital-sign observations, movement alerts, sleep reporting, and patient-safety workflow support | Which Oxevision module is in scope: Vital Signs, Activity Tracker, Sleep, Seclusion, alerts, reports, or local digital-observation workflow. | 5 official sources |
| Cadence Clinical Intelligence | AI-enabled remote chronic care, vitals monitoring, patient risk flagging, care coordination, medication titration support, and post-acute follow-up | Which care model is in scope: remote patient care, advanced primary care management, post-acute care, heart failure, hypertension, diabetes, or another pathway. | 4 official sources |
| Biofourmis Biovitals | AI-enabled physiologic monitoring, personalized vitals baselines, remote data collection, care-at-home workflows, and clinical analytics | Which Biofourmis workflow is in scope: Biovitals analytics, care delivery, specialty monitoring, hospital-at-home, clinical trial monitoring, or life-sciences services. | 3 official sources |
| Current Health | Remote patient monitoring, care-at-home platform operations, connected devices, patient engagement, telehealth, alarms, and EHR-integrated monitoring workflows | Which workflow is in scope: remote patient monitoring, chronic care management, hospital-at-home, advanced therapy delivery, post-discharge care, or commercial deployment support. | 4 official sources |
| Huma Cloud Platform | AI-first health platform, remote patient monitoring, patient-flow apps, triage, clinical dashboards, AI agents, analytics, and regulated digital health application development | Which Huma product or deployment is in scope: Workspace, Intelligence, RPM, eTriage, myGP, GDm Health, respiratory monitoring, public health, or clinical trials. | 3 official sources |
| John Snow Labs Healthcare NLP | Clinical NLP, medical language models, de-identification, entity extraction, terminology mapping, document classification, summarization, and data curation from healthcare text | Which modules are in scope: Healthcare NLP, Medical LLMs, de-identification, Generative AI Lab, terminology server, data curation, or patient-journey intelligence. | 3 official sources |
| Biobeat Cuffless Blood Pressure Monitoring | Cuffless ambulatory blood pressure monitoring, wearable vital-sign collection, remote physiologic monitoring, early-warning review, hypertension assessment, and clinician-reviewed patient reports | Which Biobeat device and workflow are in scope, including BB-613-BPM, Biobeat Platform-2, chest patch, wrist device, 24-hour ABPM, RPM, hospital, clinic, long-term care, or home use. | 7 official sources |
| Pieces Technologies | EHR-integrated inpatient AI for clinical summaries, progress-note drafting, handoffs, discharge planning, utilization-management review, and clinician-reviewed workflow automation | Which Pieces workflow is in scope: Inpatient Platform, Pieces in Your Pocket, Pieces Chat, utilization management assistant, discharge summaries, handoffs, progress notes, or ambulatory summaries. | 6 official sources |
| Validic Impact | EHR-integrated remote patient monitoring, patient-generated health data normalization, connected-device logistics, clinical dashboards, alerts, and generative AI summaries for clinician review | Which Validic workflow is in scope: Impact remote care, Inform API data infrastructure, HealthBridge patient experience, device logistics, value-based care, or EHR-embedded AI summaries. | 7 official sources |
| Awell | Care-flow orchestration, AI-assisted workflow steps, form summarization, fax or message handling, patient outreach, protocol execution, and workflow analytics | Which Awell workflow is in scope: care pathway orchestration, AI agents, fax intake, patient calls, message categorization, form summarization, Shelly insights, or custom integrations. | 7 official sources |
| Sohar Health | AI-driven insurance discovery, eligibility verification, verification of benefits, real-time payer integration, and patient intake coverage checks | Which product is in scope: Verification, Discovery, real-time eligibility, bulk verification, cost estimates, manual payer operations, or a custom payer workflow. | 6 official sources |
| Adonis Intelligence | AI-supported revenue intelligence, denial trend detection, underpayment analysis, worklist prioritization, AR visibility, and RCM alerting | Which Adonis capability is in scope: Intelligence, AI Agents, smart worklists, denial clustering, underpayment detection, collections analytics, AR dashboards, or broader RCM automation. | 5 official sources |
| Plenful | AI workflow automation for pharmacy operations, 340B audit and optimization, rebate management, benefit verification, prior authorization, order intake, and operational dashboards | Which workflow is in scope: 340B audit, rebate management, MFP reconciliation, specialty benefit verification, prior authorization, infusion order intake, dashboards, or custom automation. | 4 official sources |
| Innovaccer Gravity | Enterprise healthcare autonomy platform for unified data activation, AI agents, copilots, operational workflows, revenue-cycle automation, population health, care management, and AI governance | Which Gravity component is in scope: AI Studio, Developer Studio, Gravity Shield, Gravity Search, family of agents, data activation platform, revenue-cycle Flow, population-health Atlas, payer Galaxy, or a custom agent. | 5 official sources |
| Anterior | Clinical AI for payer prior authorization and utilization-management workflows, including intake, chart retrieval, policy matching, medical-necessity review, determination-note drafting, FHIR conversion, and clinician escalation | Which workflow is in scope: case intake, fax-to-case matching, eligibility, HIPAA verification, clinical document verification, policy digitization, DTR questionnaires, medical-necessity review, unit allocation, gold carding, summaries, or determination notes. | 6 official sources |
| SamaCare | AI-native medical benefit prior authorization, policy intelligence, submission and follow-up automation, payer benchmarks, and human-in-the-loop access workflows for specialty therapies | Which SamaCare workflow is in scope: provider prior authorization, life-sciences access intelligence, ecosystem integration, benchmarks, intervention support, or sponsored in-workflow assistance. | 6 official sources |
| Honey Health | AI back-office staff for EHR-based data fetching, pre-charting, orders, refills, fax triage, prior authorization, referrals, and revenue-cycle follow-up | Which Honey Health agents are in scope: data fetching and entry, chart prep, post-visit orders, refills, fax triage, prior authorizations, referral intake, revenue-cycle follow-up, device data, or remote-patient-monitoring support. | 7 official sources |
| PeriGen PeriWatch Vigilance | AI-supported maternal-fetal early warning, fetal heart rate pattern interpretation, uterine contraction detection, labor-progress monitoring, and perinatal command-center surveillance | Whether the deployed module uses PeriCALM Patterns 3.0, PeriWatch Vigilance, Surveillance, mobile access, command-center workflows, or quality reports, and which parts are FDA-cleared versus workflow software. | 7 official sources |
| Nuvo INVU | FDA-cleared remote maternal-fetal monitoring with wearable sensor-band acquisition, cloud processing, patient and clinician applications, fetal heart rate, maternal heart rate, and uterine activity review | Whether the deployed INVU workflow matches the current FDA-cleared indication, including gestational age, singleton pregnancy scope, antepartum fetal surveillance, home or facility use, prescription ordering, and software version. | 5 official sources |
| Spacelabs Rothman Index | FDA-cleared predictive analytics for inpatient patient deterioration surveillance, acuity scoring, early warning, rapid-response prioritization, and population-level monitoring | Exact Rothman Index, PeraServer, PeraTrend, or Spacelabs predictive analytics module in scope, including software version, intended use, FDA 510(k), supported care settings, and local regulatory status. | 5 official sources |
| Azra AI | AI-powered oncology workflow automation, cancer patient identification, registry case finding, clinical research pre-screening, incidental finding follow-up, and closed-loop patient management | Which Azra workflow is in scope: oncology, registry automation, clinical trials, incidental findings, high-risk screening, multidisciplinary meetings, enterprise analytics, or embedded navigation services. | 6 official sources |
| Clarify Meridian | AI-driven referral optimization, network intelligence, physician activation, patient activation, scheduling coordination, and closed-loop referral performance measurement | Which capabilities are in scope: Meridian Survey, Plan, Guide, Clarify Atlas data, Loyal Care Activation Platform, scheduling, AI chat, CRM, patient outreach, or Clarify Success Services. | 5 official sources |
| Teton AI | AI-enabled resident and patient monitoring that uses room sensors, anonymized computer vision, alerts, analytics, fall-risk workflows, automated rounding support, and care-team question answering | Whether the intended setting is hospital ward, senior living, long-term care, or another environment and which monitoring workflows are enabled. | 5 official sources |
| RapidClaims | Autonomous and human-reviewed AI agents for medical coding, CDI, payer-rule validation, denials, underpayment recovery, value-based care analytics, and revenue cycle management | Which module is in scope: RapidCode, RapidVBC, RapidRecovery, RapidRCM, provider queries, payer-rule validation, denials, or contract intelligence. | 4 official sources |
| Carenostics | AI administrative assistant for transplant teams that gathers outside records, extracts key findings, summarizes evaluation files, supports waitlist tracking, and clears below-license administrative work across the transplant journey | Which transplant workflow is in scope: referral intake, evaluation file review, committee packet preparation, waitlist maintenance, organ-offer readiness, post-transplant monitoring, or administrative analytics. | 4 official sources |
Open the clinical operations and revenue cycle category page
Symptom checkers, intake tools, patient navigation, post-discharge outreach, and healthcare-specific AI agents.
| Product | Primary use case | First verification check | Official sources |
|---|---|---|---|
| SkinVision | Consumer-facing AI skin spot risk assessment, skin cancer awareness, and guidance on when to seek medical review | EU MDR Class IIa certification, country availability, intended user group, app workflow, and whether the planned use is consumer self-check, insurer program, or clinical pathway. | 4 official sources |
| Hippocratic AI | Generative AI healthcare agents for outreach, access, post-discharge follow-up, remote patient monitoring adherence, inpatient nurse co-pilot, and operational patient conversations | Which agent is in scope: AI Front Door, Polaris Pro, Polaris Flash, Nurse Co-Pilot, post-discharge follow-up, RPM adherence, screening outreach, medication identification, or life-sciences calls. | 5 official sources |
| Tucuvi | Clinical voice AI conversations, automated patient follow-up, care-plan monitoring, appointment rescheduling, medication inquiry routing, and clinician alert worklists | Which LOLA workflow is in scope: outbound follow-up, inbound calls, appointment rescheduling, medication inquiries, chronic-care monitoring, post-surgery outreach, or phone-visit scribing. | 5 official sources |
| Infermedica | Symptom checking, preliminary symptom analysis, patient triage, and navigation APIs | Triage levels and emergency scripts. | 3 official sources |
| Ubie | AI symptom checking, possible-cause reports, patient education, and care-seeking guidance | Whether the intended workflow is consumer self-checking, provider front door, patient education, or partner integration. | 4 official sources |
| Hyro | Healthcare AI agents for call center automation, scheduling, patient support, and conversational intelligence | Which channels and intents the agent is allowed to handle. | 3 official sources |
| Infinitus | AI agents for healthcare calls, benefit verification, prior authorization follow-up, patient onboarding, affordability, adherence, and provider or payor outreach | Which agent type is in scope: patient navigator, benefit verification, prior authorization, formulary exception, appeals, bridge eligibility, insurance discovery, provider education, missing information, or adherence check-ins. | 4 official sources |
| Artera Harmony | AI-enabled patient communications, messaging orchestration, self-scheduling, intake, billing outreach, forms, and voice or text agents | Which Artera workflow is in scope: Harmony orchestration, AI agents, self-scheduling, intake, forms, billing, call-to-text, staff co-pilot, or sentiment analysis. | 4 official sources |
| Fabric | Care access platform for intake, triage, routing, virtual care, scheduling, and conversational AI | Whether the workflow is administrative routing, symptom collection, triage, or virtual care delivery. | 3 official sources |
| Corti | Healthcare AI agent framework, speech-to-text, coding support, documentation generation, and workflow-specific clinical agents | Which workflow is being built: speech-to-text, coding, documentation, prior authorization, guideline support, care coordination, or patient access. | 3 official sources |
| C the Signs | AI-supported cancer risk assessment, EHR-integrated pathway guidance, patient self-assessment, population scanning, and referral support | Which workflow is in scope: clinician consultation support, patient self-assessment, proactive population scanning, cancer-site prediction, or referral-pathway selection. | 6 official sources |
| Sully.ai | AI healthcare agents for documentation, receptionist workflows, triage roles, medical coding, EHR-connected task automation, and developer-facing clinical-note APIs | Which agent is in scope: scribe, receptionist, triage nurse, nurse, medical coder, interpreter, researcher, pharmacist, or custom API workflow. | 7 official sources |
| Memora Health | AI-enabled care journeys, two-way texting, symptom management, patient-reported outcomes, check-ins, education, and escalation to care teams | Which program is in scope: remote patient monitoring, symptom management, patient education, automated check-ins, patient-reported outcomes, adherence, VBC reporting, or care-team collaboration. | 4 official sources |
| Ada Health | AI-powered symptom assessment, care navigation, digital triage, clinical handover, and population insights | Whether the workflow uses consumer Ada, Ada Assess, care navigation, clinical handover, or partner-specific modules. | 4 official sources |
| Mediktor | AI-based symptom assessment, digital triage, care routing, patient assistance, and LLM-enhanced medical-agent workflows | Which Mediktor workflow is in scope: symptom checker, business platform, AI Medical Agent, telemedicine, insurer, provider, public-health, or pharma use case. | 5 official sources |
| Luma Health Navigator | AI-powered patient self-service, appointment changes, refill requests, voice-to-SMS continuity, multilingual access, and operational AI workflows | Which Luma workflow is in scope: Navigator AI concierge, Spark, Fax Transform, scheduling, waitlist, referrals, intake, payments, eligibility, reminders, or operational AI orchestration. | 5 official sources |
| Clearstep Smart Care Routing | AI chat and voice triage, symptom assessment, care navigation, scheduling handoff, and white-labeled digital front door routing | Whether the deployment uses virtual triage, AI chat, AI voice, API integration, authenticated portal workflows, scheduling, or CRM/EHR writeback. | 5 official sources |
| Fabric Health | AI assistant, conversational symptom checking, digital front door intake, triage and routing, virtual care handoff, scheduling, provider search, and care enablement workflows | Which Fabric modules are in scope: AI Assistant, Symptom Checker, Triage & Routing, Virtual Care Platform, Provider Directory, Engagement & Pathways, Clinical Network, or integrations. | 6 official sources |
| Canary Speech | Voice biomarker platform and API for behavioral, cognitive, wellness, and safety signals from short speech samples or ambient listening workflows | Which workflow is in scope: healthcare provider screening, payer outreach, call-center support, clinical trial endpoint support, behavioral health, cognitive health, safety, or wellness. | 5 official sources |
| Ellipsis Health | AI-supported depression and anxiety screening or monitoring from patient speech during care-management and telehealth workflows | Which Ellipsis workflow is in scope: voice biomarker screening, Sage care-management agent, telehealth integration, call-center workflow, or research deployment. | 5 official sources |
| Syllable Healthcare Agents | AI agents for appointment scheduling, patient verification, waitlist management, referral processing, call routing, outbound reminders, and EHR-connected patient workflows | Which agent is in scope: healthcare receptionist, appointment scheduling, Epic scheduling, patient verification, waitlist, referral processing, outbound reminder, call routing, or medical-records outreach. | 5 official sources |
| Assort Health | Specialty-trained AI voice agents for patient calls, appointment scheduling, referral conversion, intake, eligibility, waitlists, care-gap outreach, and payment follow-up | Which workflow is in scope: inbound concierge, Activate outbound outreach, referral scheduling, patient reactivation, no-show recovery, eligibility, intake, payment collection, or specialty routing. | 5 official sources |
| Anima Health | Online consultation, care navigation, GP triage, appointment workflow, document processing, messaging, analytics, ambient scribing, and AI receptionist support | Which modules are in scope: Anima Triage, Appointments, Documents, Analytics, Messaging, AI Receptionist, Collaboration, or Annie ambient scribe. | 5 official sources |
| Limbic Access | Conversational mental health intake, assessment support, referral triage, risk-level summarization, and clinician-facing assessment reports | UKCA Class IIa status, current instructions for use, regional availability, age limits, and whether the deployment is inside a NICE evidence-generation pathway. | 7 official sources |
| Wysa | AI-supported mental health coaching, digital front door workflows, structured assessments, human coach or medical-assistant escalation, and institution-sponsored support programs | Which product is in scope: Wysa app, Wysa Assure, institutional digital front door, Wysa Coach, Wysa Medical Assistant, or a region-specific clinical program. | 5 official sources |
| Ellipsis Health Sage | Emotionally intelligent AI care-management voice agent, patient engagement outreach, enrollment calls, assessments and surveys, care coordination, adherence support, transitions-of-care check-ins, and speech-based behavioral-health signal review | Which workflow is in scope: Sage AI Care Manager, Empathy Engine voice analysis, enrollment, HRA or survey calls, discharge follow-up, medication adherence, behavioral-health screening, Salesforce integration, or partner-embedded APIs. | 8 official sources |
| Woebot Health | AI-supported mental health conversation, structured self-guided support, research-grade digital therapeutic development, and partner-sponsored behavioral health access | Which Woebot product or program is actually available: general Woebot Health platform, partner-sponsored wellness access, WB001, W-DISC-MVP, research study, or another product version. | 6 official sources |
| K Health | Clinical AI intake, symptom checking, patient-facing care navigation, draft chart preparation, EHR-connected virtual care, and clinician-facing recommendations for health-system primary care | Whether the workflow is public symptom checking, K-affiliated care, Penn Medicine-style patient intake, PatientGPT, AI Physician Mode, chronic care, urgent care, or another access model. | 7 official sources |
| b.well bailey | White-label conversational health assistant grounded in longitudinal health records, FHIR-connected data, claims, pharmacy, wearable, and care-navigation workflows | Which product is in scope: bailey assistant, Health AI SDK, Large Health Model, connected health platform, SMART on FHIR integration, or a custom app embedding. | 5 official sources |
| Aiberry | AI-supported mental health screening, bot-administered interview intake, depression-risk scoring, symptom insights, transcript review, and longitudinal monitoring for clinician or program review | Which workflow is in scope: Digital MindCare, Smart AI MindCare, recovery center, corrections, corporate wellness, higher education, clinician-led intake, or self-screening. | 5 official sources |
| Twill Mental Health Sequence | Configurable digital mental health sequence combining personalized self-guided tools, community, coaching, telebehavioral health, assessments, and clinician-trained AI guidance | Which modules are included: Mental Health Sequence, Intelligent Healing Platform, Taylor therapeutic assistant, Twill Care, Happify by Twill, Duet coaching, telebehavioral health, partner services, or assessments. | 5 official sources |
| Cognoa Canvas Dx | Prescription AI-based autism spectrum disorder diagnosis aid for children ages 18 to 72 months who are at risk for developmental delay and are evaluated by qualified healthcare providers | FDA De Novo DEN200069, prescription-only status, indications for use, age range, caregiver language and smartphone requirements, exclusions, and whether any later cleared version is being deployed. | 8 official sources |
| Aiva Health | Conversational AI and voice assistant for patient requests, nurse workflow, EHR, room controls, education and smart-room administration | Which Aiva surface is in scope: mobile assistant, Alexa smart speakers, patient request routing, voice charting, conversational EHR access, room controls, communication, education content, analytics, or Mission Control administration. | 4 official sources |
| Sword Health AI Care | AI-supported care platform for musculoskeletal pain, women's health, cardiometabolic health, mental health, care navigation, and clinician-supervised member engagement | Which Sword programs are in scope: Thrive, Bloom, Pulse, Mind, Predict, Phoenix, care navigation, wearable or calendar signals, and external-provider booking. | 6 official sources |
| Microsoft Healthcare Agent Service | Azure-based healthcare agent service for symptom-checker, triage, generative answers, scheduling, healthcare intelligence, and integration with customer data sources | Which scenario is enabled: symptom checker, triage, generative answers on customer sources, Healthcare Intelligence, scheduling, staff copilot, or a custom OpenAPI plugin. | 4 official sources |
| Salesforce Agentforce for Healthcare | Agentic healthcare workflows for patient access, provider matching, eligibility, claims support, EHR-connected service, care coordination, public health, and administrative task automation | Which agent or action is enabled: patient access, provider matching, appointment reminders, contact center, eligibility, claims summary, EHR data fetch, referral, public health, clinical-trial, or life-sciences workflow. | 5 official sources |
AI and decision-support tools for medication safety monitoring, precision dosing, pharmacy analytics, adherence, and patient-specific medication education.
| Product | Primary use case | First verification check | Official sources |
|---|---|---|---|
| MedAware | AI-powered medication safety monitoring, prescribing anomaly detection, adverse drug event prevention, opioid risk identification, and alert-burden reduction | Which workflow is in scope: prescribing contraindication alerts, adverse drug event monitoring, opioid risk, prescriber risk, or fraud, waste, and abuse analytics. | 3 official sources |
| DrFirst Clinical-Grade AI | Medication history cleanup, sig translation, medication reconciliation support, prescription data codification, and AI-assisted medication management workflows | Which DrFirst workflow is deployed: medication history, SmartSuite, SmartSig, prescription renewals, e-prescribing, prior authorization, population health, or system migration. | 2 official sources |
| DoseMeRx | Bayesian precision dosing, therapeutic drug monitoring, vancomycin AUC workflows, pharmacokinetic modeling, and individualized medication dose optimization | Which drug models, specialties, and therapeutic drug monitoring workflows are included for the deployment. | 4 official sources |
| InsightRX Nova | Model-informed precision dosing, Bayesian PK/PD forecasting, therapeutic drug monitoring, EHR-connected dosing decision support, and clinical pharmacology analytics | Which InsightRX product and workflow are in scope: Nova for providers, Nova for life sciences, Apollo, Gemini, or AI features. | 4 official sources |
| Arine | AI-powered medication intelligence, comprehensive medication management, risk stratification, prescriber outreach, MTM workflows, adherence support, and high-risk member interventions | Which Arine program is in scope: Elevate, Resonate, Luminate, MTM, quality improvement, high-risk patient management, or prescriber outreach. | 5 official sources |
| Bluesight Prism | Healthcare-specific AI assistant for hospital pharmacy and compliance workflows, including natural-language analysis of controlled-substance and behavioral diversion data | Which Prism workflow is enabled and whether Prism Assistant is used inside ControlCheck, 340BCheck, CostCheck, or another Bluesight product. | 4 official sources |
| EveryDose Provider | Medication adherence monitoring, patient-specific medication reports, conversational patient-reported data capture, medication education, and EHR-connected care-team follow-up | Which product is in scope: EveryDose App, EveryDose Provider, Medication Safety, Medication Adherence, MedGuides, analytics, or an EHR-integrated workflow. | 4 official sources |
| DreaMed endo.digital | FDA-cleared diabetes clinical decision support for insulin treatment recommendations, glucose-device data review, remote diabetes management, and care-plan standardization | Which product name and clearance are in scope for the deployment, including Advisor Pro history, endo.digital Platform K232722, and the intended patient population. | 4 official sources |
| GenXys TreatGx | Precision prescribing clinical decision support using pharmacogenomic data, medication interactions, condition context, side-effect sorting, and patient-specific treatment options | Which GenXys module is in scope: TreatGx, ReviewGx, IdentifyGx, LabGx, OptimizeGx, or GenXys One. | 4 official sources |
| FDB Meducation | AI-assisted patient medication instructions, simplified sig translation, multilingual labeling, bedside medication education, discharge education, and adherence support | Which workflow is in scope: discharge, pharmacy labeling, ambulatory education, paperless instructions, medication calendar, videos, or bedside first-dose education. | 4 official sources |
| AiCure | AI-powered medication adherence verification, patient engagement, digital biomarker capture, and remote trial monitoring through smartphone workflows | Which workflow is in scope: H.Code, Patient Connect, adherence verification, dosing support, digital biomarkers, ePRO, site monitoring, or population health. | 5 official sources |
| Medisafe Maestro | Predictive medication adherence support, personalized treatment journeys, smart reminders, patient education, engagement analytics, and omnichannel intervention orchestration | Which program module is in scope: Maestro orchestration, digital companion, JITI predictive engine, provider monitoring, app, SMS, email, voice, or branded content. | 3 official sources |
| Synapse Medication Shield | AI-assisted pharmacovigilance case management, adverse drug event coding, MedDRA classification, severity prioritization, and prescribing safety support | Which Synapse module is in scope: Medication Shield, Synapse Prescribe, Synapse Secure, adverse effects, interactions, dose analysis, or e-prescribing. | 4 official sources |
| RxLogix PV Signal | AI-powered pharmacovigilance signal detection, literature mining, safety database monitoring, workflow automation, audit trails, and regulatory-aligned risk management | Which RxLogix scope is included: PV Signal, Safety-in-a-Box, PV Case Management, PV Reports, PV Central, DataHub, AI services, or managed operations. | 4 official sources |
| ArisGlobal LifeSphere Safety | AI-forward pharmacovigilance platform for safety case intake, case processing, signal analytics, regulatory workflows, translation, and LifeSphere NavaX automation | Which modules are in scope: LifeSphere Safety, NavaX, Advanced Intake, Translation, Clarity, signal detection, regulatory workflows, or managed services. | 4 official sources |
| Oracle Safety One Argus | AI- and machine-learning-supported pharmacovigilance platform for adverse-event case processing from intake through regulatory reporting | Current Safety One Argus scope, migration path from existing Argus safety systems, supported products, regulatory regions, and health-authority reporting workflows. | 3 official sources |
| IQVIA Vigilance Detect | GenAI-powered pharmacovigilance event detection and extraction from emails, audio, documents, chats, and other safety intake sources | Which channels are enabled, including email, audio, documents, chat, call-center records, literature, intake forms, and partner feeds. | 3 official sources |
| Veeva Vault Safety AI | Cloud pharmacovigilance system for adverse-event management, safety case processing, signal workflow, safety content, and Veeva AI for Safety capabilities | Which Veeva modules are included: Safety, Safety.AI, Safety Workbench, Safety Signal, SafetyDocs, gateway connections, or outsourcing oversight. | 3 official sources |
| Welldoc BlueStar | FDA-cleared diabetes digital health support, AI-driven coaching, insulin-support workflows, cardiometabolic self-management, and clinician-reviewed patient reports | Which Welldoc product and version is in scope: Welldoc Diabetes, Welldoc Diabetes Rx, BlueStar, insulin adjustment, hypertension, weight, prediabetes, or broader cardiometabolic modules. | 6 official sources |
AI-enabled hematology, cell morphology, CBC, and diagnostic laboratory systems that support lab professionals with image analysis, pre-classification, and point-of-care testing.
| Product | Primary use case | First verification check | Official sources |
|---|---|---|---|
| Scopio Full-Field Digital Cell Morphology | Full-field peripheral blood smear and bone marrow aspirate digital morphology with AI-powered decision support and remote review | Which platform and application are in scope: X100, X100HT, peripheral blood smear, bone marrow aspirate, RBC morphology, platelet estimate, or complete blood morphology. | 5 official sources |
| Sysmex DI-60 | Automated digital cell morphology and WBC differential pre-classification integrated with Sysmex hematology workflows | Whether DI-60 is registered, sold, and supported in the target market and connected to the intended Sysmex analyzer, slide maker, stainer, and LIS workflow. | 4 official sources |
| CellaVision DC-1 | Single-slide digital morphology analyzer for blood cell differential review with automated image capture and cell pre-classification | Current CE, 510(k), distributor, and market availability for the exact DC-1 configuration and geography. | 4 official sources |
| Sight OLO | Computer-vision-based complete blood count analyzer with 5-part leukocyte differential from venous or capillary whole blood | Current commercial availability, distributor support, FDA status, CLIA complexity, age range, sample types, and quality-control requirements. | 4 official sources |
| PixCell HemoScreen | AI-assisted point-of-care complete blood count analyzer with 5-part differential from capillary or venous whole blood | Current FDA, IVDR, CE, CLIA complexity, patient-age, direct capillary sampling, venous sample, and point-of-care claims for the exact model and cartridge. | 5 official sources |
| Mindray MC-80 | Automated digital blood cell morphology analysis with advanced algorithms for cell pre-classification, platelet-clump review, remote consultation, and high-throughput smear workflows | Current IVD registration, CE/IVDR, FDA, distributor, and market availability for the exact MC-80 model, software version, and geography. | 4 official sources |
| HORIBA Yumizen D20 | Robotics- and AI-assisted digital morphology system for blood and urine sample digitization, pre-classified reports, and remote review | Current IVD registration, CE/IVDR, FDA, and local authorization for blood, urine, remote review, cloud storage, and the exact Yumizen D20 module configuration. | 3 official sources |
| Noul miLab | AI-powered microscopy platform for malaria detection, parasitemia quantification, blood count and morphology workflows, and compact diagnostic laboratory testing | Which miLab workflow is in scope: Malaria, Blood Count and Morphology, cartridge type, staining workflow, software version, connectivity, and local market availability. | 4 official sources |
| SigTuple AI100 with Shonit | AI-assisted automated microscopy for peripheral blood smear digitization, pre-classification, and professional review of blood cell images | Current FDA 510(k), CE, and local authorization for AI100 with Shonit, including software version, specimen type, sample throughput, and professional-user requirements. | 3 official sources |
| CellaVision DM1200 and DM9600 | Digital morphology systems for automated blood and body-fluid image capture, WBC/RBC pre-characterization, remote review, and hematology workflow standardization | Which system, application, and workflow are in scope: DM1200, DM9600, Advanced RBC, body fluids, remote review, education, LIS, or distributor-bundled configuration. | 5 official sources |
| Roche cobas m 511 | Integrated hematology analyzer combining CBC, slide making, staining, digital cell imaging, morphology analysis, and professional review workflows | Current market availability, service support, FDA 510(k), CE/IVDR, and local authorization for the cobas m 511 system and software version. | 3 official sources |
| Copan PhenoMATRIX | AI-assisted digital microbiology plate image assessment, culture sorting, colony feature analysis, LIS-linked rules, and WASPLab workflow support | Which PhenoMATRIX package and module are in scope: Essentials, Select, Plus, Auto-Release, TAG, media type, organism workflow, and FDA-cleared versus uncleared functionality. | 5 official sources |
| BD Kiestra Urine Culture Application | AI-developed microbiology imaging application for urine culture plate review, standardized digital images, worklist organization, and laboratory workflow efficiency | Which BD Kiestra system, ReadA, BD Synapsys, urine culture application, media, specimen type, and software version are in scope. | 4 official sources |
| APAS Independence | AI-enabled automated imaging, analysis, interpretation, and triage of agar culture plates for clinical microbiology and validated environmental-monitoring workflows | Which APAS module, indication, media, specimen type, environmental-monitoring use, LIMS/LIS connection, and software version are in scope. | 6 official sources |
Open the laboratory and hematology diagnostics category page
AI platforms for genomics, oncology, real-world data, multimodal clinical data, and personalized medicine workflows.
| Product | Primary use case | First verification check | Official sources |
|---|---|---|---|
| Prenosis Sepsis ImmunoScore | FDA-authorized AI diagnostic and predictive sepsis risk assessment using EHR, vital-sign, demographic, laboratory, and biomarker inputs | FDA De Novo DEN230036 intended use, patient eligibility, blood-culture-order requirement, 24-hour risk window, and prescription-use limits. | 4 official sources |
| Cytovale IntelliSep | FDA-cleared host-response in vitro diagnostic test that uses image analysis and machine learning on white-blood-cell biophysical features to aid early sepsis detection and risk stratification in adult ED patients | FDA 510(k) K220991 intended use, any subsequent IntelliSep clearances, adult ED suspected-infection population, prescription-use status, sample requirements, and three-day sepsis-with-organ-dysfunction window. | 6 official sources |
| Anumana ECG-AI | FDA-cleared ECG-AI algorithms for identifying cardiovascular risk signals from standard 12-lead ECG workflows | Which ECG-AI algorithm is in scope: low ejection fraction, pulmonary hypertension, cardiac amyloidosis, or another pipeline module. | 6 official sources |
| Eko Health SENSORA | FDA-cleared AI analysis of ECG and heart sounds from compatible Eko digital stethoscopes to flag atrial fibrillation, structural murmurs, low ejection fraction signals, and normal sinus rhythm for clinician review | Which SENSORA algorithm, device, software version, compatible stethoscope, patient population, geography, and FDA-cleared indication are in scope. | 6 official sources |
| AliveCor Kardia 12L | FDA-cleared AI-powered handheld 12-lead resting ECG system for clinician-reviewed cardiac determinations using a simplified leadset | Which Kardia 12L device, KAI 12L algorithm version, cardiac determinations, geography, and labeling are in scope for the deployment. | 6 official sources |
| Philips Cardiologs Holter | AI-assisted Holter and ambulatory ECG analysis for arrhythmia assessment, rhythm review, clinician annotation, report generation, and ECG workflow scaling | Which product is in scope: Cardiologs Holter Platform, Philips Holter Analysis System, API integration, supported ECG source, algorithm version, and geography. | 6 official sources |
| Tempus | AI-enabled precision medicine, multimodal data, diagnostics, and clinical trial support | Which Tempus product is in scope: One, Hub, Now, Lens, Pixel, Next Pathways, Next Trials, assays, or algos. | 5 official sources |
| Tempus One | Generative AI assistant for patient insight lookup, biomarker and report context, EHR workflow assistance, clinical trial search, documentation support, and multimodal research queries | Whether Tempus One is being used in Hub, an EHR integration, Lens, a provider workflow, or a life-sciences research workflow. | 6 official sources |
| SOPHiA GENETICS | AI-powered genomic, radiomic, and multimodal data analysis through the SOPHiA DDM platform | Whether the selected module is diagnostic, research, or local-validation use. | 3 official sources |
| Guardant InfinityAI | AI-enabled precision oncology data exploration, cohort analysis, molecular pattern discovery, and real-world evidence workflows | Which InfinityAI module, data library, or Guardant product feature is being evaluated. | 3 official sources |
| ArteraAI Prostate | AI-enabled digital pathology and clinical-data test for prostate cancer prognosis, therapy-benefit prediction, and treatment-intensity personalization | Whether the patient population matches the localized, non-metastatic, post-radical-prostatectomy, or metastatic hormone-sensitive prostate workflow being considered. | 5 official sources |
| Avenda Unfold AI | FDA-cleared AI decision-support software for prostate cancer mapping, lesion documentation, biopsy planning, and prostate treatment planning workflows | FDA 510(k) K221624, current labeling, indications for use, trained-user requirements, and whether the evaluated product version is Unfold AI or an older iQuest-branded release. | 6 official sources |
| Unlearn | AI-generated digital twins for clinical trial design, control-outcome forecasting, synthetic control comparisons, and statistical power planning | Which disease-specific Digital Twin Generator and study design are in scope. | 4 official sources |
| Owkin K Pro | Agentic AI for biomedical research, multimodal patient data analysis, target prioritization, biomarker validation, and drug-development decisions | Which datasets, AI skills, and biomedical tasks are available for the research question. | 3 official sources |
| Caris Life Sciences | AI-enabled molecular profiling, precision oncology insights, and tumor board reporting | Which test, report, or AI insight is being used and its exact clinical role. | 3 official sources |
| Flatiron Assist | EHR-integrated oncology clinical decision support, treatment pathways, biomarkers, trials, and prior authorization support | Which cancers, regimens, biomarkers, pathways, and clinical-trial workflows are supported. | 2 official sources |
| Truveta | AI-supported real-world data analytics, cohort building, regulatory-grade evidence generation, and natural-language research assistance | Which Truveta product is in scope: Data, Studio, Intelligence, Evidence, Tru, or Truveta Language Model-supported workflows. | 6 official sources |
| Deep 6 AI | AI-supported cohort discovery, clinical trial matching, protocol feasibility, patient identification, and real-world data extraction | Which workflow is in scope: cohort discovery, site feasibility, patient matching, chart abstraction, sponsor search, or network analytics. | 4 official sources |
| Dyania Health Synapsis | AI-assisted chart review, clinical trial screening, protocol matching, registry abstraction, and real-world data extraction from medical records | Which Synapsis workflow is in scope: trial screening, protocol feasibility, registry abstraction, chart review, or real-world evidence extraction. | 4 official sources |
| TriNetX | Real-world data network, AI-supported cohort discovery, protocol feasibility, site identification, and clinical trial recruitment planning | Which TriNetX module, dataset, geography, and trial workflow are in scope: feasibility, protocol design, site identification, recruitment planning, or RWE. | 4 official sources |
| Medidata AI | AI-supported clinical trial planning, protocol optimization, trial risk monitoring, data quality workflows, synthetic control arms, and integrated evidence | Which Medidata AI capability is in scope: Dot, protocol optimization, study feasibility, integrated evidence, synthetic control arm, data management, or operational monitoring. | 4 official sources |
| ConcertAI | Oncology-focused real-world data, generative and predictive AI, trial feasibility, trial screening, commercial insights, and care-quality analytics | Which ConcertAI product is in scope: PrecisionExplorer, PrecisionTRIALS, PrecisionGTM, Precision360, CancerLinQ, or a trial operations workflow. | 3 official sources |
| Aetion Evidence Platform | Real-world evidence generation, data preparation, cohort definition, causal analytics, regulatory-grade study workflows, and AI-assisted variable or subgroup work | Which Aetion product is being used: Evidence Platform, Discover, Activate, Substantiate, Generate, Science and Research services, or AetionAI-supported workflows. | 4 official sources |
| nference nSights | AI-assisted multimodal real-world data exploration, cohort analysis, clinical research insights, drug development support, and predictive model development | Which nSights application, dataset, modality, institution source, or analytics tier is available for the research question. | 4 official sources |
| Dandelion Health | Multimodal real-world data, clinical AI marketplace, algorithm validation, bias checks, and regulatory-grade evidence generation | Which workflow is in scope: Dandelion Data, Clinical AI Marketplace, AI developer validation, life-sciences evidence generation, or a disease-specific data library. | 6 official sources |
| KidneyIntelX.dkd | FDA-authorized AI-enabled prognostic blood test for assessing risk of progressive kidney function decline in diabetic kidney disease | Whether the patient population matches the FDA-authorized intended use for adults with type 2 diabetes and early-stage chronic kidney disease. | 5 official sources |
| Healthy.io Minuteful Kidney | FDA-cleared smartphone-powered home urine albumin-to-creatinine ratio testing with AI and computer-vision analysis | Whether the patient population, state, health-plan arrangement, prescription workflow, and smartphone requirements match the current Minuteful Kidney terms. | 5 official sources |
| Roche Kidney Klinrisk Algorithm | CE-marked AI-powered machine-learning algorithm for CKD progression risk stratification through the navify Algorithm Suite | Whether Kidney Klinrisk Algorithm is available and certified for the deployment country, patient group, outpatient setting, and navify Algorithm Suite configuration. | 5 official sources |
| CancerIQ | Digital cancer risk assessment, patient intake, hereditary cancer screening, genetic testing workflow support, patient navigation, and oncology innovation enrollment | Which CancerIQ modules are in scope, including patient questionnaires, hereditary cancer risk assessment, provider dashboards, navigator workflows, specialist review, analytics, virtual care, EHR integration, or registry functionality. | 5 official sources |
| Freenome SimpleScreen CRC | AI-enabled multiomics colorectal cancer screening workflow using a standard blood draw, clinical-lab processing, and health-system screening program partnership | Current FDA, CLIA, state laboratory, payer, guideline, and local medical-policy status for SimpleScreen CRC at the time of ordering. | 5 official sources |
| GRAIL Galleri | AI-enabled multi-cancer early detection blood test that analyzes cell-free DNA methylation patterns, returns cancer signal detected or not detected, and predicts a likely cancer signal origin for follow-up workup | Current FDA, CLIA, CAP, payer, guideline, state laboratory, health-system policy, and medical-necessity status before offering or ordering the test. | 7 official sources |
| Rune Labs StrivePD | FDA-cleared Apple Watch symptom-data collection, Parkinson's symptom and medication tracking, clinician dashboards, trial matching, and StrivePD Guardian AI companion support for between-visit care | Which workflow is in scope: free patient app, Apple Watch movement-disorder measures, clinician dashboard, StrivePD Guardian AI companion, Guardian Premier human support, payor program, or trial data collection. | 6 official sources |
| Google Cloud Agent Search for Healthcare | Healthcare search app for FHIR R4 data and referenced unstructured files, with keyword search, natural-language queries, generative answers, citation indexes, and cloud deployment controls | Whether the project uses Agent Search healthcare search, Healthcare API, Healthcare Data Engine, Gemini models, Visual Q&A, or another Google Cloud service, because data, pricing, and risk controls differ. | 6 official sources |
Platforms for inventorying, governing, monitoring, validating, and auditing AI systems used by healthcare, payer, life-sciences, or clinical operations teams.
| Product | Primary use case | First verification check | Official sources |
|---|---|---|---|
| ModelOp Center | AI governance, model inventory, lifecycle automation, policy controls, validation evidence, and risk-based compliance for healthcare and life-sciences AI portfolios | Which inventories, controls, model cards, approval workflows, monitoring metrics, and evidence exports are included. | 2 official sources |
| Credo AI Platform | AI system registry, vendor registry, policy mapping, risk controls, evidence generation, and regulation-aligned governance workflows | Which modules are included: AI registry, vendor registry, policy packs, evaluations, evidence generation, agent governance, and integrations. | 3 official sources |
| Mendel Redact | AI-assisted de-identification of clinical documents, PHI redaction, medical-record preprocessing, and privacy-preserving data preparation for research or analytics | Which Mendel modules are in scope, including Redact, Retina OCR, clinical NLU, source-evidence extraction, or broader clinical-data structuring workflows. | 4 official sources |
| Fiddler AI Observability | AI observability, agent monitoring, drift detection, guardrails, explainability, PHI-leak detection, and auditable records for production AI systems | Which model, LLM, agent, prompt, trace, feature, drift, hallucination, PHI, fairness, and guardrail metrics are supported. | 3 official sources |
| Arize AI Observability | LLM observability, evaluations, tracing, model monitoring, drift detection, prompt-level analysis, and production issue investigation | Which Arize, Phoenix, AX, tracing, evaluation, prompt, drift, and monitoring features fit the deployed AI workflow. | 2 official sources |
| Monitaur | AI governance strategy, compliance management, model performance monitoring, validation protocols, transparency, and audit reporting | Which governance workflows cover AI inventory, model performance, validation, compliance, documentation, and reporting. | 2 official sources |
| Saidot | AI system inventory, risk classification, policy templates, governance data reuse, EU AI Act support, and cross-functional compliance workflows | Whether Saidot covers the healthcare use case, EU AI Act role, risk category, deployment country, and internal governance workflow. | 2 official sources |
| Chryso.ai | Healthcare AI compliance management, policy management, workforce training, control evidence collection, and AI agent monitoring | Which frameworks, controls, policy templates, evidence workflows, and AI-agent monitoring features are active for your deployment. | 2 official sources |
| ALIGNMT AI | Healthcare AI governance, risk monitoring, fairness and validity assessment, AI report cards, compliance programs, and production risk mitigation | Which modules are included: governance, assessment, mitigation, report cards, advisory services, data assets, or continuous monitoring. | 4 official sources |
| Risk Meridian | AI system inventory, structured risk reviews, governance controls, incident logging, disclosure generation, board reporting, and audit-ready evidence packs | Which healthcare-specific fields, risk tiers, control mappings, incident logs, disclosure templates, and board reports are available in your plan. | 5 official sources |
| Censinet RiskOps AI Governance | Healthcare AI governance, vendor AI exposure management, enterprise risk workflows, risk intelligence, benchmarking, assessment automation, and AI governance evidence collection | Which modules are live in the contracted scope: RiskOps, AI Governance, TPRM AI, ERM AI, benchmarking, GRC AI agents, or systemic-risk workflows. | 4 official sources |
| Trase OS | Governed healthcare AI agent runtime, policy enforcement, audit trails, agent-library deployment, custom agent development, third-party agent governance, and workflow automation oversight | Which agent workflows are included, such as fax routing, referral triage, clinical summarization, prior authorization, lab result interpretation, compliance audit, or medication reconciliation. | 4 official sources |
| ShadowIQ for Healthcare | Healthcare AI governance control plane for inline PHI redaction, BAA-aware model routing, policy enforcement, AI registry evidence, FDA SaMD lifecycle artifacts, and cryptographic audit trails | Which workflows are routed through ShadowIQ: clinician copilots, payer review, internal assistants, patient-facing tools, or health-tech SaaS features. | 6 official sources |
| Harness.health | Clinical AI registry, quality monitoring, safety-event capture, compliance reporting, EHR integration, and health-system governance workflow | Which AI tools, departments, contracts, owners, risk tiers, and live metrics the registry can track. | 3 official sources |
| SAIGE | Healthcare AI inventory registration, risk monitoring, vendor collaboration, traceability, and policy-aligned governance workflow | Which AI inventory fields, registration workflows, risk scoring, policy mappings, and vendor collaboration features are configured. | 3 official sources |
| Grid Health | Health-system AI visibility, performance monitoring, drift detection, adoption tracking, utilization review, cost alignment, and governance documentation | Which AI systems, vendor tools, EHR-embedded models, internal models, workflows, users, and cost data Grid can observe. | 3 official sources |
| Asher Informatics | Healthcare AI governance management, service-line controls, AI monitoring, operational utility modeling, regulatory alignment, and multimodal AI oversight | Which AshMatics Suite capabilities are included, such as governance studio, monitoring studio, service-line SOP controls, regulatory tracking, and operational utility modeling. | 2 official sources |
| Integral Privacy Engine | Privacy-preserving healthcare data preparation, HIPAA Expert Determination, PHI remediation, AI training-data pipelines, and defensible documentation for regulated data sharing | Whether the engagement uses Expert Determination, Remediation Preview, Compliant Pipeline, deployment tooling, or a forward-deployed privacy program. | 5 official sources |
| Cognome ExplainerAI | Explainable AI governance, predictive-model transparency, performance monitoring, bias analysis, drift monitoring, AI discovery, and Zero Trust-oriented AI inventory | Which ExplainerAI and AI Sniffer capabilities are in scope, including model explainability, monitoring, inventory, endpoint discovery, or public-LLM usage detection. | 4 official sources |
| Qualified Health | Healthcare-native enterprise AI platform for governed agent and workflow deployment, data integration, AI builder tools, monitoring, audit trails, education, and outcomes tracking | Which platform capabilities and deployed solutions are in scope, including Qualified Chat, builder tools, pre-built workflows, data integration, governance dashboards, education, and outcomes tracking. | 5 official sources |
| Product | Category | Risk | Use case | Official sources | Source-backed profile |
|---|---|---|---|---|---|
| OpenEvidence | Clinical evidence and questions | High | Evidence-backed clinical questions and medical literature synthesis | 3 official sources | Review profile |
| ClinicalKey AI | Clinical evidence and questions | High | Generative AI clinical question answering grounded in licensed medical reference content | 4 official sources | Review profile |
| UpToDate Expert AI | Clinical evidence and questions | High | Conversational clinical question answering grounded in UpToDate content, assumptions, source links, and clinician review | 3 official sources | Review profile |
| Dyna AI | Clinical evidence and questions | High | AI-assisted evidence retrieval and clinical question answering inside EBSCO clinical decision-support content | 4 official sources | Review profile |
| Glass Health | Clinical evidence and questions | High | AI-powered clinical decision support, ambient scribing, real-time encounter insights, differential diagnosis drafts, assessment and plan drafts, evidence-backed answers, documentation generation, and developer API workflows | 7 official sources | Review profile |
| Consensus | Clinical evidence and questions | Medium | Medical research discovery, study snapshots, and evidence-backed answers | 2 official sources | Review profile |
| Elicit | Clinical evidence and questions | Medium | Systematic-review search, screening, extraction, and research-backed reports | 3 official sources | Review profile |
| Scite | Clinical evidence and questions | Medium | Citation-context search, paper evaluation, and AI research synthesis | 2 official sources | Review profile |
| Atropos Health | Clinical evidence and questions | Medium to high | Real-world evidence generation, clinical evidence agents, and EHR-connected evidence support | 4 official sources | Review profile |
| Doximity Ask | Clinical evidence and questions | Medium to high | HIPAA-compliant clinician assistant for clinical questions, patient education, chart note templates, translation, and document drafting | 3 official sources | Review profile |
| Medwise AI | Clinical evidence and questions | Medium to high | AI-assisted clinical information search across trusted sources, guidance, literature, UK drug references, and uploaded or recorded context | 4 official sources | Review profile |
| AvoMD | Clinical evidence and questions | Medium to high | AI-assisted clinical decision support, local guideline workflows, medical calculators, pathways, and clinician-facing care algorithms | 4 official sources | Review profile |
| VisualDx | Clinical evidence and questions | Medium to high | Visual clinical decision support, differential diagnosis building, dermatology image analysis, medical image reference, and AI-assisted clinical education workflows | 5 official sources | Review profile |
| Isabel DDx Companion | Clinical evidence and questions | High | Differential diagnosis generation, symptom-to-disease matching, EMR-integrated clinical feature extraction, and evidence-linked diagnostic reasoning support | 3 official sources | Review profile |
| Causaly | Clinical evidence and questions | Medium to high | Agentic biomedical research, evidence retrieval, knowledge-graph exploration, target assessment, and scientific workflow automation | 5 official sources | Review profile |
| AMBOSS AI Mode | Clinical evidence and questions | Medium to high | AI-assisted clinical evidence search, medical question answering, study support, trusted-content navigation, and practice-focused reference workflows | 4 official sources | Review profile |
| Abridge | Clinical documentation and scribes | Lower to medium | Ambient clinical documentation and clinician-reviewed note drafts | 3 official sources | Review profile |
| Ambience Healthcare | Clinical documentation and scribes | Lower to medium | Real-time clinical documentation, coding, and CDI support | 3 official sources | Review profile |
| Nuance DAX Copilot | Clinical documentation and scribes | Lower to medium | Ambient clinical documentation automation for EHR workflows | 2 official sources | Review profile |
| Microsoft Dragon Copilot | Clinical documentation and scribes | Lower to medium | Role-based clinical AI assistant for documentation, information surfacing, reporting, coding suggestions, and workflow automation | 6 official sources | Review profile |
| Oracle Health Clinical AI Agent | Clinical documentation and scribes | Medium to high | EHR-connected clinical AI agent for chart review, documentation, scheduling, patient access, care coordination, and operational workflows | 3 official sources | Review profile |
| AWS HealthScribe | Clinical documentation and scribes | Lower to medium | API-based ambient transcription, clinical note drafting, and transcript-linked evidence mapping | 3 official sources | Review profile |
| DeepScribe | Clinical documentation and scribes | Lower to medium | Ambient AI scribing, specialty-specific clinical notes, pre-visit chart synthesis, EHR synchronization, and coding-support workflows | 6 official sources | Review profile |
| Suki | Clinical documentation and scribes | Lower to medium | Ambient documentation, coding support, clinical reasoning, and Q&A | 2 official sources | Review profile |
| Nabla | Clinical documentation and scribes | Lower to medium | AI scribe, live transcript, note drafts, and EHR-connected documentation | 3 official sources | Review profile |
| Epic Art for Clinicians | Clinical documentation and scribes | Medium to high | EHR-native AI charting, note summarization, draft documentation, ambient ordering, discharge summaries, level-of-service suggestions, and prior-authorization answer drafting | 4 official sources | Review profile |
| Freed | Clinical documentation and scribes | Lower to medium | AI scribe for SOAP notes and visit documentation | 2 official sources | Review profile |
| Heidi Health | Clinical documentation and scribes | Lower to medium | AI medical scribe, clinical note generation, evidence search, and patient communications support | 3 official sources | Review profile |
| ModMed Scribe | Clinical documentation and scribes | Lower to medium | Ambient clinical documentation, structured note suggestions, billing code suggestions, and downstream EHR workflow automation | 3 official sources | Review profile |
| Augmedix | Clinical documentation and scribes | Lower to medium | Ambient medical documentation, live note support, after-visit documentation, and EHR-connected clinical workflow support | 4 official sources | Review profile |
| Commure Ambient AI | Clinical documentation and scribes | Lower to medium | Ambient AI documentation, clinician assistant workflows, care cues, macros, coding support, and EHR-connected clinical operations | 4 official sources | Review profile |
| Tali AI | Clinical documentation and scribes | Lower to medium | AI ambient scribe, medical dictation, note generation, and clinician-reviewed documentation | 5 official sources | Review profile |
| Twofold Health | Clinical documentation and scribes | Lower to medium | AI medical scribe for structured clinical notes, therapy notes, and encounter documentation | 3 official sources | Review profile |
| Nabla Copilot | Clinical documentation and scribes | Lower to medium | Ambient AI documentation, dictation, real-time encounter summaries, patient instructions, coding-support workflows, and EHR-embedded note generation | 5 official sources | Review profile |
| Eleos Health | Clinical documentation and scribes | Medium | Behavioral health ambient documentation, progress-note drafting, compliance review, care operations automation, session insights, and note-quality improvement | 5 official sources | Review profile |
| TORTUS | Clinical documentation and scribes | Lower to medium | AI medical scribe for consultation notes, transcripts, codes, and NHS-aligned documentation workflows | 3 official sources | Review profile |
| NextGen Clinical AI | Clinical documentation and scribes | Lower to medium | Ambient visit capture, structured SOAP-note generation, patient summaries, ICD-10, medication, lab, imaging, and order suggestions inside the NextGen mobile and EHR workflow | 4 official sources | Review profile |
| Aidoc | Medical imaging and radiology | High | Radiology triage, scan analysis, care-team activation, and enterprise AI orchestration | 6 official sources | Review profile |
| AIRS Medical SwiftMR | Medical imaging and radiology | High | FDA-cleared AI MRI image enhancement, denoising, super-resolution, and scan-time reduction workflow for DICOM MRI studies | 8 official sources | Review profile |
| Viz.ai | Medical imaging and radiology | High | AI-powered care coordination around suspected disease detection and specialist activation | 6 official sources | Review profile |
| Ferrum Health | Medical imaging and radiology | High | Clinical AI governance suite for deploying, monitoring, validating, and managing imaging and other clinical AI models across existing infrastructure | 4 official sources | Review profile |
| Blackford Platform | Medical imaging and radiology | High | Enterprise radiology AI orchestration, relevancy routing, curated marketplace access, deployment monitoring, and AI application management | 4 official sources | Review profile |
| CARPL.ai | Medical imaging and radiology | High | Enterprise radiology AI marketplace, DICOM image viewing, PACS-integrated algorithm orchestration, pre-deployment validation, clinical deployment, and post-deployment monitoring | 6 official sources | Review profile |
| deepcOS | Medical imaging and radiology | High | Vendor-neutral radiology AI operating system for evaluating, integrating, orchestrating, monitoring, and scaling multiple imaging AI solutions | 3 official sources | Review profile |
| Enlitic Curie / ENDEX | Medical imaging and radiology | Medium to high | AI-enabled medical imaging data standardization, DICOM description normalization, de-identification, anonymization, routing support, and imaging-data quality management | 6 official sources | Review profile |
| Brainomix 360 Stroke | Medical imaging and radiology | High | AI-enabled CT, CTA, MRI, and mobile stroke workflow support for suspected acute stroke assessment and transfer decisions | 6 official sources | Review profile |
| Avicenna.AI CINA-ASPECTS | Medical imaging and radiology | High | AI-assisted ASPECTS scoring and heat-map support on non-contrast head CT for suspected acute ischemic stroke assessment | 6 official sources | Review profile |
| Qure.ai | Medical imaging and radiology | High | Chest X-ray, CT, lung cancer, tuberculosis, and stroke imaging workflows | 4 official sources | Review profile |
| Qure.ai qXR | Medical imaging and radiology | High | AI-assisted chest X-ray pre-read, worklist prioritization, abnormality detection, reporting support, and screening workflows | 6 official sources | Review profile |
| Oxipit ChestLink | Medical imaging and radiology | High | Autonomous reporting of high-confidence normal chest X-ray studies, chest radiograph triage, and radiologist workload reduction | 5 official sources | Review profile |
| Rad AI | Medical imaging and radiology | Medium to high | Radiology report drafting, impression generation, consensus-guideline insertion, and reporting workflow automation | 5 official sources | Review profile |
| Rad AI Continuity | Medical imaging and radiology | Medium to high | AI-assisted detection, categorization, communication, dashboard tracking, and resolution of follow-up recommendations from radiology reports | 3 official sources | Review profile |
| Sirona RadOS | Medical imaging and radiology | Medium to high | Cloud-native PACS, worklist, viewer, reporting, and AI-powered radiology workflow automation | 4 official sources | Review profile |
| Bayer Calantic Digital Solutions | Medical imaging and radiology | High | Cloud-hosted radiology AI platform for curated imaging applications, PACS-integrated viewing, triage, detection, quantification, and workflow orchestration | 4 official sources | Review profile |
| Cleerly | Medical imaging and radiology | High | AI-enabled coronary CT angiography and plaque analysis | 7 official sources | Review profile |
| Elucid PlaqueIQ | Medical imaging and radiology | High | AI-enabled coronary CTA plaque composition and lesion-level plaque analysis | 5 official sources | Review profile |
| LumineticsCore | Medical imaging and radiology | High | Autonomous AI diabetic retinopathy detection from retinal images at the point of care | 5 official sources | Review profile |
| Eyenuk EyeArt | Medical imaging and radiology | High | Autonomous AI diabetic retinopathy screening from color retinal fundus images | 5 official sources | Review profile |
| AEYE-DS | Medical imaging and radiology | High | Autonomous point-of-care diabetic retinopathy screening from tabletop or portable non-mydriatic fundus-camera images | 4 official sources | Review profile |
| RETINA-AI Galaxy | Medical imaging and radiology | High | Autonomous detection of moderate-or-worse diabetic retinopathy from supported retinal fundus cameras in primary care settings | 3 official sources | Review profile |
| RetInSight Fluid Monitor | Medical imaging and radiology | High | AI-based OCT retinal-fluid segmentation, quantification, visualization, follow-up charts, and nAMD monitoring support | 3 official sources | Review profile |
| RetinAI Discovery | Medical imaging and radiology | Medium to high | Ophthalmology image and data platform with OCT/image management, AI enrichment, trial data collection, and retinal-disease analytics | 5 official sources | Review profile |
| Cercare Medical Neurosuite | Medical imaging and radiology | High | Automated CT, MRI, and cone-beam CT perfusion post-processing for stroke, neuro-oncology, and neurovascular assessment workflows | 5 official sources | Review profile |
| RapidAI | Medical imaging and radiology | High | AI-powered imaging triage, quantification, disease detection, and care-team workflow support | 6 official sources | Review profile |
| Heartflow | Medical imaging and radiology | High | AI-powered coronary CTA analysis, FFRCT physiology analysis, plaque analysis, and coronary roadmap workflows | 7 official sources | Review profile |
| Caristo CaRi-Plaque and CaRi-Heart | Medical imaging and radiology | High | AI-assisted coronary CTA plaque analysis, stenosis quantification, coronary inflammation assessment, and cardiovascular risk reporting | 5 official sources | Review profile |
| Ultromics EchoGo | Medical imaging and radiology | High | AI-assisted echocardiography analysis for HFpEF detection support and cardiac workflow reporting | 4 official sources | Review profile |
| Us2.ai | Medical imaging and radiology | High | Automated transthoracic echocardiography analysis, measurement extraction, disease-detection support, and structured echo reporting | 6 official sources | Review profile |
| Gleamer BoneView | Medical imaging and radiology | High | AI-assisted fracture detection and trauma X-ray second-reader workflow support | 4 official sources | Review profile |
| iCAD ProFound AI | Medical imaging and radiology | High | AI-assisted breast cancer detection, mammography case scoring, density assessment, and short-term risk workflow support | 5 official sources | Review profile |
| GI Genius | Medical imaging and radiology | High | Real-time computer-aided polyp detection support during standard white-light colonoscopy | 4 official sources | Review profile |
| SKOUT | Medical imaging and radiology | High | Real-time AI-assisted colorectal polyp location support during adult screening or surveillance colonoscopy | 4 official sources | Review profile |
| Fujifilm CAD EYE | Medical imaging and radiology | High | AI-assisted real-time detection of colonic mucosal lesions during colonoscopy with Fujifilm endoscopy systems | 4 official sources | Review profile |
| Olympus CADDIE | Medical imaging and radiology | High | Cloud-connected computer-aided detection support for suspected colorectal polyps during standard white-light colonoscopy | 6 official sources | Review profile |
| MammoScreen | Medical imaging and radiology | High | AI-assisted mammography reading, suspicious-lesion scoring, pre-check workflow, priors-informed review, and breast-density support | 5 official sources | Review profile |
| Kheiron Mia | Medical imaging and radiology | High | AI-supported breast screening triage, reader workflow support, image-quality review, and mammography pathway optimization | 5 official sources | Review profile |
| ScreenPoint Transpara | Medical imaging and radiology | High | AI-assisted breast cancer detection, density assessment, temporal comparison, and mammography workflow support | 4 official sources | Review profile |
| Koios DS Breast | Medical imaging and radiology | High | AI-assisted risk assessment and computer-aided diagnosis support for breast ultrasound lesions | 4 official sources | Review profile |
| Subtle Medical | Medical imaging and radiology | High | AI-powered MRI and PET image enhancement, denoising, acceleration, and synthetic imaging workflow support | 6 official sources | Review profile |
| Lunit | Medical imaging and radiology | High | AI cancer screening, breast imaging, chest X-ray, precision oncology, and pathology biomarker workflows | 3 official sources | Review profile |
| annalise.ai | Medical imaging and radiology | High | Chest X-ray, non-contrast head CT, radiology triage, decision support, worklist prioritization, and draft reporting support | 4 official sources | Review profile |
| CureMetrix | Medical imaging and radiology | High | AI-assisted mammography worklist triage and breast-screening workflow prioritization | 3 official sources | Review profile |
| Hologic Genius AI Detection | Medical imaging and radiology | High | Deep-learning computer-aided detection and case scoring for breast tomosynthesis exams | 4 official sources | Review profile |
| GE HealthCare Caption AI | Medical imaging and radiology | High | AI-guided cardiac ultrasound acquisition and automated ejection-fraction support on compatible GE HealthCare ultrasound systems | 4 official sources | Review profile |
| UltraSight Guidance | Medical imaging and radiology | High | Real-time AI guidance and image-quality feedback for acquiring adult two-dimensional transthoracic echocardiography views on compatible ultrasound systems | 6 official sources | Review profile |
| Butterfly iQ3 | Medical imaging and radiology | High | Handheld point-of-care ultrasound with AI-enabled workflow software and gestational-age AI tooling in eligible settings | 4 official sources | Review profile |
| Sonio Detect | Medical imaging and radiology | High | AI-assisted fetal ultrasound acquisition support, view detection, anatomical-structure detection, and quality-criteria verification during routine prenatal exams | 7 official sources | Review profile |
| DeepHealth Breast Suite | Medical imaging and radiology | High | AI-supported mammography detection, density assessment, workflow triage, risk assessment, and breast imaging worklist support across modular Breast Suite applications | 6 official sources | Review profile |
| Pearl Second Opinion | Medical imaging and radiology | High | AI-assisted dental radiograph review, pathology detection, patient education, and 2D or 3D dental image analysis | 5 official sources | Review profile |
| Overjet | Medical imaging and radiology | High | FDA-cleared dental X-ray analysis, caries support, bone-level measurement, image enhancement, and dental workflow automation | 6 official sources | Review profile |
| VideaAI | Medical imaging and radiology | High | Dental X-ray AI for clinical assist, patient education, caries and periodontal findings, and practice workflow insights | 4 official sources | Review profile |
| Denti.AI | Medical imaging and radiology | High | AI-assisted dental radiograph detection, auto-charting, voice perio charting, dental scribe documentation, and PMS-connected workflow support | 6 official sources | Review profile |
| Diagnocat | Medical imaging and radiology | High | AI-assisted CBCT review, radiological reports, 3D visualization, tooth charts, segmentation, and second-read support for dental professionals | 6 official sources | Review profile |
| DentalMonitoring | Medical imaging and radiology | High | AI-powered remote orthodontic monitoring from smartphone scans, treatment-progress tracking, workflow alerts, and patient-practitioner communication | 5 official sources | Review profile |
| DermaSensor | Medical imaging and radiology | High | AI-assisted optical spectroscopy for adjunctive skin cancer risk assessment and dermatologist referral decisions | 4 official sources | Review profile |
| Skin Analytics DERM | Medical imaging and radiology | High | AI as a medical device for skin lesion assessment, urgent suspected skin cancer triage, and dermatology pathway prioritization | 4 official sources | Review profile |
| FotoFinder Moleanalyzer pro | Medical imaging and radiology | High | Dermoscopy image analysis, lesion comparison, AI score, heatmap support, and second-opinion workflow | 3 official sources | Review profile |
| DermEngine | Medical imaging and radiology | Medium to high | Dermatology image capture, storage, analytics, mole mapping, visual search, evolution tracking, and teledermatology workflow management | 4 official sources | Review profile |
| Model Dermatol | Medical imaging and radiology | Medium to high | AI-assisted dermatology image search that returns relevant skin disease information and reference links for review | 3 official sources | Review profile |
| SkinVision | Patient access, triage, and agents | Medium to high | Consumer-facing AI skin spot risk assessment, skin cancer awareness, and guidance on when to seek medical review | 4 official sources | Review profile |
| Paige | Digital pathology | High | AI-assisted digital pathology and prostate cancer detection support | 3 official sources | Review profile |
| PathAI | Digital pathology | High | FDA-cleared digital pathology image management, whole-slide viewing, LIS-connected case workflow, AI algorithm access, quality control, and lab collaboration | 8 official sources | Review profile |
| Hologic Genius Digital Diagnostics | Digital pathology | High | Digital cytology imaging, AI-assisted cervical cytology review, image management, and local or remote review-station workflow | 5 official sources | Review profile |
| Ibex Medical Analytics | Digital pathology | High | AI-powered pathology workflows for cancer detection, grading, biomarker support, and structured reporting | 6 official sources | Review profile |
| Deep Bio DeepDx Prostate | Digital pathology | High | AI diagnostic-support workflow for prostate H&E whole-slide images, cancer detection, Gleason-pattern localization, quantification, and pathologist review | 4 official sources | Review profile |
| Proscia | Digital pathology | High | Digital pathology image management, AI application deployment, model development, and lab workflow orchestration | 6 official sources | Review profile |
| Aiforia | Digital pathology | High | AI-assisted digital pathology suites for cancer diagnostics, quantitative image analysis, and case-level pathology reporting | 6 official sources | Review profile |
| Mindpeak | Digital pathology | High | AI-assisted tissue image analysis for breast biomarkers, PD-L1, HER2, tumor detection, and pathology workflow support | 4 official sources | Review profile |
| Aignostics | Digital pathology | High | Research-use digital pathology foundation-model analysis for H&E tumor microenvironment profiling and quantitative spatial metrics | 3 official sources | Review profile |
| Lumea | Digital pathology | High | Integrated digital pathology workflow with tissue-handling tools, FDA-cleared viewer, LIS-enabled case management, AI ecosystem access, and molecular test ordering | 5 official sources | Review profile |
| Visiopharm | Digital pathology | High | AI-driven precision pathology image analysis, biomarker scoring, diagnostic decision support APPs, research analysis, and workflow integrations | 5 official sources | Review profile |
| Tribun Health | Digital pathology | High | CaloPix image management, digital slide viewing, AI app integration, telepathology, archive workflow, and pathology platform modernization | 4 official sources | Review profile |
| Roche navify Digital Pathology | Digital pathology | High | Digital pathology case workflow, whole-slide image viewing, multi-slide review, collaboration, LIS/PACS integration, cloud or on-prem deployment, and access to AI-based image analysis algorithms | 6 official sources | Review profile |
| PathPresenter | Digital pathology | High | Digital pathology image management, FDA-cleared clinical viewing, remote consultations, education, biorepository workflows, and access to third-party AI models | 8 official sources | Review profile |
| DoMore Diagnostics Histotype Px Colorectal | Digital pathology | High | AI-powered digital biomarker for stage II and stage III colorectal cancer outcome prediction from routine H&E histology slides | 4 official sources | Review profile |
| Regard | Clinical operations and revenue cycle | Medium to high | Clinical insights from EHR data, pre-visit documentation, and missed-condition surfacing | 3 official sources | Review profile |
| Bayesian Health | Clinical operations and revenue cycle | High | Real-time EHR-based clinical intelligence, continuous sepsis flagging, patient risk monitoring, care-pathway activation, and performance reporting | 7 official sources | Review profile |
| CLEW ICU | Clinical operations and revenue cycle | High | AI-driven clinical surveillance and predictive alerts for adult ICU patient deterioration and hemodynamic instability | 6 official sources | Review profile |
| Mednition KATE | Clinical operations and revenue cycle | High | Real-time emergency department triage decision support, early sepsis-risk detection, and EHR-derived clinical analytics | 6 official sources | Review profile |
| Fathom | Clinical operations and revenue cycle | Medium | Autonomous medical coding and coding automation | 3 official sources | Review profile |
| CodaMetrix | Clinical operations and revenue cycle | Medium | Contextual coding automation and medical coding performance improvement | 3 official sources | Review profile |
| Apicare AuthAdvisor | Clinical operations and revenue cycle | High | AI-powered prior authorization decision support and automated routing for payer utilization-management workflows | 5 official sources | Review profile |
| Nym | Clinical operations and revenue cycle | Medium | Autonomous medical coding for emergency medicine, radiology, outpatient surgery, outpatient visits, urgent care, and inpatient professional services | 4 official sources | Review profile |
| SmarterDx | Clinical operations and revenue cycle | Medium | Clinical AI for revenue integrity, prebill diagnosis review, charge validation, denials appeals, and note-level revenue intelligence | 4 official sources | Review profile |
| Waystar AltitudeAI | Clinical operations and revenue cycle | Medium | AI-powered healthcare payment and revenue cycle automation across financial clearance, clinical integrity, claims, denials, and reporting | 3 official sources | Review profile |
| Cedar Intelligence | Clinical operations and revenue cycle | Medium | AI-powered patient financial engagement, billing personalization, bill explanations, agent guidance, and outbound payment support | 4 official sources | Review profile |
| Carta Healthcare Voyager | Clinical operations and revenue cycle | Medium | AI-assisted clinical data abstraction, registry-ready answers, FHIR-connected chart review, quality registry workflow, and data provenance support | 4 official sources | Review profile |
| Layer Health | Clinical operations and revenue cycle | Medium to high | AI-powered chart review for clinical registries, custom quality measurement, intelligent clinical pathways, evidence-grounded longitudinal chart questions, and registry abstraction workflows | 5 official sources | Review profile |
| Wellsheet Care Team Copilot | Clinical operations and revenue cycle | Medium to high | AI-powered Smart EHR UI for chart summarization, clinician questions, documentation drafts, clinical pathways, handoff, alerts, and discharge planning | 4 official sources | Review profile |
| Tennr | Clinical operations and revenue cycle | Medium | Agentic patient-flow automation for referrals, orders, document intake, eligibility, prior authorization, triage, and outreach | 4 official sources | Review profile |
| AKASA | Clinical operations and revenue cycle | Medium | Generative AI for revenue cycle, coding optimization, CDI, authorization status, and claim status workflows | 4 official sources | Review profile |
| Forus | Clinical operations and revenue cycle | Medium to high | Medication prior authorization, appeals, enrollment forms, benefit verification, specialty-pharmacy routing, affordability support, and patient communication | 3 official sources | Review profile |
| Case Health AI | Clinical operations and revenue cycle | High | AI agents for prior authorization intake, clinical abstraction, policy comparison, coverage determination support, outreach routing, and utilization management system integration | 2 official sources | Review profile |
| Notable | Clinical operations and revenue cycle | Medium | AI-powered healthcare automation for patient access, intake, authorization, scheduling, and administrative workflows | 4 official sources | Review profile |
| Qventus | Clinical operations and revenue cycle | Medium | AI-powered healthcare operations automation, inpatient capacity, surgical growth, perioperative coordination, and operational assistants | 3 official sources | Review profile |
| Caremaze | Clinical operations and revenue cycle | Medium to high | AI-powered discharge coordination, barrier detection, task orchestration, EMR-integrated transition planning, and Voice AI outreach for routine care-coordination work | 2 official sources | Review profile |
| Laudio | Clinical operations and revenue cycle | Medium | AI-enhanced frontline leader operations, workforce engagement, patient rounding, employee retention workflows, audit tracking, and high-impact action recommendations | 3 official sources | Review profile |
| LeanTaaS iQueue | Clinical operations and revenue cycle | Medium | AI and machine-learning capacity management for operating rooms, infusion centers, inpatient flow, scheduling, and hospital operations | 5 official sources | Review profile |
| Iodine AwareCDI | Clinical operations and revenue cycle | Medium to high | AI-powered clinical documentation integrity, mid-revenue-cycle review, condition capture, coding support, and CDI prioritization | 3 official sources | Review profile |
| Cohere Health | Clinical operations and revenue cycle | Medium to high | AI-powered prior authorization, utilization management, payment integrity, clinical policy review, and payer-provider collaboration | 4 official sources | Review profile |
| Rhyme | Clinical operations and revenue cycle | Medium to high | Touchless prior authorization network for preparing, submitting, tracking, observing, and reducing prior authorization work across provider and payer workflows | 5 official sources | Review profile |
| Xsolis Dragonfly | Clinical operations and revenue cycle | Medium to high | AI-powered utilization management, medical-necessity review, concurrent authorization, discharge planning, denial prevention, and payer-provider collaboration | 5 official sources | Review profile |
| Navina | Clinical operations and revenue cycle | Medium to high | AI clinician copilot for value-based care, chart review, care gap surfacing, HCC risk adjustment, quality workflows, visit summaries, and documentation support | 5 official sources | Review profile |
| Artisight | Clinical operations and revenue cycle | High | Smart hospital platform for virtual nursing, remote patient observation, smart patient rooms, computer vision, voice-enabled workflows, and ambient operational monitoring | 4 official sources | Review profile |
| care.ai | Clinical operations and revenue cycle | High | Ambient sensing, virtual nursing, smart patient rooms, protocol monitoring, command-center awareness, and AI-assisted hospital operations | 4 official sources | Review profile |
| AvaSure Intelligent Virtual Care | Clinical operations and revenue cycle | High | AI-enabled virtual nursing, continuous observation, virtual sitting, patient safety monitoring, episodic virtual care, and hospital room workflow automation | 5 official sources | Review profile |
| Caregility Connected Care | Clinical operations and revenue cycle | High | Virtual nursing, virtual observation, inpatient telehealth, smart-room devices, AI-enhanced patient safety alerts, contactless vitals trending, and connected care operations | 4 official sources | Review profile |
| Oxehealth Oxevision | Clinical operations and revenue cycle | High | Contact-free vision-based ward monitoring, spot vital-sign observations, movement alerts, sleep reporting, and patient-safety workflow support | 5 official sources | Review profile |
| Cadence Clinical Intelligence | Clinical operations and revenue cycle | Medium to high | AI-enabled remote chronic care, vitals monitoring, patient risk flagging, care coordination, medication titration support, and post-acute follow-up | 4 official sources | Review profile |
| Biofourmis Biovitals | Clinical operations and revenue cycle | High | AI-enabled physiologic monitoring, personalized vitals baselines, remote data collection, care-at-home workflows, and clinical analytics | 3 official sources | Review profile |
| Current Health | Clinical operations and revenue cycle | Medium to high | Remote patient monitoring, care-at-home platform operations, connected devices, patient engagement, telehealth, alarms, and EHR-integrated monitoring workflows | 4 official sources | Review profile |
| Huma Cloud Platform | Clinical operations and revenue cycle | Medium to high | AI-first health platform, remote patient monitoring, patient-flow apps, triage, clinical dashboards, AI agents, analytics, and regulated digital health application development | 3 official sources | Review profile |
| John Snow Labs Healthcare NLP | Clinical operations and revenue cycle | Medium to high | Clinical NLP, medical language models, de-identification, entity extraction, terminology mapping, document classification, summarization, and data curation from healthcare text | 3 official sources | Review profile |
| Hippocratic AI | Patient access, triage, and agents | Medium to high | Generative AI healthcare agents for outreach, access, post-discharge follow-up, remote patient monitoring adherence, inpatient nurse co-pilot, and operational patient conversations | 5 official sources | Review profile |
| Tucuvi | Patient access, triage, and agents | High | Clinical voice AI conversations, automated patient follow-up, care-plan monitoring, appointment rescheduling, medication inquiry routing, and clinician alert worklists | 5 official sources | Review profile |
| Infermedica | Patient access, triage, and agents | High | Symptom checking, preliminary symptom analysis, patient triage, and navigation APIs | 3 official sources | Review profile |
| Ubie | Patient access, triage, and agents | High | AI symptom checking, possible-cause reports, patient education, and care-seeking guidance | 4 official sources | Review profile |
| Hyro | Patient access, triage, and agents | Medium | Healthcare AI agents for call center automation, scheduling, patient support, and conversational intelligence | 3 official sources | Review profile |
| Infinitus | Patient access, triage, and agents | Medium to high | AI agents for healthcare calls, benefit verification, prior authorization follow-up, patient onboarding, affordability, adherence, and provider or payor outreach | 4 official sources | Review profile |
| Artera Harmony | Patient access, triage, and agents | Medium | AI-enabled patient communications, messaging orchestration, self-scheduling, intake, billing outreach, forms, and voice or text agents | 4 official sources | Review profile |
| Fabric | Patient access, triage, and agents | Medium to high | Care access platform for intake, triage, routing, virtual care, scheduling, and conversational AI | 3 official sources | Review profile |
| Corti | Patient access, triage, and agents | Medium to high | Healthcare AI agent framework, speech-to-text, coding support, documentation generation, and workflow-specific clinical agents | 3 official sources | Review profile |
| C the Signs | Patient access, triage, and agents | High | AI-supported cancer risk assessment, EHR-integrated pathway guidance, patient self-assessment, population scanning, and referral support | 6 official sources | Review profile |
| Sully.ai | Patient access, triage, and agents | Medium to high | AI healthcare agents for documentation, receptionist workflows, triage roles, medical coding, EHR-connected task automation, and developer-facing clinical-note APIs | 7 official sources | Review profile |
| Memora Health | Patient access, triage, and agents | Medium to high | AI-enabled care journeys, two-way texting, symptom management, patient-reported outcomes, check-ins, education, and escalation to care teams | 4 official sources | Review profile |
| Ada Health | Patient access, triage, and agents | High | AI-powered symptom assessment, care navigation, digital triage, clinical handover, and population insights | 4 official sources | Review profile |
| Mediktor | Patient access, triage, and agents | High | AI-based symptom assessment, digital triage, care routing, patient assistance, and LLM-enhanced medical-agent workflows | 5 official sources | Review profile |
| Luma Health Navigator | Patient access, triage, and agents | Medium to high | AI-powered patient self-service, appointment changes, refill requests, voice-to-SMS continuity, multilingual access, and operational AI workflows | 5 official sources | Review profile |
| Clearstep Smart Care Routing | Patient access, triage, and agents | High | AI chat and voice triage, symptom assessment, care navigation, scheduling handoff, and white-labeled digital front door routing | 5 official sources | Review profile |
| Fabric Health | Patient access, triage, and agents | Medium to high | AI assistant, conversational symptom checking, digital front door intake, triage and routing, virtual care handoff, scheduling, provider search, and care enablement workflows | 6 official sources | Review profile |
| Canary Speech | Patient access, triage, and agents | Medium to high | Voice biomarker platform and API for behavioral, cognitive, wellness, and safety signals from short speech samples or ambient listening workflows | 5 official sources | Review profile |
| Ellipsis Health | Patient access, triage, and agents | High | AI-supported depression and anxiety screening or monitoring from patient speech during care-management and telehealth workflows | 5 official sources | Review profile |
| Syllable Healthcare Agents | Patient access, triage, and agents | Medium to high | AI agents for appointment scheduling, patient verification, waitlist management, referral processing, call routing, outbound reminders, and EHR-connected patient workflows | 5 official sources | Review profile |
| Assort Health | Patient access, triage, and agents | Medium to high | Specialty-trained AI voice agents for patient calls, appointment scheduling, referral conversion, intake, eligibility, waitlists, care-gap outreach, and payment follow-up | 5 official sources | Review profile |
| Anima Health | Patient access, triage, and agents | Medium to high | Online consultation, care navigation, GP triage, appointment workflow, document processing, messaging, analytics, ambient scribing, and AI receptionist support | 5 official sources | Review profile |
| Limbic Access | Patient access, triage, and agents | High | Conversational mental health intake, assessment support, referral triage, risk-level summarization, and clinician-facing assessment reports | 7 official sources | Review profile |
| Wysa | Patient access, triage, and agents | High | AI-supported mental health coaching, digital front door workflows, structured assessments, human coach or medical-assistant escalation, and institution-sponsored support programs | 5 official sources | Review profile |
| Ellipsis Health Sage | Patient access, triage, and agents | High | Emotionally intelligent AI care-management voice agent, patient engagement outreach, enrollment calls, assessments and surveys, care coordination, adherence support, transitions-of-care check-ins, and speech-based behavioral-health signal review | 8 official sources | Review profile |
| Woebot Health | Patient access, triage, and agents | High | AI-supported mental health conversation, structured self-guided support, research-grade digital therapeutic development, and partner-sponsored behavioral health access | 6 official sources | Review profile |
| K Health | Patient access, triage, and agents | High | Clinical AI intake, symptom checking, patient-facing care navigation, draft chart preparation, EHR-connected virtual care, and clinician-facing recommendations for health-system primary care | 7 official sources | Review profile |
| MedAware | Medication safety and dosing | High | AI-powered medication safety monitoring, prescribing anomaly detection, adverse drug event prevention, opioid risk identification, and alert-burden reduction | 3 official sources | Review profile |
| DrFirst Clinical-Grade AI | Medication safety and dosing | Medium to high | Medication history cleanup, sig translation, medication reconciliation support, prescription data codification, and AI-assisted medication management workflows | 2 official sources | Review profile |
| DoseMeRx | Medication safety and dosing | High | Bayesian precision dosing, therapeutic drug monitoring, vancomycin AUC workflows, pharmacokinetic modeling, and individualized medication dose optimization | 4 official sources | Review profile |
| InsightRX Nova | Medication safety and dosing | High | Model-informed precision dosing, Bayesian PK/PD forecasting, therapeutic drug monitoring, EHR-connected dosing decision support, and clinical pharmacology analytics | 4 official sources | Review profile |
| Arine | Medication safety and dosing | Medium to high | AI-powered medication intelligence, comprehensive medication management, risk stratification, prescriber outreach, MTM workflows, adherence support, and high-risk member interventions | 5 official sources | Review profile |
| Bluesight Prism | Medication safety and dosing | Medium to high | Healthcare-specific AI assistant for hospital pharmacy and compliance workflows, including natural-language analysis of controlled-substance and behavioral diversion data | 4 official sources | Review profile |
| EveryDose Provider | Medication safety and dosing | Medium | Medication adherence monitoring, patient-specific medication reports, conversational patient-reported data capture, medication education, and EHR-connected care-team follow-up | 4 official sources | Review profile |
| DreaMed endo.digital | Medication safety and dosing | High | FDA-cleared diabetes clinical decision support for insulin treatment recommendations, glucose-device data review, remote diabetes management, and care-plan standardization | 4 official sources | Review profile |
| GenXys TreatGx | Medication safety and dosing | Medium to high | Precision prescribing clinical decision support using pharmacogenomic data, medication interactions, condition context, side-effect sorting, and patient-specific treatment options | 4 official sources | Review profile |
| FDB Meducation | Medication safety and dosing | Medium | AI-assisted patient medication instructions, simplified sig translation, multilingual labeling, bedside medication education, discharge education, and adherence support | 4 official sources | Review profile |
| AiCure | Medication safety and dosing | Medium to high | AI-powered medication adherence verification, patient engagement, digital biomarker capture, and remote trial monitoring through smartphone workflows | 5 official sources | Review profile |
| Medisafe Maestro | Medication safety and dosing | Medium | Predictive medication adherence support, personalized treatment journeys, smart reminders, patient education, engagement analytics, and omnichannel intervention orchestration | 3 official sources | Review profile |
| Synapse Medication Shield | Medication safety and dosing | Medium to high | AI-assisted pharmacovigilance case management, adverse drug event coding, MedDRA classification, severity prioritization, and prescribing safety support | 4 official sources | Review profile |
| RxLogix PV Signal | Medication safety and dosing | Medium to high | AI-powered pharmacovigilance signal detection, literature mining, safety database monitoring, workflow automation, audit trails, and regulatory-aligned risk management | 4 official sources | Review profile |
| ArisGlobal LifeSphere Safety | Medication safety and dosing | Medium to high | AI-forward pharmacovigilance platform for safety case intake, case processing, signal analytics, regulatory workflows, translation, and LifeSphere NavaX automation | 4 official sources | Review profile |
| Oracle Safety One Argus | Medication safety and dosing | Medium to high | AI- and machine-learning-supported pharmacovigilance platform for adverse-event case processing from intake through regulatory reporting | 3 official sources | Review profile |
| IQVIA Vigilance Detect | Medication safety and dosing | Medium to high | GenAI-powered pharmacovigilance event detection and extraction from emails, audio, documents, chats, and other safety intake sources | 3 official sources | Review profile |
| Veeva Vault Safety AI | Medication safety and dosing | Medium to high | Cloud pharmacovigilance system for adverse-event management, safety case processing, signal workflow, safety content, and Veeva AI for Safety capabilities | 3 official sources | Review profile |
| Prenosis Sepsis ImmunoScore | Precision medicine and data | High | FDA-authorized AI diagnostic and predictive sepsis risk assessment using EHR, vital-sign, demographic, laboratory, and biomarker inputs | 4 official sources | Review profile |
| Cytovale IntelliSep | Precision medicine and data | High | FDA-cleared host-response in vitro diagnostic test that uses image analysis and machine learning on white-blood-cell biophysical features to aid early sepsis detection and risk stratification in adult ED patients | 6 official sources | Review profile |
| Anumana ECG-AI | Precision medicine and data | High | FDA-cleared ECG-AI algorithms for identifying cardiovascular risk signals from standard 12-lead ECG workflows | 6 official sources | Review profile |
| Eko Health SENSORA | Precision medicine and data | High | FDA-cleared AI analysis of ECG and heart sounds from compatible Eko digital stethoscopes to flag atrial fibrillation, structural murmurs, low ejection fraction signals, and normal sinus rhythm for clinician review | 6 official sources | Review profile |
| AliveCor Kardia 12L | Precision medicine and data | High | FDA-cleared AI-powered handheld 12-lead resting ECG system for clinician-reviewed cardiac determinations using a simplified leadset | 6 official sources | Review profile |
| Philips Cardiologs Holter | Precision medicine and data | High | AI-assisted Holter and ambulatory ECG analysis for arrhythmia assessment, rhythm review, clinician annotation, report generation, and ECG workflow scaling | 6 official sources | Review profile |
| Tempus | Precision medicine and data | High | AI-enabled precision medicine, multimodal data, diagnostics, and clinical trial support | 5 official sources | Review profile |
| Tempus One | Precision medicine and data | High | Generative AI assistant for patient insight lookup, biomarker and report context, EHR workflow assistance, clinical trial search, documentation support, and multimodal research queries | 6 official sources | Review profile |
| SOPHiA GENETICS | Precision medicine and data | High | AI-powered genomic, radiomic, and multimodal data analysis through the SOPHiA DDM platform | 3 official sources | Review profile |
| Guardant InfinityAI | Precision medicine and data | High | AI-enabled precision oncology data exploration, cohort analysis, molecular pattern discovery, and real-world evidence workflows | 3 official sources | Review profile |
| ArteraAI Prostate | Precision medicine and data | High | AI-enabled digital pathology and clinical-data test for prostate cancer prognosis, therapy-benefit prediction, and treatment-intensity personalization | 5 official sources | Review profile |
| Avenda Unfold AI | Precision medicine and data | High | FDA-cleared AI decision-support software for prostate cancer mapping, lesion documentation, biopsy planning, and prostate treatment planning workflows | 6 official sources | Review profile |
| Unlearn | Precision medicine and data | High | AI-generated digital twins for clinical trial design, control-outcome forecasting, synthetic control comparisons, and statistical power planning | 4 official sources | Review profile |
| Owkin K Pro | Precision medicine and data | High | Agentic AI for biomedical research, multimodal patient data analysis, target prioritization, biomarker validation, and drug-development decisions | 3 official sources | Review profile |
| Caris Life Sciences | Precision medicine and data | High | AI-enabled molecular profiling, precision oncology insights, and tumor board reporting | 3 official sources | Review profile |
| Flatiron Assist | Precision medicine and data | High | EHR-integrated oncology clinical decision support, treatment pathways, biomarkers, trials, and prior authorization support | 2 official sources | Review profile |
| Truveta | Precision medicine and data | High | AI-supported real-world data analytics, cohort building, regulatory-grade evidence generation, and natural-language research assistance | 6 official sources | Review profile |
| Deep 6 AI | Precision medicine and data | High | AI-supported cohort discovery, clinical trial matching, protocol feasibility, patient identification, and real-world data extraction | 4 official sources | Review profile |
| Dyania Health Synapsis | Precision medicine and data | High | AI-assisted chart review, clinical trial screening, protocol matching, registry abstraction, and real-world data extraction from medical records | 4 official sources | Review profile |
| TriNetX | Precision medicine and data | High | Real-world data network, AI-supported cohort discovery, protocol feasibility, site identification, and clinical trial recruitment planning | 4 official sources | Review profile |
| Medidata AI | Precision medicine and data | High | AI-supported clinical trial planning, protocol optimization, trial risk monitoring, data quality workflows, synthetic control arms, and integrated evidence | 4 official sources | Review profile |
| ConcertAI | Precision medicine and data | High | Oncology-focused real-world data, generative and predictive AI, trial feasibility, trial screening, commercial insights, and care-quality analytics | 3 official sources | Review profile |
| Aetion Evidence Platform | Precision medicine and data | High | Real-world evidence generation, data preparation, cohort definition, causal analytics, regulatory-grade study workflows, and AI-assisted variable or subgroup work | 4 official sources | Review profile |
| nference nSights | Precision medicine and data | High | AI-assisted multimodal real-world data exploration, cohort analysis, clinical research insights, drug development support, and predictive model development | 4 official sources | Review profile |
| Dandelion Health | Precision medicine and data | High | Multimodal real-world data, clinical AI marketplace, algorithm validation, bias checks, and regulatory-grade evidence generation | 6 official sources | Review profile |
| KidneyIntelX.dkd | Precision medicine and data | High | FDA-authorized AI-enabled prognostic blood test for assessing risk of progressive kidney function decline in diabetic kidney disease | 5 official sources | Review profile |
| Healthy.io Minuteful Kidney | Precision medicine and data | High | FDA-cleared smartphone-powered home urine albumin-to-creatinine ratio testing with AI and computer-vision analysis | 5 official sources | Review profile |
| Roche Kidney Klinrisk Algorithm | Precision medicine and data | High | CE-marked AI-powered machine-learning algorithm for CKD progression risk stratification through the navify Algorithm Suite | 5 official sources | Review profile |
| Swift Medical | Medical imaging and radiology | High | AI-supported wound imaging, measurement, documentation, analytics, reimbursement documentation, and care-team coordination | 3 official sources | Review profile |
| Net Health Tissue Analytics | Medical imaging and radiology | High | AI-powered mobile wound imaging, segmentation, measurement, tissue classification, analytics, and EHR-integrated wound documentation | 2 official sources | Review profile |
| eKare inSight | Medical imaging and radiology | High | 3D wound imaging, measurement, tissue analysis, documentation, telehealth workflow, and wound healing analytics | 4 official sources | Review profile |
| Healthy.io Minuteful for Wound | Medical imaging and radiology | High | Smartphone-based wound scanning, 3D wound imaging, automatic measurement, tissue distribution, documentation, and remote review | 3 official sources | Review profile |
| MolecuLight | Medical imaging and radiology | High | Point-of-care fluorescence wound imaging, elevated bacterial-load detection support, wound measurement, and longitudinal wound monitoring | 3 official sources | Review profile |
| Spectral AI DeepView | Medical imaging and radiology | High | AI-enabled multispectral wound imaging for burn wound healing assessment and treatment-planning support | 3 official sources | Review profile |
| ModelOp Center | AI governance and monitoring | Medium to high | AI governance, model inventory, lifecycle automation, policy controls, validation evidence, and risk-based compliance for healthcare and life-sciences AI portfolios | 2 official sources | Review profile |
| Credo AI Platform | AI governance and monitoring | Medium to high | AI system registry, vendor registry, policy mapping, risk controls, evidence generation, and regulation-aligned governance workflows | 3 official sources | Review profile |
| Mendel Redact | AI governance and monitoring | Medium to high | AI-assisted de-identification of clinical documents, PHI redaction, medical-record preprocessing, and privacy-preserving data preparation for research or analytics | 4 official sources | Review profile |
| Fiddler AI Observability | AI governance and monitoring | Medium to high | AI observability, agent monitoring, drift detection, guardrails, explainability, PHI-leak detection, and auditable records for production AI systems | 3 official sources | Review profile |
| Arize AI Observability | AI governance and monitoring | Medium to high | LLM observability, evaluations, tracing, model monitoring, drift detection, prompt-level analysis, and production issue investigation | 2 official sources | Review profile |
| Monitaur | AI governance and monitoring | Medium to high | AI governance strategy, compliance management, model performance monitoring, validation protocols, transparency, and audit reporting | 2 official sources | Review profile |
| Saidot | AI governance and monitoring | Medium to high | AI system inventory, risk classification, policy templates, governance data reuse, EU AI Act support, and cross-functional compliance workflows | 2 official sources | Review profile |
| Chryso.ai | AI governance and monitoring | Medium to high | Healthcare AI compliance management, policy management, workforce training, control evidence collection, and AI agent monitoring | 2 official sources | Review profile |
| ALIGNMT AI | AI governance and monitoring | Medium to high | Healthcare AI governance, risk monitoring, fairness and validity assessment, AI report cards, compliance programs, and production risk mitigation | 4 official sources | Review profile |
| Risk Meridian | AI governance and monitoring | Medium to high | AI system inventory, structured risk reviews, governance controls, incident logging, disclosure generation, board reporting, and audit-ready evidence packs | 5 official sources | Review profile |
| Censinet RiskOps AI Governance | AI governance and monitoring | Medium to high | Healthcare AI governance, vendor AI exposure management, enterprise risk workflows, risk intelligence, benchmarking, assessment automation, and AI governance evidence collection | 4 official sources | Review profile |
| Trase OS | AI governance and monitoring | Medium to high | Governed healthcare AI agent runtime, policy enforcement, audit trails, agent-library deployment, custom agent development, third-party agent governance, and workflow automation oversight | 4 official sources | Review profile |
| ShadowIQ for Healthcare | AI governance and monitoring | Medium to high | Healthcare AI governance control plane for inline PHI redaction, BAA-aware model routing, policy enforcement, AI registry evidence, FDA SaMD lifecycle artifacts, and cryptographic audit trails | 6 official sources | Review profile |
| Harness.health | AI governance and monitoring | Medium to high | Clinical AI registry, quality monitoring, safety-event capture, compliance reporting, EHR integration, and health-system governance workflow | 3 official sources | Review profile |
| SAIGE | AI governance and monitoring | Medium to high | Healthcare AI inventory registration, risk monitoring, vendor collaboration, traceability, and policy-aligned governance workflow | 3 official sources | Review profile |
| Grid Health | AI governance and monitoring | Medium to high | Health-system AI visibility, performance monitoring, drift detection, adoption tracking, utilization review, cost alignment, and governance documentation | 3 official sources | Review profile |
| Asher Informatics | AI governance and monitoring | Medium to high | Healthcare AI governance management, service-line controls, AI monitoring, operational utility modeling, regulatory alignment, and multimodal AI oversight | 2 official sources | Review profile |
| Integral Privacy Engine | AI governance and monitoring | Medium to high | Privacy-preserving healthcare data preparation, HIPAA Expert Determination, PHI remediation, AI training-data pipelines, and defensible documentation for regulated data sharing | 5 official sources | Review profile |
| Cognome ExplainerAI | AI governance and monitoring | Medium to high | Explainable AI governance, predictive-model transparency, performance monitoring, bias analysis, drift monitoring, AI discovery, and Zero Trust-oriented AI inventory | 4 official sources | Review profile |
| Qualified Health | AI governance and monitoring | Medium to high | Healthcare-native enterprise AI platform for governed agent and workflow deployment, data integration, AI builder tools, monitoring, audit trails, education, and outcomes tracking | 5 official sources | Review profile |
| Caresyntax | Surgery and procedural intelligence | High | Connected operating-room integration, surgical video and device data capture, AI-powered multi-modal analytics, quality improvement, workflow optimization, and perioperative performance monitoring | 4 official sources | Review profile |
| Theator | Surgery and procedural intelligence | High | Surgical video capture, AI analysis, procedure mapping, operative-report support, quality review, training, and OR intelligence | 3 official sources | Review profile |
| Proximie | Surgery and procedural intelligence | High | Connected operating-room platform, remote collaboration, surgical video library, workflow orchestration, and AI-powered surgical intelligence | 2 official sources | Review profile |
| Medtronic Touch Surgery ecosystem | Surgery and procedural intelligence | High | AI-enabled surgical video management, postoperative review, performance assessment, education, and procedural insight workflows | 3 official sources | Review profile |
| Moon Surgical Maestro | Surgery and procedural intelligence | High | Collaborative robotic assistance, laparoscope control, intraoperative data capture, and procedure-level insights for minimally invasive surgery | 4 official sources | Review profile |
| Activ Surgical ActivSight | Surgery and procedural intelligence | High | Intraoperative surgical visualization, perfusion-related visual insight, AI-enabled case support, and augmented-reality surgical intelligence | 3 official sources | Review profile |
| Apella | Surgery and procedural intelligence | High | Ambient operating-room intelligence, real-time OR monitoring, automated case-event documentation, delay prediction, capacity optimization, and perioperative analytics | 4 official sources | Review profile |
| Surgical Safety Technologies OR Black Box | Surgery and procedural intelligence | High | AI-driven multimodal OR data capture, de-identified procedure review, safety analytics, quality improvement, team training, and operating-room performance insights | 3 official sources | Review profile |
| Cydar Maps | Surgery and procedural intelligence | High | AI-enhanced endovascular procedure planning, 3D surgical maps, intraoperative image guidance, automatic registration, volume assessment, and post-operative analysis | 4 official sources | Review profile |
| Asensus Intelligent Surgical Unit | Surgery and procedural intelligence | High | Augmented-intelligence support for robotic surgery, machine-vision camera control, digital tools, visual guidance, and procedure-data insights with the Senhance Surgical System | 4 official sources | Review profile |
| Proprio Paradigm | Surgery and procedural intelligence | High | AI-powered spine-surgery navigation, real-time 3D surgical guidance, light-field computer vision, intraoperative measurement, and structured surgical data capture | 5 official sources | Review profile |
| PathKeeper System | Surgery and procedural intelligence | High | AI-driven 3D optical spine navigation, preoperative CT-based planning, intraoperative registration, instrument tracking, and radiation-free pedicle-screw guidance workflow | 4 official sources | Review profile |
| ZEISS Surgery Optimizer | Surgery and procedural intelligence | High | AI-assisted cataract surgical video library, phase segmentation, case review, benchmarking, teaching, and performance-improvement workflow | 4 official sources | Review profile |
| SurgeryView.ai | Surgery and procedural intelligence | High | Post-procedure surgical video library, AI PII detection, phase segmentation, longitudinal analytics, benchmarking, case review, and training workflow | 4 official sources | Review profile |
| Stryker SurgiCount+ with Triton | Surgery and procedural intelligence | High | AI-assisted surgical blood-loss estimation, sponge counting, retained-sponge prevention workflow, EMR-connected charting, and perioperative hemorrhage response support | 4 official sources | Review profile |
| Intuitive da Vinci 5 Surgical Insights | Surgery and procedural intelligence | High | Robotic surgery platform software for real-time force visualization, intraoperative video replay, remote software updates, surgeon learning, and procedural analytics | 5 official sources | Review profile |
| TrackiMed | Surgery and procedural intelligence | High | Vision and voice AI for live OR item counting, instrument tracking, sponge and needle workflow support, voice documentation, usage analytics, and retained-item prevention | 2 official sources | Review profile |
| Osso VR | Surgery and procedural intelligence | Medium | Virtual reality procedural training, skill assessment, scenario-based onboarding, structured debriefing, learner dashboards, supervisor analytics, and surgical or nursing workflow rehearsal | 3 official sources | Review profile |
| Radformation AutoContour | Medical imaging and radiology | High | Deep-learning auto-contouring, organ-at-risk segmentation, treatment-planning structure generation, DICOM workflow integration, and radiation oncology planning acceleration | 4 official sources | Review profile |
| MIM Contour ProtegeAI | Medical imaging and radiology | High | AI auto-segmentation for radiation oncology contours, CT and MR structure generation, molecular radiotherapy contour support, and MIM workflow automation | 4 official sources | Review profile |
| Siemens Healthineers DirectORGANS | Medical imaging and radiology | High | CT-simulator-integrated AI autocontouring, organ-at-risk structure generation, optimized reconstruction, and radiation therapy simulation workflow support | 4 official sources | Review profile |
| MVision Contour+ | Medical imaging and radiology | High | AI-powered auto-contouring, guideline-based organ-at-risk and lymph-node segmentation, CT and MR contour templates, and treatment-planning workflow acceleration | 4 official sources | Review profile |
| TheraPanacea Annotate | Medical imaging and radiology | High | AI-enhanced contouring for organs-at-risk, lymph nodes, treatment-planning segmentation, batch contouring, and radiotherapy preparation workflows | 4 official sources | Review profile |
| Mirada DLCExpert | Medical imaging and radiology | High | Deep-learning contouring for organs-at-risk, zero-click autocontouring workflows, CT treatment-planning structures, and radiotherapy contour quality support | 4 official sources | Review profile |
| RayStation Deep Learning Segmentation | Medical imaging and radiology | High | Deep-learning organ segmentation inside RayStation, radiation therapy contour generation, automated planning support, and treatment-planning workflow consistency | 5 official sources | Review profile |
| GE HealthCare Critical Care Suite | Medical imaging and radiology | High | On-device chest X-ray AI for pneumothorax notification, worklist prioritization, image-quality checks, and endotracheal tube position measurement | 3 official sources | Review profile |
| Imbio Lung Density Analysis | Medical imaging and radiology | High | AI-assisted chest CT lung-density quantification, emphysema visualization, COPD component mapping, low-dose CT screening support, and patient LungMap reporting | 6 official sources | Review profile |
| icometrix icobrain | Medical imaging and radiology | High | FDA-cleared AI brain MRI quantification, longitudinal lesion and volume tracking, ARIA monitoring support, and disease-specific neurology imaging reports | 6 official sources | Review profile |
| Behold.ai red dot | Medical imaging and radiology | High | AI-assisted chest X-ray triage, high-confidence-normal rule-out workflows, suspected lung cancer prioritization, pneumothorax notification, and RIS/PACS worklist support | 6 official sources | Review profile |
| Biobeat Cuffless Blood Pressure Monitoring | Clinical operations and revenue cycle | Medium to high | Cuffless ambulatory blood pressure monitoring, wearable vital-sign collection, remote physiologic monitoring, early-warning review, hypertension assessment, and clinician-reviewed patient reports | 7 official sources | Review profile |
| Pieces Technologies | Clinical operations and revenue cycle | Medium to high | EHR-integrated inpatient AI for clinical summaries, progress-note drafting, handoffs, discharge planning, utilization-management review, and clinician-reviewed workflow automation | 6 official sources | Review profile |
| PreciseDx PreciseBreast | Digital pathology | High | AI-enabled digital pathology prognostic testing for early-stage invasive breast cancer recurrence risk using H&E whole-slide images and clinical factors | 5 official sources | Review profile |
| Lunit SCOPE | Digital pathology | High | AI-powered digital pathology analysis for tumor microenvironment profiling, IHC quantification, PD-L1 scoring support, genotype prediction research, and biomarker development workflows | 6 official sources | Review profile |
| Indica Labs HALO AP and HALO AP Dx | Digital pathology | High | AI-ready digital pathology case management, primary-diagnosis viewing where cleared, remote review, LIS/LIMS integration, clinical AI module deployment, and whole-slide-image quality or biomarker analysis workflows | 5 official sources | Review profile |
| Validic Impact | Clinical operations and revenue cycle | Medium to high | EHR-integrated remote patient monitoring, patient-generated health data normalization, connected-device logistics, clinical dashboards, alerts, and generative AI summaries for clinician review | 7 official sources | Review profile |
| Awell | Clinical operations and revenue cycle | Medium | Care-flow orchestration, AI-assisted workflow steps, form summarization, fax or message handling, patient outreach, protocol execution, and workflow analytics | 7 official sources | Review profile |
| b.well bailey | Patient access, triage, and agents | Medium to high | White-label conversational health assistant grounded in longitudinal health records, FHIR-connected data, claims, pharmacy, wearable, and care-navigation workflows | 5 official sources | Review profile |
| Welldoc BlueStar | Medication safety and dosing | High | FDA-cleared diabetes digital health support, AI-driven coaching, insulin-support workflows, cardiometabolic self-management, and clinician-reviewed patient reports | 6 official sources | Review profile |
| Ailva | Clinical evidence and questions | High | Clinical intelligence search, evidence-backed question answering, cross-specialty reasoning, citation verification, and clinician-reviewed reference support | 4 official sources | Review profile |
| Eolas Medical | Clinical evidence and questions | Medium to high | Healthcare knowledge management, guideline search, protocol access, retrieval-augmented AI answers, staff education, and content-use analytics | 5 official sources | Review profile |
| Aiberry | Patient access, triage, and agents | High | AI-supported mental health screening, bot-administered interview intake, depression-risk scoring, symptom insights, transcript review, and longitudinal monitoring for clinician or program review | 5 official sources | Review profile |
| Twill Mental Health Sequence | Patient access, triage, and agents | Medium to high | Configurable digital mental health sequence combining personalized self-guided tools, community, coaching, telebehavioral health, assessments, and clinician-trained AI guidance | 5 official sources | Review profile |
| Cognoa Canvas Dx | Patient access, triage, and agents | High | Prescription AI-based autism spectrum disorder diagnosis aid for children ages 18 to 72 months who are at risk for developmental delay and are evaluated by qualified healthcare providers | 8 official sources | Review profile |
| Sohar Health | Clinical operations and revenue cycle | Medium | AI-driven insurance discovery, eligibility verification, verification of benefits, real-time payer integration, and patient intake coverage checks | 6 official sources | Review profile |
| Adonis Intelligence | Clinical operations and revenue cycle | Medium | AI-supported revenue intelligence, denial trend detection, underpayment analysis, worklist prioritization, AR visibility, and RCM alerting | 5 official sources | Review profile |
| Plenful | Clinical operations and revenue cycle | Medium | AI workflow automation for pharmacy operations, 340B audit and optimization, rebate management, benefit verification, prior authorization, order intake, and operational dashboards | 4 official sources | Review profile |
| Innovaccer Gravity | Clinical operations and revenue cycle | High | Enterprise healthcare autonomy platform for unified data activation, AI agents, copilots, operational workflows, revenue-cycle automation, population health, care management, and AI governance | 5 official sources | Review profile |
| Anterior | Clinical operations and revenue cycle | High | Clinical AI for payer prior authorization and utilization-management workflows, including intake, chart retrieval, policy matching, medical-necessity review, determination-note drafting, FHIR conversion, and clinician escalation | 6 official sources | Review profile |
| SmarterNotes | Clinical documentation and scribes | Medium | AI-generated inpatient clinical notes that combine chart context, clinician editing, documentation completeness prompts, coding/CDI signals, and revenue-cycle intelligence | 5 official sources | Review profile |
| SamaCare | Clinical operations and revenue cycle | Medium to high | AI-native medical benefit prior authorization, policy intelligence, submission and follow-up automation, payer benchmarks, and human-in-the-loop access workflows for specialty therapies | 6 official sources | Review profile |
| Aiva Health | Patient access, triage, and agents | Medium to high | Conversational AI and voice assistant for patient requests, nurse workflow, EHR, room controls, education and smart-room administration | 4 official sources | Review profile |
| Sunoh.ai | Clinical documentation and scribes | Medium | Ambient medical scribe for visit transcripts, progress-note drafts, summaries, order-entry details, and approved-note sync into browser-based EHRs | 5 official sources | Review profile |
| Tandem Health | Clinical documentation and scribes | Medium to high | Regulated AI medical scribe and coding assistant for consultation capture, draft notes, related documents, clinical codes, and one-click transfer to medical record systems | 6 official sources | Review profile |
| Honey Health | Clinical operations and revenue cycle | Medium to high | AI back-office staff for EHR-based data fetching, pre-charting, orders, refills, fax triage, prior authorization, referrals, and revenue-cycle follow-up | 7 official sources | Review profile |
| Sword Health AI Care | Patient access, triage, and agents | Medium to high | AI-supported care platform for musculoskeletal pain, women's health, cardiometabolic health, mental health, care navigation, and clinician-supervised member engagement | 6 official sources | Review profile |
| Clairity Breast | Medical imaging and radiology | High | FDA-authorized AI risk prediction from bilateral screening mammograms to estimate five-year future breast cancer risk after radiologist interpretation | 6 official sources | Review profile |
| CancerIQ | Precision medicine and data | High | Digital cancer risk assessment, patient intake, hereditary cancer screening, genetic testing workflow support, patient navigation, and oncology innovation enrollment | 5 official sources | Review profile |
| Nanox.AI HealthCCSng | Medical imaging and radiology | High | FDA-cleared AI post-processing of routine non-gated, non-contrast CT studies to identify coronary artery calcium and add CAC scoring or category output to radiology and follow-up workflows | 4 official sources | Review profile |
| PeriGen PeriWatch Vigilance | Clinical operations and revenue cycle | High | AI-supported maternal-fetal early warning, fetal heart rate pattern interpretation, uterine contraction detection, labor-progress monitoring, and perinatal command-center surveillance | 7 official sources | Review profile |
| Nuvo INVU | Clinical operations and revenue cycle | High | FDA-cleared remote maternal-fetal monitoring with wearable sensor-band acquisition, cloud processing, patient and clinician applications, fetal heart rate, maternal heart rate, and uterine activity review | 5 official sources | Review profile |
| Spacelabs Rothman Index | Clinical operations and revenue cycle | High | FDA-cleared predictive analytics for inpatient patient deterioration surveillance, acuity scoring, early warning, rapid-response prioritization, and population-level monitoring | 5 official sources | Review profile |
| Azra AI | Clinical operations and revenue cycle | Medium to high | AI-powered oncology workflow automation, cancer patient identification, registry case finding, clinical research pre-screening, incidental finding follow-up, and closed-loop patient management | 6 official sources | Review profile |
| Clarify Meridian | Clinical operations and revenue cycle | Medium | AI-driven referral optimization, network intelligence, physician activation, patient activation, scheduling coordination, and closed-loop referral performance measurement | 5 official sources | Review profile |
| Freenome SimpleScreen CRC | Precision medicine and data | High | AI-enabled multiomics colorectal cancer screening workflow using a standard blood draw, clinical-lab processing, and health-system screening program partnership | 5 official sources | Review profile |
| GRAIL Galleri | Precision medicine and data | High | AI-enabled multi-cancer early detection blood test that analyzes cell-free DNA methylation patterns, returns cancer signal detected or not detected, and predicts a likely cancer signal origin for follow-up workup | 7 official sources | Review profile |
| Median eyonis LCS | Medical imaging and radiology | High | AI-enabled CADe/CADx software that analyzes low-dose CT lung cancer screening studies to help radiologists detect, localize, and characterize pulmonary nodules suspicious for malignancy | 5 official sources | Review profile |
| Teton AI | Clinical operations and revenue cycle | Medium to high | AI-enabled resident and patient monitoring that uses room sensors, anonymized computer vision, alerts, analytics, fall-risk workflows, automated rounding support, and care-team question answering | 5 official sources | Review profile |
| RapidClaims | Clinical operations and revenue cycle | Medium | Autonomous and human-reviewed AI agents for medical coding, CDI, payer-rule validation, denials, underpayment recovery, value-based care analytics, and revenue cycle management | 4 official sources | Review profile |
| Covera Health | Medical imaging and radiology | Medium to high | Clinical intelligence platform that applies AI-powered quality insights to radiology networks, diagnostic pathways, peer learning, patient outcomes, and value-based imaging programs | 4 official sources | Review profile |
| Bunkerhill Carebricks | Medical imaging and radiology | High | Generative workflow platform and FDA-cleared CT algorithms that surface actionable incidental findings such as coronary artery calcium, aortic valve calcification, abdominal aortic enlargement, mitral annular calcification, and low bone density for clinician review and care coordination | 7 official sources | Review profile |
| Riverain ClearRead CT | Medical imaging and radiology | High | Cardiothoracic CT AI suite for vessel suppression, pulmonary nodule detection and comparison, reporting support, coronary artery calcium scoring on ungated non-contrast chest CT, and research-use lung tissue analysis | 5 official sources | Review profile |
| Carenostics | Clinical operations and revenue cycle | Medium to high | AI administrative assistant for transplant teams that gathers outside records, extracts key findings, summarizes evaluation files, supports waitlist tracking, and clears below-license administrative work across the transplant journey | 4 official sources | Review profile |
| Rune Labs StrivePD | Precision medicine and data | High | FDA-cleared Apple Watch symptom-data collection, Parkinson's symptom and medication tracking, clinician dashboards, trial matching, and StrivePD Guardian AI companion support for between-visit care | 6 official sources | Review profile |
| Microsoft Healthcare Agent Service | Patient access, triage, and agents | Medium to high | Azure-based healthcare agent service for symptom-checker, triage, generative answers, scheduling, healthcare intelligence, and integration with customer data sources | 4 official sources | Review profile |
| Salesforce Agentforce for Healthcare | Patient access, triage, and agents | Medium to high | Agentic healthcare workflows for patient access, provider matching, eligibility, claims support, EHR-connected service, care coordination, public health, and administrative task automation | 5 official sources | Review profile |
| Google Cloud Agent Search for Healthcare | Precision medicine and data | High | Healthcare search app for FHIR R4 data and referenced unstructured files, with keyword search, natural-language queries, generative answers, citation indexes, and cloud deployment controls | 6 official sources | Review profile |
| AskTrip | Clinical evidence and questions | Medium to high | AI-powered clinical question answering inside Trip Database that helps users explore evidence, guidelines, reviews, and source-linked answers for clinical questions | 4 official sources | Review profile |
| Techcyte Fusion | Digital pathology | High | Unified digital pathology platform with AI-assisted workflows for anatomic pathology, clinical pathology, image management, custom AI tools, reporting, and LIS integration | 5 official sources | Review profile |
| Artisight Smart Operating Room | Surgery and procedural intelligence | High | Ambient OR intelligence for case progress tracking, predictive scheduling, RTLS-enabled coordination, procedural milestones, Epic-connected operative-note support, and performance analytics | 4 official sources | Review profile |
| Scopio Full-Field Digital Cell Morphology | Laboratory and hematology diagnostics | High | Full-field peripheral blood smear and bone marrow aspirate digital morphology with AI-powered decision support and remote review | 5 official sources | Review profile |
| Sysmex DI-60 | Laboratory and hematology diagnostics | High | Automated digital cell morphology and WBC differential pre-classification integrated with Sysmex hematology workflows | 4 official sources | Review profile |
| CellaVision DC-1 | Laboratory and hematology diagnostics | High | Single-slide digital morphology analyzer for blood cell differential review with automated image capture and cell pre-classification | 4 official sources | Review profile |
| Sight OLO | Laboratory and hematology diagnostics | High | Computer-vision-based complete blood count analyzer with 5-part leukocyte differential from venous or capillary whole blood | 4 official sources | Review profile |
| PixCell HemoScreen | Laboratory and hematology diagnostics | High | AI-assisted point-of-care complete blood count analyzer with 5-part differential from capillary or venous whole blood | 5 official sources | Review profile |
| Mindray MC-80 | Laboratory and hematology diagnostics | High | Automated digital blood cell morphology analysis with advanced algorithms for cell pre-classification, platelet-clump review, remote consultation, and high-throughput smear workflows | 4 official sources | Review profile |
| HORIBA Yumizen D20 | Laboratory and hematology diagnostics | High | Robotics- and AI-assisted digital morphology system for blood and urine sample digitization, pre-classified reports, and remote review | 3 official sources | Review profile |
| Noul miLab | Laboratory and hematology diagnostics | High | AI-powered microscopy platform for malaria detection, parasitemia quantification, blood count and morphology workflows, and compact diagnostic laboratory testing | 4 official sources | Review profile |
| SigTuple AI100 with Shonit | Laboratory and hematology diagnostics | High | AI-assisted automated microscopy for peripheral blood smear digitization, pre-classification, and professional review of blood cell images | 3 official sources | Review profile |
| CellaVision DM1200 and DM9600 | Laboratory and hematology diagnostics | High | Digital morphology systems for automated blood and body-fluid image capture, WBC/RBC pre-characterization, remote review, and hematology workflow standardization | 5 official sources | Review profile |
| Roche cobas m 511 | Laboratory and hematology diagnostics | High | Integrated hematology analyzer combining CBC, slide making, staining, digital cell imaging, morphology analysis, and professional review workflows | 3 official sources | Review profile |
| Copan PhenoMATRIX | Laboratory and hematology diagnostics | High | AI-assisted digital microbiology plate image assessment, culture sorting, colony feature analysis, LIS-linked rules, and WASPLab workflow support | 5 official sources | Review profile |
| BD Kiestra Urine Culture Application | Laboratory and hematology diagnostics | High | AI-developed microbiology imaging application for urine culture plate review, standardized digital images, worklist organization, and laboratory workflow efficiency | 4 official sources | Review profile |
| APAS Independence | Laboratory and hematology diagnostics | High | AI-enabled automated imaging, analysis, interpretation, and triage of agar culture plates for clinical microbiology and validated environmental-monitoring workflows | 6 official sources | Review profile |